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Cell adhesion to the extracellular matrix through cell-surface integrin receptors is 
essential to development, wound healing, and tissue remodeling and therefore represents 
a central theme in the design of bioactive surfaces that successfully interface with the 
body.  This is especially significant in the areas of integrative implant coatings and tissue 
engineering, since adhesion triggers signals that regulate cell cycle progression and 
differentiation in multiple cellular systems. 
This research project focuses on establishing a molecular strategy for engineering 
biomimetic surfaces that promote bone formation and osseointegration.  The objective is 
to engineer bioactive hybrid surfaces that support osteoblastic differentiation and promote 
osseointegration by targeting specific integrin receptors that are critical to osteoblast 
function.  The central hypothesis of this project is that the controlled presentation of type 
I collagen and fibronectin binding domains onto well-defined substrates will result in 
integrin-specific bioadhesive surfaces that support osteoblastic differentiation, matrix 
mineralization, and osseointegration. 
 We tested this central hypothesis by designing and characterizing a collagen-
mimetic peptide that specifically targets the α2β1 integrin by incorporating the necessary 
primary, secondary, and tertiary conformations.  The integrin α2β1 recognizes the 
glycine-phenylalanine-hydroxyproline-glycine-glutamate-arginine (GFOGER) motif in 
residues 502-507 of the α1[I] chain of type I collagen.  Integrin recognition is entirely 
dependent on the triple-helical conformation of the ligand similar to that of native 
collagen.  Our first study focuses on engineering α2β1-specific bioadhesive surfaces by 
 xxi
immobilizing our triple-helical collagen-mimetic peptide incorporating the GFOGER 
binding sequence onto model non-adhesive substrates. Circular dichroism spectroscopy 
verified that this peptide adopts a stable triple-helical conformation in solution.  Passively 
adsorbed GFOGER-peptide exhibited dose-dependent HT1080 cell adhesion and 
spreading comparable to that observed on type I collagen.  Subsequent antibody blocking 
conditions verified the involvement of integrin α2β1 in these adhesion events.  Focal 
adhesion formation was observed by immunofluorescent staining for α2β1 and vinculin 
on MC3T3-E1 cells.  Model functionalized surfaces were then engineered using three 
complementary peptide tethering schemes.  These peptide-functionalized substrates 
supported α2β1-mediated cell adhesion and focal adhesion assembly.  Our results 
demonstrate that this peptide is active in an immobilized conformation and may be 
applied as a surface modification agent to promote α2β1–specific cell adhesion.   
Several studies indicate that the α2β1 integrin interaction with type I collagen is a 
crucial signal for the induction of osteoblastic differentiation and matrix mineralization. 
Our next study demonstrates that the α2β1 integrin-specific GFOGER-peptide triggers the 
activation of focal adhesion kinase (FAK) and alkaline phosphatase in MC3T3-E1 
murine immature osteoblast-like cells - two proteins that have been implicated in the 
osteoblastic differentiation pathway.  These GFOGER-peptide surfaces also support the 
expression of multiple osteoblast-specific genes, including osteocalcin and bone 
sialoprotein, and induce calcification and matrix mineralization in a manner similar to 
type I collagen, suggesting that this triple-helical peptide represents a promising surface 
modification strategy for the design of collagen-mimetic bioadhesive surfaces that 
support osteoblastic differentiation and bone formation. 
 xxii
Implant osseointegration, defined as close bone apposition and functional 
fixation, is a prerequisite for clinical success in orthopaedic and dental applications, many 
of which are restricted by implant loosening.(Pilliar, 2005),(Anderson, 2001)  Our 
strategy to improve osseointegration of titanium implants focuses on presenting the 
GFOGER collagen-mimetic peptide that triggers α2β1 cellular integrin receptor binding, 
which is crucial for bone mineral deposition.  Titanium surfaces presenting integrin-
specific GFOGER-peptide trigger osteoblastic differentiation in primary rat bone marrow 
stromal cells, including bone-specific gene expression, alkaline phosphatase activity, and 
mineral deposition, leading enhanced osteoblastic function compared to unmodified 
orthopaedic-grade titanium.  Furthermore, this integrin-targeted surface coating 
significantly improved peri-implant bone regeneration and mechanical osseointegration 
compared to untreated titanium in a rat tibia cortical bone implant model.  Faster 
integration of these GFOGER coated implants would result in sooner and more reliable 
loading in a clinical setting, improving device function and patient outcomes.  This study 
establishes a simple, single-step biologically active implant coating that enhances bone 
repair and titanium implant integration for clinical orthopaedic and dental applications. 
The objective of our next study was to engineer bioactive hybrid surfaces that 
control cell function by mimicking integrin-ECM interactions.  We target two specific 
integrins essential to differentiation in several cell systems – the type I collagen (COL-I) 
receptor α2β1 and the fibronectin (FN) receptor α5β1 – by tethering varying densities of a 
collagen-mimetic peptide and a recombinant fragment of FN onto non-adhesive supports. 
The wide range of controlled mixed ligand densities generated by this process 
demonstrates the feasibility of generating integrin-specific hybrid surfaces. Results 
 xxiii
indicate increased cell adhesion and synergistic activation of FAK, which underscore the 
advantage of specifically targeting more than one integrin implicated in a particular 
signaling pathway and downstream cellular effect.  Proliferation rate results confirm that 
the enhanced signaling effects of mixed ligand surfaces translate to downstream cellular 
responses.  This study suggests that, instead of focusing on a single integrin-ligand 
interaction, in some cases it may be advantageous to consider the interplay of multiple 
integrins implicated in a desired cell response and their combined effect on downstream 
cellular signals. 
Extracellular matrix proteins are also attractive biomimetic targets for 
functionalizing orthopaedic implant surfaces in order to promote healing, bone formation, 
and implant fixation.  Again, we target two specific integrins essential to differentiation 
in osteoblast cells – the type I collagen (COL-I) receptor α2β1 and the fibronectin (FN) 
receptor α5β1 – using the GFOGER triple helical peptide and the recombinant FNIII7-10 
fibronectin fragment.  This final study compares the osseointegrative potential of these 
single-component integrin-specific peptides to a mixed surface treatment presenting both 
peptides.  We also examine the efficacy of the biomimetic integrin-targeted peptides 
compared to their native matrix proteins as implant coating treatments. 
The in vivo results indicate that either of the integrin-targeted peptide treatments 
is sufficient to improve bone formation and implant mechanical integration compared to 
unmodified titanium.  These biomimetic peptides also show improved osseointegration 
over the native matrix proteins, fibronectin and type I collagen.  However, the 
combination treatment of both biomimetic peptides did not confer any osseointegrative 
advantage over the single-component coatings. 
 xxiv
This thesis proposes a specific biomolecular strategy to engineer implant surfaces 
that enhance bone formation and osseointegration.  We designed and evaluated a collagen 
mimetic peptide as an α2β1 integrin-specific surface modification agent for biomaterials, 
implant surface treatments, and tissue engineering scaffolds.  This peptide was verified in 
the osteoblast cell model, but may be applied to several other cell systems that express 
α2β1, including platelets, epithelial cells, fibroblasts, chondrocytes, endothelial cells, and 
lymphocytes.  We also established the extent to which the presentation of multiple 
integrin-binding ligands synergize to enhance intracellular signaling.  This allows for the 
rational engineering of optimal biospecific surfaces for implant coatings and tissue 
engineering scaffolds.  Finally, by analyzing the osseointegrative properties of these 
bioinspired materials, we have established the potential of this biomimetic ligand 
approach as a beneficial surface treatment for orthopaedic implants.  As a whole, this 
project has established a targeted biomolecular surface engineering strategy for designing 
and optimizing biologically active implant coatings and grafting substrates that enhance 






Implant integration is critical to numerous orthopaedic replacement applications, 
many of which are limited by implant loosening and wear, especially in younger patients.  
Current implant surface technologies focus on porous coatings for bone ingrowth and 
bone-bonding ceramic coatings to promote integration with the surrounding bone and 
provide mechanical friction.  However, these approaches are restricted by inadequate 
cell-surface interactions leading to slow rates of osseointegration and poor mechanical 
integrity.  Therefore, developing biologically active osseous implant coatings should 
address the inadequate bone cell-material interactions that currently hinder existing 
technologies. 
Cell adhesion to the extracellular matrix through cell-surface integrin receptors is 
essential to development, wound healing, and tissue remodeling and therefore represents 
a central theme in the design of bioactive surfaces that successfully interface with the 
body.  This is especially significant in the areas of integrative implant coatings and tissue 
engineering, since adhesion triggers signals that regulate cell cycle progression and 
differentiation in multiple cellular systems. 
 This research project focuses on establishing a molecular strategy for engineering 
biomimetic surfaces that promote bone formation and osseointegration.  The objective is 
to engineer bioactive hybrid surfaces that support osteoblastic differentiation and 
promote osseointegration by targeting specific integrin receptors that are critical to 
osteoblast function.  The central hypothesis of this project is that the controlled 
 2
presentation of mixed type I collagen and fibronectin binding domains onto well-
defined substrates will result in integrin-specific bioadhesive surfaces that support 
osteoblastic differentiation, matrix mineralization, and osseointegration.  Binding of 
specific integrins to the extracellular matrix proteins fibronectin and type I collagen has 
been shown to induce differentiation and bone matrix mineralization in several 
osteoblastic cell models. 
Aim 1:  Engineer α2β1 integrin-specific surfaces that support cell adhesion and 
direct osteoblastic differentiation in vitro. 
 The working hypothesis is that a type I collagen-mimetic synthetic peptide of 
minimal recognition sequence can be grafted to a stable, non-adhesive substrate to 
produce biologically active, chemically well-defined surfaces that support α2β1-specific 
cell adhesion and direct osteoblastic differentiation.  A triple-helical collagen mimetic 
peptide will be designed to incorporate the central α2β1-binding domain from type I 
collagen.  Its bioadhesive activity will be characterized using several surface modification 
techniques, including passive adsorption, specific noncovalent surface interaction, and 
covalent immobilization. 
Aim 2:  Identify optimal surface densities of mixed fibronectin- and type I collagen-
mimetic ligands that promote osteoblastic differentiation and matrix mineralization. 
 The working hypothesis is that controlled presentation of mixed fibronectin- and 
type I collagen-mimetic ligands will support immature osteoblast cell adhesion, 
osteoblastic differentiation, and mineralization more effectively than single ligand or 
non-functionalized surfaces.  Model integrin-specific surfaces, such as mixed biotinylated 
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ligands on avidin substrates, will be used to screen a wide range of mixed surface 
formulations and identify optimal ligand densities for biomimetic implant coatings. 
Aim 3:  Evaluate the ability of integrin-specific biomimetic surfaces to improve 
osseointegration. 
 The working hypothesis is that biomimetic surfaces presenting mixed fibronectin 
and type I collagen ligands will exhibit enhanced osseointegrative properties compared 
with single ligand or unmodified implant surfaces.  Titanium implants will be 
functionalized with single and mixed biomimetic ligands.  Osseointegration will be 
evaluated in a rat tibia cortical bone model using quantitative histomorphometry and pull-
out mechanical testing. 
Project Significance 
 Orthopedic disorders, including non-union fractures and bone loss associated with 
trauma, joint replacements, and tumors, have a tremendous socioeconomic impact in the 
U.S. in terms of personal and occupational disability and related health care costs.  For 
example, over 713,000 joint arthoplasties, primarily hip and knee procedures in arthritic 
patients, at a cost of approximately $15 billion were performed in 2000.(American 
Academy of Orthopaedic Surgeons, 2000)  One of the most compelling factors that 
restrict current joint replacement applications is insufficient implant integration into the 
surrounding bone, resulting in implant loosening.  This often leads to patient discomfort, 
pain and ultimately revision surgery.  More importantly, the lifetime of these implants 
must increase as the number of younger patients needing joint replacements continues to 
steadily increase.(Arthritis Foundation and CDC, 1999)  Considerable efforts have 
focused on implant surface technologies that promote early integration into the 
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surrounding bone, particularly porous coatings for bone ingrowth and bone-bonding 
ceramic coatings.(Bauer and Schils, 1999b)  However, slow osseointegration and 
biological activity, particularly in terms of bone cell-materials interactions, severely 
hinder these current approaches.(Ducheyne and Cuckler, 1992)  With this project, we 
have established a specific biomolecular strategy to overcome these inadequate 
osteogenic cell-material interactions associated with current implant coatings.  The 
research is significant because it seeks to engineer biospecific surfaces targeting 
particular integrin receptors associated with cellular responses that are critical to 
osseointegration and bone repair.  Numerous bioadhesive surfaces have been designed 
to incorporate short cell binding sequences such as the fibronectin triplet RGD, which 
binds a variety of cell surface receptors.  However this project is fundamentally different 
in that its objective is to target two specific integrin receptors essential to osteoblast 
differentiation – the type I collagen receptor α2β1 and the fibronectin receptor α5β1 – by 
presenting peptides with specific secondary conformations and binding site orientations.  
This integrin-targeted biomolecular approach provides a versatile and robust 
strategy for developing bioactive surfaces that support osteoblastic differentiation 
and enhance bone repair.  Due to the fundamental character of the receptor-ligand 
principles addressed in this research project, these general engineering strategies can be 
applied to a variety of other cell systems in the body and may well contribute to the 
genesis of research projects that address medical concerns in areas other than orthopedic 







Bone Anatomy and Function 
 Bone tissue serves three primary functions in the human body (Yaszemski et al., 
1996b).  First, bone is the central calcium reservoir for the body, exchanging this mineral 
with the extracellular fluids to maintain tightly regulated ion homeostasis.  Second, the 
marrow cavities within bone supply hematopoietic and mesenchymal stem cells and 
infection-fighting white blood cells.  Finally, the third function of bone is its mechanical 
role as the structural support for the body and its vital organs and tissues as well as the 
skeletal anchor points for muscles, tendons, and ligaments that generate force and provide 
locomotion.  It is mainly this mechanical function of bone that drives the development of 
bone regeneration, transplantation, and fixation strategies in a wide variety of clinical 
settings.  The restoration of compromised mechanical integrity is a central requirement in 
a patient’s skeletal rehabilitation (Puleo and Nanci, 1999;Yaszemski, Payne, Hayes, 
Langer, and Mikos, 1996b).   
There are three groups of bones – short, flat, and long (Stewart, 1997).  Short 
bones, such as the tarsals, carpals, and vertebral bodies, have approximately the same 
dimensions in all directions.  Flat and long bones have one dimension that longer or 
shorter than the other two.  Long bones, such as femur and tibia, form extended cylinders 
with a flared structure at either end (epiphysis and metaphysis), flanking a thick-walled 
central region (diaphysis) (Yaszemski et al., 1996a).   
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Morphologically, the mature human skeleton consists of trabecular (cancellous) 
bone and cortical (compact) bone, each of which is defined by the spatial orientation of 
the mineral and by its characteristic locations in the body (Marks and Hermey, 
1996;Yaszemski, Payne, Hayes, Langer, and Mikos, 1996a;Buckwalter et al., 1995a).  
Cortical bone is denser than trabecular bone and consists of concentric lamellae of 
densely packed collagen fibrils.  This type of bone comprises the outer cylindrical shell 
of the long bones and the outer surfaces of the short and flat bones and generally provides 
the mechanical and protective functions of the bone tissue (Marks and Hermey, 1996).  
Trabecular bone has a loosely organized, porous structure, resembling open-celled foam 
and comprised of rods and plates.  It occurs near the ends of the long bones, the interior 
of short bones, and between the outer surfaces of flat bones (Yaszemski, Payne, Hayes, 
Langer, and Mikos, 1996a) and represents the primary site of bone’s metabolic functions 
(Marks and Hermey, 1996). 
Bone Cell Types and Functions 
 The cells within bone tissue have the unique capacity to heal fractures and defects 
without the formation of a fibrous scar tissue.  The four main cell types are osteoblasts, 
osteocytes, and bone-lining cells that originate from the mesenchymal stem-cell line and 
osteoclasts that originate from the hematopoietic stem-cell line (Marks and Hermey, 
1996).   
Osteoblasts are the differentiated cells responsible for the deposition and 
mineralization of the bone matrix at the tissue surface (Aubin and Liu, 1996).  The 
cytoplasmic processes of osteoblasts extend through the osteoid matrix to come into 
contact with osteocytes within the mineralized matrix (Buckwalter, Glimcher, Cooper, 
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and Recker, 1995a).  These specialized cell contacts may help to coordinate the activities 
of these two types of cells.  Systemic hormones, such as parathyroid hormone, and local 
cytokines also stimulate these osteoblasts to release mediators that activate osteoclasts in 
order to regulate skeletal homeostasis (Athanasou, 1996;Buckwalter, Glimcher, Cooper, 
and Recker, 1995a).  Active osteoblasts may follow one of three fates.  They may remain 
on the surface of the bone, decrease their synthetic activity, and assume the flatter form 
of bone-lining cells; they may surround themselves with matrix and become osteocytes; 
or they may disappear from the site of bone formation (Buckwalter, Glimcher, Cooper, 
and Recker, 1995a). 
Bone-lining cells, sometimes referred to as resting osteoblasts or surface 
osteocytes, sit directly on resting bone surfaces and have a flattened morphology (Marks 
and Hermey, 1996;Buckwalter, Glimcher, Cooper, and Recker, 1995a). In the presence of 
parathyroid hormone, these cells contract and secrete enzymes that remove the thin layer 
of osteoid that covers the mineralized matrix, permitting osteoclasts to attach to the 
surface begin resorption of bone (Buckwalter, Glimcher, Cooper, and Recker, 1995a). 
Through these and other actions, bone-lining cells may have a role in attracting 
osteoclasts to specific sites and in stimulating them to resorb bone. 
Comprising more than 90 percent of the bone cells in the human skeleton, 
osteocytes are mature osteoblasts that have become embedded in bone matrix and are 
responsible for tissue maintenance (Buckwalter, Glimcher, Cooper, and Recker, 1995a).  
Each osteocyte occupies a single lacunae within the matrix and extends long, branching 
cytoplasmic processes through the canaliculi to contact processes of adjacent cells 
(Marks and Hermey, 1996;Buckwalter, Glimcher, Cooper, and Recker, 1995a).  These 
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connections allow communication with neighboring osteocytes, the internal and external 
surfaces of the bone, and with blood vessels and also allow the bone cell network to sense 
deformation of the bone matrix and streaming potentials. 
Osteoclasts are large multi-nucleated cells that resorb bone through mineral 
dissolution and enzymatic digestion of the organic matrix (Marks and Hermey, 
1996;Athanasou, 1996;Buckwalter, Glimcher, Cooper, and Recker, 1995a).  They are 
characterized by plentiful mitochondria, which fill much of their cytoplasm to supply the 
energy that is required to resorb bone, and by the complex folding of their cytoplasmic 
membranes at the sites of bone matrix resorption.  Within these ruffled borders, 
membrane-bound proton pumps transport protons into the sealed space at the interface of 
the bone, decreasing the pH from approximately 7 to approximately 4.  This acidic pH 
solubilizes the bone mineral.  To degrade the remaining organic matrix, the osteoclasts 
secrete acid proteases. 
Bone Matrix 
 Bone is a composite material consisting of an organic and an inorganic 
component (Buckwalter, Glimcher, Cooper, and Recker, 1995a). The inorganic 
component contributes approximately 65 percent of the wet weight of the bone. The 
organic component usually contributes approximately 20 percent of the wet weight, and 
water contributes approximately 10 percent. The organic component, primarily collagen, 
gives bone its form and tensile strength, while the inorganic, or mineral, component 
primarily resists compression. 
 The organic matrix is composed mainly of collagens, particularly type I collagen.  
The remaining 10 percent of the organic matrix consists of non-collagenous 
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glycoproteins and bone-specific proteoglycans that may influence the organization of the 
matrix, the mineralization of the bone, and the behavior of the bone cells.  These proteins 
include osteocalcin, osteonectin, bone sialoprotein, bone phosphoproteins, and small 
proteoglycans. 
 The inorganic mineral phase of bone serves as an ion reservoir.  Approximately 
99 percent of the body’s calcium, approximately 85 percent of phosphorus, and between 
40 and 60 percent of sodium and magnesium are associated with the bone mineral 
crystals, which are the major source of these ions to and from the extracellular fluid 
(Buckwalter, Glimcher, Cooper, and Recker, 1995a).  The calcium-phosphate crystals 
(hydroxyapatite with both carbonate and acid phosphate substitutions) of the mineral 
phase also give bone much of its stiffness and strength. 
Bone Formation, Remodeling, and Healing 
 Bone formation can be first recognized when undifferentiated mesenchymal cells 
or preosteoblasts develop into osteoblasts and begin to secrete a specialized extracellular 
matrix (Buckwalter et al., 1995b).  As this matrix mineralizes, the osteoblasts that are 
surrounded by the resultant mineral become osteocytes.  Osteoclasts are then mobilized 
to begin the remodeling process that converts immature woven bone into mature, 
structurally sound lamellar bone. 
 This process of bone formation may occur within cartilage (enchondral 
ossification), within an organic matrix membrane (intramembranous ossification), or by 
deposition of new bone on existing bone (appositional bone formation) (Buckwalter, 
Glimcher, Cooper, and Recker, 1995b).   
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 Endochondral ossification is responsible for the formation of embryonic long 
bones and weight-bearing bones, such as vertebrae, and occurs via a preexisting 
cartilaginous template (Buckwalter, Glimcher, Cooper, and Recker, 1995b).  After the 
formation of hyaline or hyaline-like cartilage, the chondrocytes become hypertrophic and 
initiate calcification of the template.  These cells then become apoptotic triggering 
vascular buds to invade the cartilage and incomings cells to resorb portions of the 
cartilage, creating marrow cavities.  Osteoprogenitor cells invade the region and 
differentiate into osteoblasts, which form bone matrix on the mineralized cartilage.  
Osteoclasts then resorb the calcified cartilage and immature bone, and osteoblasts replace 
the mixture of calcified cartilage and immature bone with mature lamellar bone. 
 Intramembranous ossification leads to the development of flat bones, such as the 
skull, and occurs without the presence of a cartilaginous intermediate (Buckwalter, 
Glimcher, Cooper, and Recker, 1995b).  Instead this process is triggered by the 
aggregation of undifferentiated mesenchymal cells into layers or membranes.  These cells 
synthesize a loose organic matrix that often contains blood vessels, fibroblasts, and 
osteoprogenitor cells.  The osteoprogenitor cells differentiate into osteoblasts and initiate 
the assembly of osteoid (uncalcified bone matrix).  Trabecular bone and vascular 
structures then begin to form within this tissue.  As the trabecular bone fragments thicken 
they begin to fuse into continuous plates, and the irregular woven bone is replaced with 
structured lamellar bone. 
 Appositional bone formation occurs during periosteal enlargement of bones and 
during bone-modeling and remodeling (Buckwalter, Glimcher, Cooper, and Recker, 
1995b).  Unlike endochondral or intramembranous ossification, appositional formation 
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begins with the alignment of osteoblasts on an existing bone surface.  These cells then 
synthesize osteoid, often in successive layers that form bone lamellae. 
 After the initial ossification of the embryonic skeleton, osteoclasts and osteoblasts 
begin modeling and remodeling each bone (Marks and Hermey, 1996;Buckwalter, 
Glimcher, Cooper, and Recker, 1995b).  Bone remodeling is a highly coordinated balance 
between osteoclast resorption and osteoblast production, through a sequence of events 
that include osteoclast activation, resorption of bone, osteoblast activation, and formation 
of new bone at the site of resorption.   
 Bone modeling and remodeling can also be associated with bone implants, as 
more types of implants are developed and the use of these devices increases.  The 
stabilization of fracture-fixation devices, implants designed to correct skeletal deformity, 
and joint replacements to the underlying bone structure necessarily alters the loading 
pattern of the skeleton.  For instance, a stiff plate rigidly fixed to bone tends to unload the 
bone, leading to increased porosity of the cortex (Buckwalter, Glimcher, Cooper, and 
Recker, 1995b).  Adaptive modeling or remodeling also occurs in response to other types 
of implants, including joint replacements (Vasu et al., 1986). 
 A fracture to the bone disrupts skeletal continuity, mechanical function, and blood 
supply.  This triggers the process of fracture healing, which via distinct biological stages 
(Yaszemski, Payne, Hayes, Langer, and Mikos, 1996a).  The biological stages are 
inflammation, repair, and remodeling by which the defect heals through endochondral 
ossification.  The first event after trauma is the development of a haematoma and fibrin 
clot due to damaged blood vessels.  The clotting and inflammatory cascades proceed, 
with aggregated platelets releasing vasoactive mediators and growth factors.  Acute 
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inflammatory cells (polymorphonuclear leukocytes, macrophages) arrive at the site and 
remove the necrotic tissue.   
 The repair phase is marked by osteoblasts and osteoprogenitor cells infiltrating 
the defect site from the blood stream and marrow tissues (Yaszemski, Payne, Hayes, 
Langer, and Mikos, 1996a).  These cells secrete organic matrix which ossifies to form 
new woven bone.  This new material, consisting of osteoblasts, cartilaginous matrix, and 
woven bone, forms the fracture callous. 
 The third and longest biological stage in fracture healing is remodeling.  In this 
phase, the woven bone goes through several steps of resorption and deposition to form 
organized lamellar bone, in which the mineral and organic phases are optimally aligned 
to resist local stresses (Yaszemski, Payne, Hayes, Langer, and Mikos, 1996a). 
Bone-Anchored Implants 
 Over 700,000 joint arthroplasties and between 100,000 and 300,000 dental 
implant surgeries are performed each year in the United States to replace or regenerate 
function to damaged and diseased tissues at a cost of over $15 billion (Puleo and Nanci, 
1999),(American Academy of Orthopaedic Surgeons, )  Today many of these titanium 
implant-based surgeries and joint replacements are relatively successful, with restored 
function lasting over ten years in some cases.  However, implant loosening still remains 
one of the most compelling complications of all major joint arthroplasty and bone 
fixation surgeries, due to poorly optimized anchorage of the implant to the bone tissue 
(Puleo and Nanci, 1999). This often leads to patient discomfort, pain, and ultimately 
revision surgery, resulting in a significant socioeconomic impact in the U.S., in terms of 
both personal disability and health care costs.  More importantly, the lifetime of these 
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implants must increase as the number of younger patients needing joint replacements 
continues to steadily increase (Arthritis Foundation and CDC, 1999). In this clinical 
climate, advances in bone in-growth and osseointegration, by optimizing the bone-
implant interface, should improve the long term results of these procedures. 
Osseointegration 
 The goal of current orthopedic implantology is the design of devices that induce 
controlled, guided, and rapid healing and osseointegration.  Osseointegration is defined as 
the direct anchorage of an implant to bone through the formation of bony tissue around 
the implant without the growth of a fibrous capsule at the bone-implant interface 
(Branemark, 1996). 
 R. Branemark and R. Skalak have proposed a complete definition of 
osseointegration as the sum of definitions from various viewpoints as reproduced below 
(Branemark, 1996). 
 
1. From the viewpoint of the patient: 
An implant fixture is osseointegrated if it provides a stable and apparently 
immobile support of a prosthesis under functional loads, without pain, 
inflammation, or loosening over the lifetime of the patient. 
2. From the viewpoint of macro- and microscopic biology and medicine: 
Osseointegration of a fixture in bone is defined as the close apposition of new and 
reformed bone in congruency with the fixture, including surface irregularities, so 
that at light microscopic level there is no interpositioned connective or fibrous 
tissue and that a direct structural and functional connection is established, capable 
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of carrying normal physiological loads without excessive deformation and 
without initiating rejecting mechanisms. 
3. From a macroscopic, biomechanical point of view: 
A fixture is osseointegrated if there is no progressive relative motion between the 
fixture and the surrounding living bone and marrow under functional levels and 
types of loading for the entire life of the patient and exhibits deformations of the 
same order of magnitude as when the same loads are applied directly to the bone. 
4. From a microscopic biophysical point of view: 
Osseointegration implies that at light microscopic and electron microscopic 
levels, the identifiable components of tissue within a thin zone of a fixture surface 
are identified as normal bone and marrow constituents which continuously grade 
into a normal bone structure surrounding the fixture and that mineralized tissue is 
found to be in contact with the fixture surface over most of the surface within 
nanometers so that no functionally significant intervening material exists at the 
interface. 
 
 These outcomes allow for faster patient recuperation and stable fixation between 
the bone and the implant that would permit early or immediate loading of the device 
(Puleo and Nanci, 1999).  This has great potential in terms of decreased patient 
morbidity, improved patient psychology, and decreased healthcare costs.  Achieving 
these goals, however, requires an intimate understanding of the tissue healing events 
involves in a rigid orthopedic biomaterial implantation. 
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Host Response and Healing at the Bone-Implant Interface 
 The tissue response to implants surgically anchored in bone involves a cascade of 
cell and matrix events that ideally result in the intimate apposition of bone to the 
biomaterial (i.e. osseointegration).  Development of this interface is complex, involving 
numerous factors primarily at the bone-implant junction.  These disparate factors include 
implant material, shape, topography, and surface chemistry as well as mechanical 
loading, surgical technique, and patient bone quality (Puleo and Nanci, 1999;Boyan et al., 
1996;Kieswetter et al., 1996;Schwartz and Boyan, 1994). 
The surgical trauma associated with bone implantation is similar to that of a bone 
fracture previously described.  After implantation, a hematoma is formed, which initiates 
the clotting cascade.  Bone debris produced during drilling and implant fixation is 
deposited around the implantation site (Branemark, 1996), which will eventually be 
cleared by macrophages and multinucleated foreign body giant cells and/or covered by 
new bone (Sennerby et al., 1993).  Approximately three days after implantation of 
titanium implants, mesenchymal cells migrate from the bone marrow into the defect site 
and osteoblasts begin producing osteoid at the endosteal surface of the cortex (Sennerby, 
Thomsen, and Ericson, 1993).  Woven bone formation begins to occur after three to five 
days both at the implant, at the endosteal surface, and in the intermedullary canal 
(Branemark, 1996).  Thus bone formation occurs in two directions; healing bone 
approaches the biomaterial, and bone extends from the implant toward the healing bone 
(Puleo and Nanci, 1999).  In fact, fluorochrome labeling indicates that the bone extending 
away from the implant forms about 30 percent faster than the bone moving toward the 
implant (Puleo and Nanci, 1999).  This initial woven bone is gradually remodeled into 
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more mature compact lamellar bone, which is evident after three to four weeks 
(Branemark, 1996;Murai et al., 1996;Schwartz and Boyan, 1994).  Mature bone 
morphology is event at four to six weeks (Branemark, 1996;Murai, Takeshita, Ayukawa, 
Kiyoshima, Suetsugu, and Tanaka, 1996).  In most cases, around the seventh day, 
multinuclear foreign body giant cells are in direct contact with the implant and form a 
near continuous layer along the material surface (Sennerby, Thomsen, and Ericson, 
1993).  The number of these giant cells decreases with both time and increased bone-
implant contact.   
During this time, unfavorable conditions, such as excessive interfacial 
micromotion, will disrupt the newly forming tissue, leading to the formation of a fibrous 
capsule and poor osseointegration (Joos et al., 2006;Puleo and Nanci, 1999).  It is 
possible that the relative motion between the bone and the implant surface damages the 
initial fibrin network and vasculature that form during the early bone healing process.  
Thus the events are shifted from a normal healing process to repair by scar tissue (Joos, 
Wiesmann, Szuwart, and Meyer, 2006;Puleo and Nanci, 1999). 
This cascade of healing events around bone-anchored implants is similar to the 
sequence of fracture healing, but is modulated by the host response induced by implant 
shape, material, and surface properties (Joos, Wiesmann, Szuwart, and Meyer, 
2006;Branemark, 1996).  The process is also dependent on the quality of the tissue, with 
increased healing capacity for growing skeletal tissue and decreased healing capacity in 
older individuals (Joos, Wiesmann, Szuwart, and Meyer, 2006;Murai, Takeshita, 
Ayukawa, Kiyoshima, Suetsugu, and Tanaka, 1996;Roberts et al., 1984).  Variability in 
the host physiology is also a critical factor in the healing response, which is influenced by 
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nutrition, hormonal status, pharmaceutical history, immunology, or the presence of 
disease or infection (Schwartz and Boyan, 1994).  Finally the mechanical and physical 
stresses that are translated to the implant or the healing tissue can have a significant 
impact on the healing process as well as the remodeling and maturation of the initial 
osseous template (Schwartz and Boyan, 1994). 
Material Response at the Bone-Implant Interface 
 The first event that occurs upon implantation of metals, as with all biomaterials, is 
the adsorption of proteins from blood and tissue fluids at the wound site and later from 
cellular activity in the periprosthetic region (Puleo and Nanci, 1999;Horbett, 
1996;Horbett and Brash, 1987).  Once on the surface, these proteins can desorb, denature, 
or remain on the device to mediate tissue-biomaterial interactions by interacting with cell 
membrane receptors, such as integrins.  Other organic and inorganic moieties may also 
coat the device surface, including lipids, and ions (Kieswetter, Schwartz, Dean, and 
Boyan, 1996).  The catalogue of adsorbed proteins and other components initially present 
on an implant surface is highly dependent on surface characteristics, such as surface 
composition, roughness, topography, and surface energy, which collectively dictate the 
biological response to an implanted device (Kieswetter, Schwartz, Dean, and Boyan, 
1996). 
 In addition to protein adsorption, significant changes also occur in the materials 
surface.  While most implant biomaterials are chosen for their stable oxide layers, these 
metals may still undergo electrochemical changes in a physiological environment that 
increase the thickness of the oxide film (Puleo and Nanci, 1999).  Several studies have 
demonstrated that oxide films on pure titanium implants may grow as much a three times 
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thicker in human tissue (Puleo and Nanci, 1999).  These events may also result in the 
release of metal ions into the tissue that accumulate locally and, in some cases, spread 
systemically (Puleo and Nanci, 1999). 
Implant Material Selection 
 The vast majority of orthopedic implant materials are metals, metallic alloys, or 
metal composites, due to their bone-compatible biomaterial properties, such as tensile 
strength, stiffness, fracture toughness, and fatigue resistance (Muller et al., 2005b;Boyan, 
Hummert, Dean, and Schwartz, 1996).  Stainless steels are often used for fracture fixation 
devices, such as bone plates and screws and spinal rods, because of favorable mechanical 
properties and cost effectiveness compared to other metallic implant materials (Muller, 
Abke, Schnell, Macionczyk, Gbureck, Mehrl, Ruszczak, Kujat, Englert, Nerlich, and 
Angele, 2005b;Disegi and Eschbach, 2000).  Stainless steel bone screws are also 
desirable because, unlike titanium, the stainless steel allows the surgeon to feel the onset 
of plastic deformation and thus avoid overtorquing the device (Disegi and Eschbach, 
2000).  However, although stainless steel implants provide better biomechanical 
properties than cobalt or titanium alloys, their reduced corrosion resistance and 
biocompatibility limit their clinical applications (Muller, Abke, Schnell, Macionczyk, 
Gbureck, Mehrl, Ruszczak, Kujat, Englert, Nerlich, and Angele, 2005b). 
 Cobalt alloys (e.g. CoCrW, CoCrMo, etc.) are often chosen for implant materials 
because they are non-magnetic and wear, corrosion, and heat-resistant, exhibiting high 
strength even at elevated temperatures (Marti, 2000).  They are mainly used in orthopedic 
prostheses for the knee, hip, and shoulder, which are long-term implants that must meet 
extremely stringent requirements for biocompatibility and corrosion resistance.  
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However, these alloys are extremely difficult to fabricate and are limited to joint 
replacement devices in which their favorable material properties compensate for more 
demanding and costly manufacturing (Marti, 2000).  In other orthopedic applications, 
such as fracture fixation, the particular advantages of cobalt alloys are less effective in 
comparison with stainless steel and titanium. 
 Commercially pure titanium has been the most extensively used metal for 
osseointegrated implants, particularly in the fields of osteosynthesis, oral implantology, 
and in certain joint prosthetics (Pohler, 2000;Branemark, 1996).  In the presence of 
oxygen, an oxide layer is rapidly formed on the titanium surface, consisting mainly of 
TiO2.  This passive oxide film adheres closely to the bulk metal and is very dense, 
rendering titanium one of the most highly corrosion-resistant metals in existence, even in 
the demanding physiological environment.  The oxide layer forms near instantaneously 
after mechanical destruction and therefore no corrosion attach is evident under fretting 
conditions, such are relative motion between titanium screw heads and plate holes 
(Pohler, 2000).   
Titanium oxide also has a high dielectric constant, resulting in stronger van der 
Waals bonds on titanium oxide relative to other oxides (Branemark, 1996).  This may 
contribute to titanium’s excellent biocompatibility as evidenced by very favorable tissue 
responses and the absence of allergic reactions (Pohler, 2000).  Titanium is also well-
known for its impressive osseointegrative properties.  In orthopedic applications, bone 
cells and mineralized bone matrix are closely associated with titanium surfaces without 
interposition of other tissues (Pohler, 2000), making titanium the gold-standard for bulk 
orthopedic implant materials.   
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Titanium also exhibits a lower elastic modulus and greater flexibility than other 
orthopedic biomaterials (other than polymers).  In fact, the elastic deformation of 
titanium implants is much closer to that of bone, reducing local stress concentrations and 
avoiding the stress shielding phenomena common to stiffer metals that result in bone 
resorption (Pohler, 2000).  Titanium’s mechanical properties may also be modified within 
a certain range by choosing different titanium grades (different trace element profiles) 
and by work hardening.   
For applications in which greater strength is required, there are several suitable 
titanium alloys with improved strength and correspondingly more difficult manufacturing 
and processing procedures (Disegi, 2000).  The most commonly used titanium implant 
alloys in orthopedic applications are Ti-6Al-7Nb (TAN) and Ti-6Al-4V (TAV).  These 
applications include fracture fixation devices such as cannulated bone screws, 
intramedullary nails, spinal clamps, and stabilization plates. 
Implant Surface Technologies 
 A wide variety of approaches are currently being used in the ongoing effort to 
obtain an optimal bone-implant interface.  Because biological tissues mainly interact with 
the outermost atomic layers of an implant, many of these efforts focus on methods to 
modify existing biomaterial surfaces to achieve the desired biological response.  Surface 
modification approaches fall into three categories -  physicochemical, morphological, or 
biochemical (Puleo and Nanci, 1999). 
Physicochemical Methods 
 Physicochemical characteristics, such as surface energy, surface charge, and 
surface composition, have been altered in order to improve the relative strength with 
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which certain serum constituents interact with the surface.   This initial interaction 
between the host environment and the biomaterial can have significant downstream 
effects on cellular attachment and ultimately tissue response.  Tailoring the surface 
chemistry of an implant material to elicit favorable protein adsorption, cell adhesion, and 
matrix production has emerged as a powerful tool for improving bone cell differentiation 
and osseointegration (Keselowsky et al., 2005a;Boyan, Hummert, Dean, and Schwartz, 
1996;Schwartz and Boyan, 1994).  Our lab has demonstrated that integrin binding 
specificity for adsorbed fibronectin protein regulates the differential effects of biomaterial 
surface chemistry on osteoblast differentiation and mineralization (Keselowsky, Collard, 
and Garcia, 2005a). 
 Given the role of electrostatic interactions in many biological events, presenting 
charged surfaces has been proposed as a method to optimize tissue integration (Schwartz 
and Boyan, 1994).  Likewise, increased surface energy has also been shown to improve 
osteoblast differentiation on modified titanium surfaces (Zhao et al., 2005).  Glow 
discharge has also been used to alter charge density and increase surface energy in order 
to increase tissue adhesion to implant surfaces (Puleo and Nanci, 1999).   
Similarly, hydroxyapatite coatings have been investigated due to their chemical 
resemblance to native bone mineral and their ability to support rapid bone formation 
(Puleo and Nanci, 1999;Schwartz and Boyan, 1994).  It is hypothesized that this surface 
many present a favorable surface energy for binding serum proteins and growth factors 
that support bone growth (Schwartz and Boyan, 1994).   
Morphological Methods 
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 Modifications of surface roughness and topography have also been used to 
improve cell and tissue responses to implants.  Macro-porous coatings have been 
investigated based on the hypothesis that bone ingrowth would increase the stability and 
fixation of implants due to mechanical interlocking (Puleo and Nanci, 1999).  In general, 
the short- and intermediate-term clinical results have been satisfactory.  Based on 
retrieved porous components of joint replacements, implants are well-fixed, bone 
ingrowth is consistent, and osseointegration is enhanced, particularly in areas of rigid 
fixation and intimate apposition (Galante and Jacobs, 1992). However, a number of 
issues have emerged that may jeopardize the long-term success of porous-coated devices.  
These include femoral component subsidence, porous-surface delamination, endosteal 
bone loss, and proximal femoral atrophy (Galante and Jacobs, 1992).  Retrieval data also 
demonstrates that only a relatively small percentage of the available pore volume is filled 
with bone mineral (Puleo and Nanci, 1999). 
 While porous coatings exploit mechanical interlocking phenomena to improve 
implant stability, several in vivo and in vitro studies have focused on generating surfaces 
with rough microtopographies to improve osteoblast differentiation and bone formation 
(Lossdorfer et al., 2004;Boyan et al., 2003;Li et al., 2002;Martin et al., 1995;Groessner-
Schreiber and Tuan, 1992;Buser et al., 1991;Roberts, Smith, Zilberman, Mozsary, and 
Smith, 1984).  In vivo studies have demonstrated that rougher surfaces promote higher 
levels of bone formation and apposition compared to smoother surfaces (Buser, Schenk, 
Steinemann, Fiorellini, Fox, and Stich, 1991) and exhibit increased removal torque (Li, 
Ferguson, Beutler, Cochran, Sittig, Hirt, and Buser, 2002).  In vitro studies reveal that 
microrough implant surface topographies improve the phenotypic expression of 
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osteoblast-like cells (Martin, Schwartz, Hummert, Schraub, Simpson, Lankford, Jr., 
Dean, Cochran, and Boyan, 1995;Groessner-Schreiber and Tuan, 1992), promote the 
formation of an osteogenic microenvironment (Boyan, Lossdorfer, Wang, Zhao, 
Lohmann, Cochran, and Schwartz, 2003), and reduce osteoclast formation and activity 
(Lossdorfer, Schwartz, Wang, Lohmann, Turner, Wieland, Cochran, and Boyan, 2004).  
These results have lead to the development of several methods to produce rougher 
implant surfaces, including plasma-spraying, acid etching, and sandblasting as well as 
sintered-bead and metal fiber surfaces.  These surface roughness approaches not only 
improve mechanical interlocking and stability and enhance surface area for greater 
binding of attachment proteins and growth facts, but they also alter phenotypic 
expression in osteoblast (Schwartz and Boyan, 1994).  However, while these approaches 
are generally successful, they can be restricted by slow rates of osseointegration and poor 
mechanical anchorage in challenging clinical cases, such as those associated with large 
bone loss and poor bone quality (Bauer and Schils, 1999a). 
Biochemical Methods 
 Significant advances in understanding the role of biomolecules in regulating cell 
adhesion, differentiation, and tissue remodeling have led to the investigation of 
biochemical methods of surface modification.  These involve immobilizing proteins, 
peptides, enzymes, or growth factors onto biomaterial surfaces to induce specific cell and 
tissue responses.  The goal, in this case, is to control the tissue-implant integration with 
bioactive molecules delivered directly to the interface. 
Since the extracellular matrix controls both cell adhesion and function, recent 
biomimetic strategies have focused on the immobilization of matrix components, 
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including native structural proteins, (Bernhardt et al., 2005;Becker et al., 2002) peptide 
sequences, (Bernhardt, van den, Bierbaum, Beutner, Scharnweber, Jansen, Beckmann, 
and Worch, 2005;Elmengaard et al., 2005a;Elmengaard et al., 2005b;Alsberg et al., 
2002b;Ferris et al., 1999b) or synthetic derivatives based on matrix molecules (Lutolf and 
Hubbell, 2005).  The most common peptide-based strategy involves the surface 
deposition of peptides containing the Arg-Gly-Asp (RGD) sequence, which mediates cell 
attachment to several matrix proteins, including fibronectin, vitronectin, osteopontin, and 
bone sialoprotein.  However, these bio-inspired strategies have yielded marginal 
increases in implant integration and mechanical fixation.  Because RGD is recognized by 
a large number of integrins in numerous cell types, this approach lacks specificity for 
particular targeted integrin signaling and results in non-discriminatory attachment of cells 
to the RGD-coated surfaces.  Therefore, engineering peptides that specifically target 
integrin signaling cascades implicated in specific tissue responses, for example 
osteogenesis, would allow the optimization of surface coatings for enhanced integration 
and performance. 
Some groups are addressing this problem by using longer peptide derivatives or 
proteins that are more specifically associated with the bone environment, such as bone 
sialoprotein (Rezania et al., 1997), type I collagen (Muller, Abke, Schnell, Macionczyk, 
Gbureck, Mehrl, Ruszczak, Kujat, Englert, Nerlich, and Angele, 2005b;Becker, Geissler, 
Hempel, Bierbaum, Scharnweber, Worch, and Wenzel, 2002;Geissler et al., 2000),  or 
heparin-binding domains (Rezania and Healy, 1999;Dee et al., 1998).   
While cell adhesion molecules may improve initial bone-implant interactions and 
cell phenotype, growth factors have also been applied to implant surfaces in order to 
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improve bone formation.  For example, FGF-2 improves proliferation and TGF-β1 
enhances collagen synthesis (Puleo and Nanci, 1999).  Recently, bone morphogenetic 
proteins (BMPs) have proven effective in inducing osteogenesis in a wide variety of 
applications.  Several studies focus on combining immobilized peptides or matrix 
coatings BMPs to improve mineralization (Dee et al., 1996;Rutherford et al., 1992).  It is 
evident that biomimetic peptide and growth factor approaches have great potential for 
improving the rate and quality of new bone formation at an implant interface, although 
optimal delivery methods still remain elusive. 
Delivery of Biomolecules to the Tissue-Implant Interface 
Several factors must be considered in choosing a delivery method for these 
biomolecules.  The biomolecule must be present at the implantation site at or above some 
threshold concentration, and it must remain for a long enough period of time in order to 
initiate favorable cellular events (Puleo and Nanci, 1999).  To control levels of exposure 
and concentration, retention and/or release of biomolecules can be modified using 
methods such as adsorption, covalent immobilization, and release from coatings (Puleo 
and Nanci, 1999). 
The simplest way to delivery biomolecules to the tissue-implant interface is to 
adsorb from a protein solution prior to implantation.  Studies have shown that simple 
adsorption of TGF-b onto porous coatings can enhance bone ingrowth (Sumner et al., 
1995).  Similar approaches demonstrated that adsorbed alkaline phosphatase adsorbed on 
plasma-sprayed titanium improved periprosthetic bone formation (Piattelli et al., 1996).  
Clearly a major disadvantage with adsorption method is that it allows very little control 
over the delivery, including retention, release, and orientation of the biomolecules.  
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Certain biomolecules with stringent exposure, concentration, or conformation 
requirements may not be compatible with an adsorption delivery method.  However, 
positive responses to adsorbed surfaces have been observed and the simplicity of this 
approach is particularly attractive for clinical applications. 
Covalent tethering of biomolecules to implant surfaces is an alternative to passive 
adsorption for delivery to the tissue-implant interface.  However, in this case, the protein 
will not be released from the surface, which may be a disadvantage for certain growth 
factor approaches.  Also, for orthopedic and dental applications, metals are particularly 
deficient in functional groups necessary for immobilizing chemical species, with only 
oxide layers presenting anchoring sites.  For example, silanes have been covalently 
immobilized to implant materials through surface hydroxyl groups present on the 
passivating oxide film (Nanci et al., 1998;Puleo, 1997;Puleo, 1995).  Plasma treatments 
and self-assembled monolayers (SAMs) have been used to circumvent the lack of 
functional group diversity on implant metals.  Plasma treatments can increase the number 
of available hydroxyl groups as well as deposit reactive amino and carboxyl groups, 
offering versatility for protein tethering (Puleo and Nanci, 1999)  Studies have 
demonstrated that these plasma-deposited films are stable and effective for biomolecule 
immobilization (Morra and Cassinelli, 1997).  Similarly, stable SAMs can be formed by 
depositing alkanethiols with different terminal functional groups on gold substrates 
(Tanahashi and Matsuda, 1997;Mrksich et al., 1996).  However, deposition of gold and/or 
assembly of SAMs on the imperfect surfaces of polycrystalline implant metals have not 
been adequately explored.   
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Coatings that are impregnated with biomolecules are also being used to delivery 
biomolecules to the tissue-implant interface.  This approach is advantageous because it 
addresses the issues of exposure time and concentration in a more controlled manner.  
Coating materials for this application have included ethylene vinyl acetate (EVAc) 
(Walsh et al., 1995), poly(lactide-co-glycolide) (PLGA) (Agrawal et al., 1997), and 
collagen (Puleo, 1999).   
Experimental Models of Osseointegration 
 Several experimental models have been proposed for the mechanical evaluation of 
implant osseointegration.  These can be divided into four categories (Branemark, 1996): 
 
1. Push- or pull-out test of transcortically placed implants (Table 2.1) 
Transcortical implantations represent the simplest in vivo model in terms of surgical 
procedure and mechanical evaluation.  Due to their simplicity, these methods are used 
extensively in testing orthopaedic biomaterials. 
2. Push- or pull-out test of intramedullary placed implants (Table 2.2) 
Intramedullary implantations are clinically relevant models for joint replacement 
applications such as the total hip replacement. These models are also used for 
investigating the influence of cyclic loading. 
3. Removal torque of rotationally symmetrical implants (Table 2.3) 
Removal torque is often used to evaluate materials for fixation devices, such as bone 
screws, and relies on rotational symmetry of cylindrical, often threaded, implants. 
4. Misc. tests, including fracture mechanics 
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Push-out, pull-out, and torsion tests are essentially structural evaluations and only 
provide an apparent bond strength, obtained by dividing the load at failure by the 
interfacial area or area of bone apposition (if available).  More recently, a fracture 
mechanics approach was proposed to evaluate the interfacial strength in terms of fracture 
toughness (Wang et al., 1996).  This method measures the energy required to extend an 
interfacial crack and measures interfacial bonding strength in terms of an intrinsic 
fracture property.  
Several studies indicate that there is little value in comparing absolute results 
from different test setups, especially the push- or pull-out tests (Wang, Subramanian, 
Dhanda, and Agrawal, 1996;Shirazi-Adl et al., 1994;Dhert et al., 1992;Harrigan et al., 
1990).  In particular, differences in species, implantation site (e.g. cortex, trabecular 
bone, intramedullar), surgical technique (e.g. drilling/cooling methods, mode of 
insertion), loading conditions, and evaluation procedures all have profound effects on the 
removal load or shear stress measured in in vivo osseointegration models.  Specimen size 
and geometry are also important factors in interfacial strength testing (Wang, 
Subramanian, Dhanda, and Agrawal, 1996). 
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Table 2.1.  Push- or pull-out tests of transcortically placed implants* 
(? = conditions not clearly stated) 








Anderson et al 
(1984)(Anderson 
et al., 1984)66 





Porous 1.9 -27.1 
Bobyn et al 
(1980)(Bobyn et 
al., 1980)67 




powder coated Porous 
3.5 – 
17.2 
Boone et al 
(1989)(Boone et al., 
1989)68 




Porous 0.048 – 8.19 
Branemark et al 
(1995)(Branemark 
et al., 1998)69 
Dog 14 – 18 weeks Fresh Tibia Ti - 
78.64 – 
124.44 
Branemark et al 
(1997)(Branemark 
et al., 1997)70 
Rat 0, 2, 4, 8, 16 weeks Fresh Tibia Ti - 11 - 16 
Cook et al 
(1985)(Cook et al., 
1985)71 
Dog 12 weeks Fresh  Femur Co-Cr-Mo Porous 13.3 – 22.6 
Dhert et al 
(1991)(Dhert et al., 
1991)72 


































Klein et al 
(1991)(Klein et al., 
1991)73  
Dog 3 months Within 1 hour Femur 
Ti-6Al-4V, 
HA, TCP Rough 
9.7 - 
34.3 
Lee et al 
(2001)(Lee et al., 
2001)74 





Lee et al 
(2004)(Lee et al., 
2004)75 





Muller et al 
(2005)(Muller et 
al., 2005a)76 




Femur Ti-6Al-4V Open pores 
3.95 - 
20.49 
Thomas et al 
(1985)(Thomas et 
al., 1985)77 
Dog 12 - 24 weks 
Within 





* modified from Branemark,R. A biomechanical study of osseointegration: In-vivo measurements in rat, rabbit, dog, and 




Table 2.2.  Push- or pull-out tests of intramedullary placed implants 
(? = conditions not clearly stated) 











mow et al., 
1981) 
Rabbit 3, 12 weeks ? Femur Ti-6Al-4V Porous 3.53 - 8.64 
de Groot et 
al (1987)(de 
et al., 1987) 
Dog 
6 weeks, 
3, 6, 12 
months 




heyne et al., 
1977) 
Dog 8 weeks Frozen at -32ºC Femur 
Stainless 




han et al., 
1995) 
Rabbit 12 weeks Within 24 hours Femur Ti-6Al-4V 
Polished 
blasted 0.5 - 3.5 
Heck et al 
(1986)(Hec
k et al., 
1986) 
Dog 12 weeks Frozen Femur, tibia 
Ti-6Al-4V 
sintered 
with cp Ti 




ishi et al., 
1989) 




oole et al., 
2004) 
Rat 10, 20, 30 days Fresh Femur Ti 
Etched, BSP 
coated -  
Rivero et al 
(1988)(Rive
ro et al., 
1988) 
Dog 1, 2, 3, 6 weeks Frozen Humerus cp Ti Porous Fiber 0.75 - 2.75 
Wong et al 
(1995)(Won
g et al., 
1995) 





* modified from Branemark,R. A biomechanical study of osseointegration: In-vivo measurements in rat, rabbit, dog, and 




Table 2.3.  Removal torque tests on rotationally symmetrical implants 
(? = conditions not clearly stated) 




























edsen et al., 
1992) 






Sheep 14, 26, 45 weeks ? Femur cp Ti Plasma coating 
0.103 - 
17.24 
 Ivanoff et al 
(1996)(Ivano
ff et al., 
1996) 
Rabbit 6, 12 weeks In vivo Tibia cp Ti Machined 7.9 - 11.3 
* modified from Branemark,R. A biomechanical study of osseointegration: In-vivo measurements in rat, rabbit, dog, and 
man. 1-89. 1996. Goteborg University. Thesis/Dissertation. 
 
Cell Adhesion and Osteoblast Differentiation 
Cell adhesion to extracellular matrix (ECM) proteins controls complex biological 
processes such as development, wound healing, immune response, and tissue function 
through specific and dynamic regulation of cell behavior (Hynes, 2002).  Cell attachment 
to the ECM is primarily mediated by integrins, a widely expressed family of 
heterodimeric cell surface adhesion receptors consisting of non-covalently associated α 
and β subunits (Hynes, 2002).  In addition to anchoring cells and providing tissue 
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structure, integrins transmit intracellular signals that direct cell migration, proliferation, 
cell cycle progression, and differentiation (Nobes and Hall, 1999;Leng et al., 
1999;Sechler and Schwarzbauer, 1998;Zhu et al., 1996;Clark and Brugge, 
1995;Roskelley et al., 1994). Integrins thus function as the principal mediators of the 
molecular dialogue between a cell and its ECM environment. 
The interactions of osteoblasts with their surrounding ECM are essential for 
skeletal development and homeostasis and the maintenance of the mature osteoblastic 
phenotype (Xiao et al., 2002;Suzawa et al., 2002;Ikeuchi et al., 2002;Mizuno and 
Kuboki, 2001;Regazzoni et al., 2001;Tamura et al., 2001b;Mizuno et al., 2000;Xiao et 
al., 2000a;Jikko et al., 1999;Takeuchi et al., 1997b;Lynch et al., 1995).  During the early 
stages of differentiation, osteoblasts synthesize an ECM consisting primarily of type I 
collagen.  As matrix deposition progresses, the osteoblastic differentiation pathway is 
characterized by the activation of transcriptional pathways leading to the temporal 
expression of multiple proteins, including alkaline phosphatase, osteocalcin, and bone 
sialoprotein (Aubin and Liu, 1996;Stein et al., 1996).  The distinctive feature of the 
mature osteoblastic phenotype is their ability to induce the mineralization of the ECM 
(Aubin and Liu, 1996).   
Integrins are the central transducers of ECM signals that regulate this process of 
osteoblast commitment and differentiation.  The integrins α1β1 and α2β1 are the major 
collagen-binding integrins, with α1β1 having a higher affinity for the basement membrane 
type IV collagen and α2β1 having a higher affinity for the fibrillar type I collagen, the 
major protein constituent of bone (Tulla et al., 2001;Kapyla et al., 2000;Nykvist et al., 
2000).  In fact, the α2β1 integrin is highly expressed on osteoblast-like cells and is one of 
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the predominant adhesion receptors used by osteoblast-like cells to adhere to the collagen 
matrix (Gronthos et al., 1997).  Several studies indicate that the α2β1 integrin interaction 
with type I collagen is a crucial signal for the induction of osteoblastic differentiation and 
matrix mineralization (Suzawa, Tamura, Fukumoto, Miyazono, Fujita, Kato, and 
Takeuchi, 2002;Mizuno and Kuboki, 2001;Mizuno, Fujisawa, and Kuboki, 2000;Jikko, 
Harris, Chen, Mendrick, and Damsky, 1999;Xiao et al., 1998;Takeuchi et al., 1997a).  
For example, α2β1-mediated osteoblast adhesion to type I collagen activates 
Runx2/Cbfa1, a transcription factor that controls osteoblast differentiation and matrix 
mineralization (Xiao, Wang, Benson, Karsenty, and Franceschi, 1998;Takeuchi, Suzawa, 
Kikuchi, Nishida, Fujita, and Matsumoto, 1997a).  Furthermore, the collagen-α2β1 
integrin interaction has been shown to induce the osteoblastic phenotype in multipotent 
bone marrow cells (Mizuno and Kuboki, 2001;Mizuno, Fujisawa, and Kuboki, 2000).  
Integrin α2β1-mediated attachment to type I collagen stimulates the tyrosine 
phosphorylation of focal adhesion kinase (FAK) and subsequently the activation of 
extracellular signal-related kinase (ERK), a mitogen-activated protein kinase (MAPK) 
that has been implicated in the control of osteoblast-specific gene expression and matrix 
mineralization (Suzawa, Tamura, Fukumoto, Miyazono, Fujita, Kato, and Takeuchi, 
2002;Tamura, Takeuchi, Suzawa, Fukumoto, Kato, Miyazono, and Fujita, 2001b;Xiao et 
al., 2000b;Takeuchi, Suzawa, Kikuchi, Nishida, Fujita, and Matsumoto, 1997b).  
Disrupting the α2β1 integrin interaction with type I collagen using function-blocking 
antibodies blocks the expression of osteoblast-specific genes, such as osteocalcin, and 
inhibits calcification and formation of a mineralized matrix (Mizuno, Fujisawa, and 
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Kuboki, 2000;Jikko, Harris, Chen, Mendrick, and Damsky, 1999;Xiao, Wang, Benson, 
Karsenty, and Franceschi, 1998). 
 Osteoblasts and osteoprogenitor cells also express α5β1, the principal fibronectin 
receptor (Gronthos, Stewart, Graves, Hay, and Simmons, 1997).  Adhesive interactions 
involving α5β1 and fibronectin have also been identified as central to osteoblastic 
functions.  For example, using blocking antibodies in primary osteoblast cultures, 
Damsky and colleagues demonstrated that α5β1 integrin binding to fibronectin is essential 
to osteoblast survival, proliferation, osteoblast-specific gene expression, and matrix 
mineralization (Globus et al., 1998;Moursi et al., 1997a;Moursi et al., 1996). 
α2β1 Integrin and Type I Collagen Peptides 
The collagens constitute a family of abundant ECM molecules that contribute 
significantly to the integrity and mechanical properties of tissues such as bone, skin, 
cartilage, and tendon (Prockop and Kivirikko, 1995).  These structural proteins also play 
a fundamental role in promoting cell adhesion and mediating intracellular signals critical 
to tissue function (Heino, 2000;McCarthy et al., 1996).  Integrin-type collagen receptors, 
such as α1β1, α2β1, α3β1, α10β1, and α11β1, mediate cell adhesion to various collagen types 
and activate cytoplasmic signal transduction pathways (Broberg et al., 2001;McCarthy, 
Vachhani, and Iida, 1996).  In particular, integrin α2β1, the primary receptor for type I 
collagen, is abundantly expressed on platelets, epithelial cells, fibroblasts, osteoblasts, 
chondrocytes, endothelial cells, and lymphocytes (Heino, 2000).   
Collagen tertiary structure consists of three left-handed polyproline-like chains 
supercoiled in a right-handed helix about a common axis, yielding a characteristic triple 
helical coiled-coil (Lehninger et al., 1993).  The primary sequence of these polypeptide 
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units often consists of the repeating trimer (Gly-X-Y)n.  The strict sequence constraint of 
glycine at every third position is required for close packing at the interface of the three 
strands.  The X and Y positions of the repeat units are frequently occupied by proline and 
4-hydroxyproline, respectively.  These two imino acids further stabilize the triple helical 
structure by imparting a high degree of steric restriction on the local twisting of 
polypeptide chains.  The repeating 4-hydroxyproline non-standard imino acid also 
enables intramolecular hydrogen bonding. 
Using cyanogen bromide-derived collagen fragments and overlapping collagen 
model peptides, recent studies have proposed the hexapeptide sequence GFOGER from 
residues 502-507 of the α1(I) chain of type I collagen as a major binding locus for the 
α2β1 integrin (Knight et al., 2000;Knight et al., 1998;Morton et al., 1994).  These studies 
correlate with recent protein-mapping data that identifies the GFOGER sequence as 
residing in a major integrin-binding region of human type I collagen (Di Lullo et al., 
2002).  This hexapeptide sequence fully supported α2β1-dependent cell adhesion and 
exhibited divalent cation-dependent binding to isolated α2β1 and recombinant α2 I-
domain (Onley et al., 2000;Knight, Morton, Peachey, Tuckwell, Farndale, and Barnes, 
2000).  In addition, recognition of this sequence is entirely dependent upon the presence 
of a triple helical conformation, underscoring the crucial role of collagen’s tertiary 
structure in α2β1 integrin binding (Knight, Morton, Peachey, Tuckwell, Farndale, and 
Barnes, 2000;Messent et al., 1998;Morton et al., 1997;Morton, Peachey, Zijenah, 
Goodall, Humphries, and Barnes, 1994).  Recently, a triple helical model peptide 
containing the GFOGER adhesion motif was co-crystallized with the α2 I-domain, 
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verifying its association with the integrin’s metal ion-dependent adhesion site (MIDAS) 
(Emsley et al., 2000). 
Engineering Bioadhesive Surfaces 
Incorporating discrete cell adhesion motifs, such as the GFOGER hexapeptide, 
into bioactive materials and surfaces offers a robust strategy to enhance cell-material 
interactions and encourage biospecific cell adhesion (Hubbell, 1999).  Numerous cell 
adhesive surfaces have been designed to incorporate the RGD tripeptide sequence found 
in a wide variety of ECM proteins and recognized by a number of integrins, including 
αvβ3, and αIIbβ3 (Ruoslahti, 1996). Several critical factors limit the potential of this 
approach for bone repair.  First, the biological activity of short linear adhesive peptides is 
significantly lower than that of the native protein, due to conformation-dependent effects 
and the absence of additional functional domains (Akiyama et al., 1995;Aota et al., 
1994a).  More significantly, RGD peptides are limited by a lack of specificity for 
particular integrins and thus allow minimal control over cellular responses.  RGD also 
does not bind α5β1, a crucial receptor in osteoblast function.  α5β1-binding requires both 
the PHSRN sequence in the 9th type III repeat and the RGD motif in the 10th type III 
repeat of fibronectin (Aota, Nomizu, and Yamada, 1994a).  Due to the acute sensitivity of 
α5β1 to small perturbations in the orientation of these domains, the development of 
proper structural orientation using synthetic peptides remains a challenge.  Finally, 
osteogenic cells require signals from non RGD-binding integrins, particularly α2β1, for 
osteoblastic differentiation and matrix mineralization.  This study addresses these critical 
limitations by engineering surfaces that specifically target α2β1 and α5β1, using collagen- 
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and fibronectin-mimetic ligands with optimal secondary conformations and binding site 
orientations.   
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CHAPTER 3 
ENGINEERING INTEGRIN-SPECIFIC ADHESIVE SURFACES 
WITH A TRIPLE-HELICAL COLLAGEN-MIMETIC PEPTIDE* 
 
Summary 
 Integrin-mediated cell adhesion to extracellular matrix proteins anchors cells and 
triggers signals that direct cell function.  The integrin α2β1 recognizes the glycine-
phenylalanine-hydroxyproline-glycine-glutamate-arginine (GFOGER) motif in residues 
502-507 of the α1[I] chain of type I collagen.  Integrin recognition is entirely dependent 
on the triple-helical conformation of the ligand similar to that of native collagen.  This 
study focuses on engineering α2β1-specific bioadhesive surfaces by immobilizing a 
triple-helical collagen-mimetic peptide incorporating the GFOGER binding sequence 
onto model non-adhesive substrates. Circular dichroism spectroscopy verified that this 
peptide adopts a stable triple-helical conformation in solution.  Passively adsorbed 
GFOGER-peptide exhibited dose-dependent HT1080 cell adhesion and spreading 
comparable to that observed on type I collagen.  Subsequent antibody blocking 
conditions verified the involvement of integrin α2β1 in these adhesion events.  Focal 
adhesion formation was observed by immunofluorescent staining for α2β1 and vinculin 
on MC3T3-E1 cells.  Model functionalized surfaces were then engineered using three 
complementary peptide tethering schemes.  These peptide-functionalized substrates 
*Modified from Reyes,C.D. & Garcia,A.J. Engineering integrin-specific surfaces with a triple-
helical collagen- mimetic peptide. J. Biomed. Mater. Res. 65A, 511-523 (2003). 
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supported α2β1-mediated cell adhesion and focal adhesion assembly.  Our results suggest 
that this peptide is active in an immobilized conformation and may be applied as a 
surface modification agent to promote α2β1–specific cell adhesion.  Engineering surfaces 
that specifically target certain integrin-ligand interactions and signaling cascades 
provides a biomolecular strategy for optimizing cellular responses in biomaterials and 
tissue engineering applications.  
Introduction 
 Incorporating discrete cell adhesion motifs, such as the GFOGER hexapeptide, 
into bioactive materials and surfaces offers a robust strategy to enhance cell-material 
interactions and encourage biospecific cell adhesion (Hubbell, 1999).  Numerous cell 
adhesive surfaces have been designed to incorporate the RGD tripeptide sequence found 
in a wide variety of ECM proteins and recognized by a number of integrins, including 
α5β1, αvβ3, and αIIbβ3 (Ruoslahti, 1996).  Such surfaces are often limited by a lack of 
specificity for particular integrins and thus allow minimal control over cellular responses.  
The presentation of short sequences, such as RGD, may also result in the loss of full 
biological activity due to the absence of additional functional domains present in the 
native, three-dimensional structure of the ECM molecule (Danen et al., 1995;Aota, 
Nomizu, and Yamada, 1994a).  The goal of this study is to engineer stable bioadhesive 
surfaces that specifically target the α2β1 integrin, allowing us to directly control 
intracellular signaling and, ultimately, cell function.  We designed a stable triple-helical, 
collagen-mimetic peptide that contains the GFOGER adhesion motif from type I 
collagen.  This peptide specifically targets the α2β1 integrin receptor, and its cell adhesion 
activity is comparable to that of type I collagen.  We also demonstrate that the peptide is 
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active for three complementary immobilization schemes suggesting that this triple-helical 
peptide represents a robust and versatile approach to the design of collagen-mimetic 
bioadhesive surfaces that specifically target the α2β1 integrin.  Controlling specific 
integrin binding through this biomolecular strategy may provide a versatile approach to 
optimize cell function for applications such as biomaterials and tissue engineering 
scaffold design. 
Materials and Methods 
Cells and Reagents 
HT1080 human fibrosarcoma cells (CCL-121, American Type Culture Collection, 
Manassas, VA) were grown in Dulbecco’s Modified Eagle medium containing 10% fetal 
bovine serum and 1% penicillin-streptomycin.  MC3T3-E1 murine immature osteoblast-
like cells (RIKEN Cell Bank, Tokyo, Japan) were cultured in α-Modified Eagle Medium 
supplemented with 10% fetal bovine serum and 1% penicillin-streptomycin.  Both cell 
types were subcultured every two days using standard techniques. 
Goat anti-biotin antibody was obtained from Pierce (Rockford, IL).  Rabbit anti-
integrin β1 polyclonal antibody (AB1952) and adhesion-blocking mouse anti-human 
integrin alpha 2 monoclonal antibody (MAB1950Z) were purchased from Chemicon 
(Temecula, CA).  Alkaline phosphatase-conjugated donkey anti-goat IgG and anti-rabbit 
IgG were obtained from Jackson ImmunoResearch Laboratories (West Grove, PA).  
Alkaline phosphatase-conjugated monoclonal mouse anti-biotin IgG was ordered from 
Sigma (St. Louis, MO).  Mouse monoclonal anti-vinculin IgG was obtained from Upstate 
Biotechnology (Lake Placid, NY).  AlexaFluor 488 goat anti-rabbit and anti-mouse IgG 
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conjugates, rhodamine-phalloidin, and calcein-AM were purchased from Molecular 
Probes (Eugene, OR).  Bovine type I collagen (Vitrogen-100) was purchased from 
Cohesion (Palo Alto, CA).  All cross-linking and biotinylation reagents were obtained 
from Pierce.  Fetal bovine serum was purchased from Hyclone (Logan, UT).  Additional 
cell culture reagents were obtained from Invitrogen (Carlsbad, CA).  All other reagents 
were purchased from Sigma. 
Peptide Synthesis 
The peptide GGYGGGPC(GPP)5GFOGER(GPP)5GPC [O=hydroxyproline] was 
designed by C. D. Reyes and synthesized by the Emory University Microchemical 
Facility at the Winship Cancer Institute, Atlanta, GA.  The synthesis was performed on 
an Applied Biosystem 430A peptide synthesizer by stepwise solid-phase procedures on a 
t-Boc-L-Gly-PAM resin.  The t-Boc group was used for amino terminus protection.  The 
peptides were cleaved from the resin using hydrogen fluoride and redissolved in 0.1% 
trifluoroacetic acid (TFA).  The purity of the peptide was greater than 99% by analytical 
reverse-phase HPLC on an Applied Biosystems 130A microbore HPLC and mass 
spectrometry on a Bruker Model Protein-TOF MALDI mass spectrometer.  Peptide was 
supplied in the purified form as a TFA salt and reconstituted at a stock concentration of 
10 mg/ml in 0.1% TFA.  In some experiments, the peptide was diluted to 10 µg/ml in 
0.1%TFA for cross-linking to create a multimer as previously described(Morton et al., 
1995).  The heterobifunctional cross-linking reagent, 3-(2-pyridyldithio)propionic acid N-
hydroxysuccinimide ester (SPDP), was added to the peptide solution at a 1mM 
concentration.  The cross-linking reaction proceeded for 1 hour at room temperature. 
Circular Dichroism 
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Circular dichroism (CD) spectra and melting curves were recorded on a Jasco 
Model J-810 spectropolarimeter (Jasco, Easton, MD).  Peptide samples were prepared at 
a concentration of 0.33 mg/ml in Dulbecco’s phosphate buffered saline (DPBS).  Type I 
collagen samples were prepared at a concentration of 0.37 mg/ml in DPBS.  A quartz 
cuvette with a path length of 1 mm was filled with 200 µl of sample, and the temperature 
in the cuvette was controlled with a Peltier thermoelectric temperature controller.  For 
continuous wavelength scans, the data pitch was 0.1 nm and the scan speed was 100 
nm/min.  Data were recorded at 25 ºC.  For equilibrium melting transitions, the 
temperature in the cell was increased at a rate of 2 ºC/min and equilibrated for 1 min at 
each temperature before collecting a data point.  Data were recorded at a constant 
wavelength of 225 nm. 
Peptide Biotinylation 
For surface density measurements and immobilization, the peptide was 
biotinylated using a biotin-LC-PEO-amine reagent.  The terminal primary amine of this 
molecule selectively labels the terminal carboxyl group of the peptide.  The peptide and 
the biotin reagent were dissolved in 0.1 M N-morpholinoethane sulfonic acid (MES) 
buffer, pH 5.5.  A water soluble diimide, 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide 
hydrochloride (EDC), was added to the solution at 100 mg/ml to form an O-acylisourea 
intermediate on the peptide carboxyl which in turn reacts with amine of the biotin 
reagent.  The reaction was incubated for 2 hours at room temperature on a vortexer.  The 
sample was then dialyzed in DPBS without Ca2+/Mg2+ to remove any unreacted 
biotinylation reagent and EDC by-products from biotinylated peptide.  The final 
concentration of biotinylated peptide was determined by monitoring the 280 nm 
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absorbance on a Shimadzu UV-1601 UV-visible spectrophotometer (Shimadzu, 
Columbia, MD). 
Biotinylated Peptide Immobilization 
Tissue culture-treated polystyrene surfaces were incubated with goat anti-biotin 
antibody (1:50,000 dilution) or avidin (NeutrAvidin, 100 µg/ml, Pierce) for 1 hour at 
room temperature.  After washing, the surface was blocked with 1% heat denatured 
bovine serum albumin (BSA) for 1 hour to prevent non-specific protein adsorption.  
Varying concentrations of biotinylated peptide were then introduced to the surfaces for 1 
hour at room temperature, followed by blocking in 1% heat denatured BSA for 1 hour. 
Covalent Peptide Immobilization 
Tissue culture treated polystyrene surfaces were preadsorbed with 1% heat 
denatured BSA for 1 hour at room temperature.  The cross-linking agents N-
hydroxysulfosuccinimide (sulfo-NHS, 5 mM) and 1-ethyl-3-(3-
dimethylaminopropyl)carbodiimide (EDC, 2 mM) were dissolved in an activation buffer 
(0.1 M MES, 0.5 M NaCl, pH 6.0) and added to each BSA-coated surface for 15 minutes 
at room temperature.  Unreacted EDC was quenched with 20 mM 2-mercaptoethanol in 
activation buffer.  Following aspiration, peptide was introduced to the activated surfaces 
in varying concentrations for 2 hours at room temperature.  Unreacted sulfo-NHS was 
quenched with 20 mM glycine.  The surfaces were then blocked in 1% heat denatured 
BSA for 1 hour. 
Surface Density Measurements 
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Biotinylated peptide was adsorbed or immobilized onto a 96-well plate as 
previously described and blocked with blocking buffer (5% horse serum in DPBS) for 1 
hour.  The surfaces were then incubated in goat anti-biotin antibodies (1:50,000 dilution) 
for 1 hour at 37°C.  After washing, wells were incubated in alkaline phosphatase-
conjugated donkey anti-goat IgG (1:4000 dilution) for 1 hour at 37°C.  Substrate (4-
methyl-umbelliferyl-phosphate, 60 µg/ml) was then added for 1 hour at 37°C.  Reaction 
product fluorescence was measured in a microwell plate reader (360-nm excitation, 465-
nm emission).  Because BSA contains IgG that reacts with anti-goat IgG, the covalently 
immobilized peptide surfaces were probed with an alkaline phosphatase-conjugated 
mouse anti-biotin antibody (1:10,000 dilution).  All experiments were performed in 
triplicate.  
Cell Adhesion Assay 
Cell adhesion to modified surfaces was measured using a centrifugation assay that 
applies controlled detachment forces.  Tissue culture polystyrene 96-well plates were 
coated with peptide or cross-linked peptide diluted in 0.1% TFA or DPBS for 1 hour at 
room temperature or treated with the immobilization scheme described above.  
Additional control wells were coated with type I collagen in deionized water.  All wells 
were then blocked in 1% heat denatured BSA for 1 hour to prevent non-specific protein 
adsorption.  
Near-confluent HT1080 cells were loaded with 2 µg/ml calcein-AM (Molecular 
Probes), a membrane permeable green-fluorescent dye, detached using trypsin + EDTA, 
and resuspended serum-free in PBS + 2 mM dextrose.  Cells were seeded onto the 
substrates (10,000 cells/well) and allowed to attach for 1 hour at room temperature.  For 
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blocking experiments, cells were incubated in the presence of 1 µg/ml anti-human α2 
antibody.  Each well was then aspirated and refilled with PBS-dextrose for an initial 
fluorescence reading to determine the density of cells prior to detachment.  The plate was 
covered with sealing tape and centrifuged upside-down at the specified speed for 5 
minutes on a Beckman Allegra 6 centrifuge (GH 6.8 rotor) to detach the cells.  Again the 
wells were aspirated and refilled with PBS-dextrose for a post-spin fluorescence reading 
to determine the number of adherent cells.  Fluorescence data was obtained from a Perkin 
Elmer HTS 7000 Plus Bio Assay microwell plate reader (485 nm excitation, 535 nm 
emission).  The post-spin fluorescence data was normalized by the pre-spin data and 
plotted against ligand concentration to obtain adhesion profiles (fraction of adherent cells 
vs. coating concentration).  Adhesion profiles were fitted to the following 4-parameter 
sigmoidal curve to obtain estimates for the 50% detachment points (C50) using SigmaPlot 











The parameters fsat and b represent the maximum adhesive fraction and the slope of the 
curve at the inflection point, respectively.  The parameter C50 represents the concentration 
of protein/peptide required for 50% maximal adhesion and was used as a measure of 
adhesion strength to compare different surfaces.  All experiments were performed in 
triplicate. 
Immunofluorescent Staining for Focal Adhesions 
Substrates were prepared as described above and MC3T3-E1 cells were seeded at 
a density of 225 cells/mm2 in 0.1% serum for 6 hours.  Cells were then permeabilized in 
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ice-cold buffer (50 mM NaCl, 150 mM sucrose, 3 mM MgCl2, 50 mM Tris, pH 6.8) 
supplemented with 0.5% Triton X-100 and protease inhibitors (20 µg/ml aprotinin, 1 
µg/ml leupeptin, 2 mM phenylmethylsulfonyl fluoride) for 5 minutes to remove 
membranes and soluble non-cytoskeletal cytoplasmic components.  Detergent extracted 
cells were fixed in cold formaldehyde (3.7% in DPBS) for 5 minutes, blocked in blocking 
buffer (5% fetal bovine serum in DPBS) for 1 hour, and incubated with primary 
antibodies (anti-β1, anti-vinculin; 1:500 dilution) diluted in blocking buffer for 60 
minutes at room temperature.  Primary antibodies were visualized using AlexaFluor 488-
conjugated secondary antibodies (anti-rabbit IgG, anti-mouse IgG; 1:200 dilution) 
incubated for 1 hour and F-actin was simultaneously stained with rhodamine-phalloidin 
(1:200) diluted in DPBS.  Images were captured using a Nikon Eclipse E400 fluorescence 
microscope with a 60x objective and ImagePro Plus image acquisition software. 
Statistics 
Results were analyzed by one-way ANOVA using SYSTAT 8.0 (SPSS).  If 
treatment level differences were determined to be significant, pair-wise comparisons 
were performed with a Tukey post-hoc test.  A 95% confidence level was significant. 
Results 
The collagen-mimetic peptide used in these experiments has the following 
primary sequence: GGYGGGPC(GPP)5GFOGER(GPP)5GPC.  The GPP triplets on either 
side of the GFOGER recognition site provide cooperative clusters that promote the 
formation of a stable right-handed triple helical structure at room temperature (Knight, 
Morton, Peachey, Tuckwell, Farndale, and Barnes, 2000;Nagarajan et al., 1998;Fields 
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and Prockop, 1996).  This triple-helical conformation is essential for integrin recognition 
and α2β1-mediated cell adhesion(Messent, Tuckwell, Knauper, Humphries, Murphy, and 
Gavrilovic, 1998;Morton, Peachey, Knight, Farndale, and Barnes, 1997;Morton, Peachey, 
Zijenah, Goodall, Humphries, and Barnes, 1994).  The GPC triplets allow peptide 
polymerization, which is necessary to evaluate the effects of collagen’s quaternary 
structure on α2β1-mediated cell adhesion.  The tyrosine residue allows for future 
radiolabeling experiments.  
Circular Dichroism Spectroscopy 
CD spectroscopy was used to verify that the collagen-mimetic peptide adopts a 
triple helical conformation in solution.  The CD spectrum of the peptide exhibited the 
spectral features characteristic of a triple helix, including a small positive peak near 225 
nm, a crossover around 215 nm, and a large negative trough near 197 nm (Fig. 3.1.a) 
(Goodman et al., 1998;Fields and Prockop, 1996).  In addition, the peptide exhibited the 
same general spectral characteristics as a control sample of type I collagen, 
demonstrating that the peptide adopts a stable collagen-like triple helix in solution (Fig. 
3.1.b).  The thermal transition curve of the peptide (Fig. 3.2.a), obtained by monitoring 
the change in molar ellipticity at 225 nm, indicates a triple-helix ↔ random coil 
transition similar to that observed for type I collagen (Fig. 3.2.b).  The midpoint of the 
peptide’s folding transition (Tm) differs significantly from collagen’s Tm, which is to be 
expected given the considerable difference in size between the peptide and the full 
collagen protein.  This size difference may also explain the broadness of the peptide’s 
melting curve relative to the sharp, cooperative folding transition observed for type I 










































































Figure 3.1.  CD spectra of (a) GFOGER-peptide, 0.33 mg/ml, and (b) type I collagen, 










































































Figure 3.2.  Thermal transition curves for (a) GFOGER-peptide, 0.33 mg/ml, and (b) 
type I collagen, 0.37 mg/ml in DPBS at 225 nm. 
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melted or denatured triple helix with little or no residual structure for both the peptide 
and the control collagen sample.  These results demonstrate that the collagen-mimetic 
peptide has a stable triple helical structure at physiological temperature. 
Peptide Activity 
We initially examined the activity of the peptide passively adsorbed onto tissue-
culture treated polystyrene at varying concentrations.  An HT1080 human fibrosarcoma 
cell model was chosen because these cells adhere to type I collagen by a single 
mechanism involving the integrin α2β1 (Messent, Tuckwell, Knauper, Humphries, 
Murphy, and Gavrilovic, 1998;Ruggiero et al., 1996;Tuckwell et al., 1995;Weston et al., 
1994;Grenz et al., 1993;Cardarelli et al., 1992).  Cell adhesion was examined using a 
centrifugation assay in which the cells are seeded for 1 hour under serum-free conditions 
and then the substrate is centrifuged at 12g for 5 minutes to detach the cells.  As shown in 
Fig. 3.3, cells adhered to the adsorbed peptide in a density-dependent manner.  This 
adhesion was statistically comparable to that observed on the control type I collagen 
surfaces.  In addition, incubating cells on the adsorbed peptide surfaces with an anti-α2 
antibody completely blocked all adhesion above background indicating that the cell 
adhesion activity of this peptide is specific for the α2β1 integrin. 
Peptide Quaternary Structure 
Recent literature has shown that collagen’s quaternary structure (polymerized 
fibrils) as well as its tertiary triple helix is essential for platelet aggregation and implies 
that it may also be necessary for cell adhesion (Morton, Hargreaves, Farndale, Young, 
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Figure 3.3.  Dose-dependent HT1080 cell adhesion to adsorbed peptide and 
adsorbed type I collagen (1 hour cell adhesion, centrifugation at 12g for 5 min). 
Anti- α2 antibody blocking demonstrates specificity for the α2β1 integrin. (mean 
± standard error; three separate experiments in triplicate)  ANOVA: 
p<0.00000001;  Pairwise comparisons:  *peptide 10 µg/ml > peptide 2.5 µg/ml 
(p<0.04); †peptide 10 µg/ml > peptide 0.675 µg/ml (p<0.00002);  ‡peptide 10 
µg/ml > BSA (p<0.000007);  **peptide 2.5 µg/ml > peptide 0.675 µg/ml 




















Figure 3.4.  ELISA results for adsorbed peptide and polymerized peptide (1 hour 

























Figure 3.5.  HT1080 cell adhesion to adsorbed peptide, adsorbed polymerized 
peptide, and adsorbed type I collagen (1 hour cell adhesion, centrifugation at 12g 
for 5 min).  (mean ± standard error; three separate experiments in triplicate) 
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.  To further examine this issue, the GFOGER peptides were cross-linked to produce a 
polymeric or fibrillar network using SPDP, a heterobifunctional cross-linker that tethers a 
primary amine to the thiol in cysteine.  MALDI-TOF mass spectrometry verified that, 
prior to the addition of SPDP, the GFOGER peptide exists as a monomer in aqueous 
solution and does not undergo any appreciable disulfide bond formation (data not 
shown). 
To detect the peptide via a standard enzyme-linked immunosorbant assay 
(ELISA), the carboxyl terminus of the peptide was biotinylated using a polyethylene 
oxide (PEO) linker arm attached to a biotin group.  Surfaces were then probed with an 
anti-biotin antibody and amplified with a labeled secondary.  The results in Fig. 3.4 
verified that the relative peptide surface density can be controlled by varying the 
concentration of either the polymerized peptide or the peptide monomer in solution.  The 
difference between the two curves may be due to differences in the peptide adsorption 
profiles but may also be attributed to antibody accessibility.  These ELISA results 
demonstrate concentration-mediated control over the relative surface density of both the 
polymerized peptide and peptide monomer on the adsorbed surfaces. 
To investigate the importance of collagen’s quaternary structure in α2β1 integrin 
binding events, a centrifugation cell adhesion assay was used to compare the activity of 
the polymerized peptide to the peptide monomer. Cells exhibited concentration-
dependent adhesion profiles for both peptide systems, although adhesion to the 
polymerized peptide was significantly lower than adhesion to the peptide monomer 
surfaces and nearly half that of type I collagen (Fig. 3.5).  These differences most likely 
arise from differences in adsorbed density or recognition site accessibility.  Nevertheless,  
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this data demonstrates that collagen’s quaternary structure is not necessary for α2β1-
mediated cell adhesion. 
Effects of Adsorption Buffer on Peptide Activity 
An acidic buffer is preferable for peptide reconstitution and stabilization; however 
dilution in a buffer with a pH closer to neutral would optimize crosslinking and 
immobilization conditions, yielding greater reaction efficiency than an acidic 
environment.  Therefore ELISA and cell adhesion assays were used to evaluate the 
activity of the peptide diluted in two different buffers – 0.1% trifluoroacetic acid (TFA) 
in H2O and Dulbecco’s phosphate buffered saline (DPBS, pH 7.4) – to rule out loss of 
activity due to partial unfolding of the triple helix or to clumping and precipitation of the 
peptide.  ELISA results (Fig. 3.6) verify the concentration-dependent adsorption of the 
peptide under the two solvent conditions.  Similarly, the adhesion profiles shown in Fig. 
3.7 reveal an increase in cell adhesion with increasing peptide concentration,  
demonstrating that either solvent is conducive to the concentration-dependent cell 
adhesion activity of the peptide.  All subsequent experiments were performed in DPBS 
for convenience and reagent compatibility. 
Surface Immobilization Schemes 
We next designed three complementary schemes for tethering this peptide to a 
model surface to assess its activity in an immobilized conformation and ultimately its 
potential as a surface modification agent for biomaterials and tissue engineering 
applications (Fig. 3.8).  The first two immobilization schemes involve biotinylating the 
carboxyl terminus of the peptide using a PEO linker arm attached to a biotin group.  The 
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Figure 3.6.  ELISA results for peptide adsorbed in trifluoroacetic acid (TFA) and 
peptide adsorbed in phosphate buffered saline (PBS).  (mean ± standard error; two 
separate experiments in triplicate) 
Figure 3.7.  HT1080 cell adhesion to peptide adsorbed in trifluoroacetic acid 
(TFA) and peptide adsorbed in phosphate buffered saline (PBS) (1 hour cell 
adhesion, centrifugation at 12g for 5 min).  (mean ± standard error; three separate 
experiments in triplicate) 
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Figure 3.8.  Three complementary schemes for tethering the GFOGER peptide 
to a surface.  The first two immobilization schemes involve biotinylating the 
peptide and introducing it to surfaces treated with either adsorbed avidin or 
adsorbed anti-biotin antibody.  The third scheme involves covalently cross-
linking the peptide to passively adsorbed bovine serum albumin using the cross-
linking agents EDC ands sulfo-NHS.   
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or adsorbed anti-biotin antibody.  The third scheme involved covalently crosslinking the 
peptide to passively adsorbed bovine serum albumin using the crosslinking agents EDC 
ands sulfo-NHS.  The BSA provided a non-fouling, non-adhesive background surface 
with carboxylate anchoring groups for the peptide. 
1.  Antibody-Mediated Surface Immobilization 
To immobilize the peptide to an underlying surface, the carboxyl terminus of the 
peptide was biotinylated using a polyethylene oxide (PEO) linker arm attached to a biotin 
group, as previously described.  The biotinylated peptide was then introduced to surfaces 
treated with adsorbed anti-biotin antibody to exploit the specificity and integrity of 
antibody-antigen associations.  Fig. 3.9 shows that the biotinylated peptide promotes 
concentration-dependent cell adhesion on anti-biotin coated surfaces.  Although this 
adhesion is slightly lower than that observed on control type I collagen and adsorbed 
peptide surfaces, results demonstrate peptide activity in this immobilized conformation. 
2.  Avidin Surface Immobilization 
To complement the antibody surface immobilization results, the biotinylated 
peptide was also introduced to surfaces treated with adsorbed NeutrAvidin™ biotin-
binding protein, a commercially available deglycosylated avidin derivative with 
exceptionally low nonspecific binding properties.  The avidin-biotin interaction was 
chosen to demonstrate peptide immobilization because it represents the strongest known 
noncovalent biological recognition between protein and ligand (Ka=1015 M-1).  In 
addition, the bond formation between biotin and avidin occurs very rapidly.  Once 
formed, it is unaffected by most extremes of pH, organic solvents, and other denaturing 























Adsorbed Type I Collagen
Adsorbed Peptide
Figure 3.9.  HT1080 cell adhesion to antibody immobilized peptide, adsorbed 
peptide, and adsorbed type I collagen (1 hour cell adhesion, centrifugation at 
12g for 5 min).  (mean ± standard error; three separate experiments in 
triplicate) 
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reversible.  Cell adhesion results showed that the biotinylated peptide also promotes 
concentration-dependent cell adhesion on the avidin-coated surfaces (Fig. 3.10).  This 
adhesion was comparable, although slightly lower, than that observed on control type I 
collagen and adsorbed peptide surfaces.  To demonstrate that this cell adhesion activity is 
a consequence of the peptide immobilization treatment and not a result of non-specific 
peptide adsorption, the experiment was repeated with non-biotinylated peptide.  As 
shown in Fig. 3.10, eliminating the peptide immobilization potential completely 
eliminated all cell adhesion, indicating that the previously observed peptide activity was a 
direct result of this particular immobilization treatment.  In addition, incubating cells on 
the avidin-immobilized peptide surfaces with an anti-α2 antibody completely blocked all 
adhesion above background demonstrating that the cell adhesion activity of the 
immobilized peptide is specific for the α2β1 integrin. 
3.  Covalent Surface Immobilization 
Covalent surface modification remains the most promising technique for 
immobilizing bioactive ligands such as the GFOGER-peptide.  The third immobilization 
scheme evaluated in this study involved covalently tethering the peptide to passively 
adsorbed bovine serum albumin (BSA) using a sequential coupling reaction with the 
cross-linking agents EDC and sulfo-NHS (Grabarek and Gergely, 1990;Staros et al., 
1986).  The EDC reacts with carboxyl groups on the BSA surface to form an intermediate 
that is unstable in aqueous solutions unless stabilized by sulfo-NHS.  This sulfo-NHS 
reaction results in an amine reactive NHS ester that subsequently couples with the 
GFOGER peptide, immobilizing it to the underlying BSA layer.  The BSA provides a 
non-fouling, non-adhesive background surface with carboxylate anchoring groups for the  
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Figure 3.10.  HT1080 cell adhesion to NeutrAvidin immobilized peptide.  The 
two positive controls are adsorbed peptide and adsorbed type I collagen.  The 
negative control is a surface treated non-biotinylated peptide.  Anti- α2
antibody blocking demonstrates specificity for the α2β1 integrin.  (1 hour cell 
adhesion, centrifugation at 12g for 5 min).  (mean ± standard error; three 
separate experiments in triplicate)  ANOVA of C50 values: p<0.0000001; 
NeutrAvidin > antibody blocking (p<0.000008); NeutrAvidin > NeutrAvidin 
w/o biotin (p<0.000008); adsorbed peptide > NeutrAvidin (p<0.001); adsorbed 
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peptide.  A centrifugation cell adhesion assay was used to assess the activity of this 
covalently immobilized peptide layer.  The two positive controls were adsorbed peptide 
and adsorbed type I collagen.  The negative control treatment was a surface treated with 
BSA and peptide as in the standard covalent immobilization scheme, except that both 
cross-linkers were omitted.  Fig. 3.11 demonstrates that cell adhesion to the immobilized 
peptide was nearly five fold that of the negative control treatment and the adhesion 
profile was similar to that of adsorbed peptide and collagen, although somewhat reduced.  
This reduction in cell adhesion on the immobilized peptide surface could be due to 
differences in peptide density based on the efficiency of the crosslinking reaction.  To 
assess possible differences in peptide surface density, an ELISA assay was performed on 
surfaces treated with the covalently immobilization scheme.  The results in Fig. 3.12 
reveal a 6-fold lower density of peptide on these surfaces compared with adsorbed 
peptide.  Given that the cell adhesion to the covalently immobilized peptide was only 
about half of the adhesion observed on the adsorbed peptide surfaces, these ELISA 
results suggest that the peptide is nearly three times more active in the immobilized 
conformation compared with passive absorption.  In addition, incubating cells on the 
covalently immobilized peptide surfaces with an anti-α2 antibody completely blocked all 
adhesion above background demonstrating that this cell adhesion activity is specific for 
the α2β1 integrin (Fig. 3.11). 
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Figure 3.11.  HT1080 cell adhesion to covalently immobilized peptide.  The 
two positive controls are adsorbed peptide and adsorbed type I collagen.  The 
negative control treatment is a surface treated without the addition of cross-
linking agents.  Anti-α2 antibody blocking demonstrates specificity for the 
α2β1 integrin.  (1 hour cell adhesion, centrifugation at 12g for 5 min).  (mean ± 
standard error; three separate experiments in triplicate)  ANOVA of C50 values: 
p<0.003;  covalently immobilized peptide > negative control (p<0.02); 
covalently immobilized peptide > antibody blocking (p<0.02); adsorbed 
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Figure 3.12.  ELISA results for covalently immobilized peptide and adsorbed 
peptide.  (mean ± standard error; two separate experiments in triplicate) 
Conc., µg/ml


















Immunofluorescent Staining for Focal Adhesions 
MC3T3-E1 murine immature osteoblast-like cells were seeded onto covalently 
immobilized peptide surfaces, adsorbed peptide surfaces, and control type I collagen 
surfaces for 6 hours in 0.1% serum to promote the formation of mature integrin-mediated 
focal adhesions.  The cells were then extracted, fixed, and stained for α2β1 integrin 
subunits and vinculin, an intracellular structural protein that localizes to focal adhesion 
plaques.  These cells were selected because they assemble robust integrin-containing 
focal adhesion plaques characterized by clustered integrin components and intracellular 
structural and signaling proteins attached to the actin cytoskeleton (Stephansson et al., 
2002;Tamura et al., 2001a).  These cells also exhibited collagen-like adhesion profiles on 
GFOGER-peptide surfaces comparable to those reported for HT1080 cells (unpublished 
observations), and thus represent a particularly relevant model for focal adhesion 
formation on these surfaces.  In addition, MC3T3-E1 cells express osteoblast-specific 
proteins and produce mineralized nodules during in vitro maturation, and therefore will 
be examined in future studies as a model for osteoblast differentiation on GFOGER-
peptide modified surfaces (Choi et al., 1996;Sudo et al., 1983). 
Fig. 3.13 demonstrates that MC3T3-E1 cells assemble vinculin- and β1 subunit-
containing focal adhesions on the adsorbed and immobilized GFOGER-peptide surfaces.  
The co-localization of vinculin and β1 integrin subunit on the periphery of the cells 
suggests that both peptide surfaces promote the formation of mature integrin-mediated 
focal adhesions.  In addition, these adhesions plaques localize to the periphery of the cells 
in a pattern similar to that observed on control type I collagen, verifying the collagen-
mimetic nature of the GFOGER-peptide surfaces. 
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Figure 3.13.  Immunofluorescent images demonstrating co-localization of β1
integrin subunit and vinculin focal adhesion protein on the periphery of 
MC3T3-E1 cells seeded for 6 hours in 0.1% serum on covalently immobilized 
peptide, adsorbed peptide, and adsorbed type I collagen surfaces. 
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Bioactive surfaces that provide specific signals to cells through well-characterized 
integrin-ligand interactions may lead to controlled cellular responses and improved tissue 
formation in tissue engineering and wound healing applications.  Previous studies have 
incorporated the minimal cell recognition sequence RGD found in a wide variety of ECM 
proteins and implicated in a number of ligand-receptor interactions, (Ruoslahti, 1996).  
While its ability to bind a wide variety of cells makes it an exceptionally useful sequence 
for promoting general cell adhesion, the RGD tripeptide exhibits limited specificity for 
specific integrins and thus allows minimal control over cellular responses.  The 
presentation of short sequences, such as RGD, may also result in the loss of full 
biological activity due to the absence of additional functional domains present in the 
native, three-dimensional structure of the ECM molecule (Danen, Aota, van Kraats, 
Yamada, Ruiter, and van Muijen, 1995;Aota, Nomizu, and Yamada, 1994a). This work 
fundamentally differs from such studies in that its objective is to engineer surfaces that 
mimic the tertiary or three-dimensional structure as well as primary structure of collagen 
and thus exhibit specificity for the particular integrin receptor, α2β1.  In order to engineer 
an integrin-specific bioadhesive surface, we have designed a triple helical collagen-
mimetic peptide that incorporates the hexapeptide sequence GFOGER from residues 502-
507 of the α1(I) chain of type I collagen, a major binding site for the α2β1 integrin.  CD 
spectroscopy verified that this peptide adopts a stable triple helical conformation and that 
its triple helix is similar to that observed in native type I collagen.  Passively adsorbed 
GFOGER-peptide actively promoted HT1080 concentration-dependent cell adhesion and 
spreading comparable to that observed on type I collagen.  The involvement of integrin 
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α2β1 in these adhesion events was verified with antibody blocking conditions, fulfilling 
our requirement of integrin-specific peptide activity. 
Recent literature has shown that collagen’s quaternary or polymeric structure as 
well as its tertiary triple helix is essential for platelet aggregation and activation (Morton, 
Peachey, Knight, Farndale, and Barnes, 1997;Morton, Hargreaves, Farndale, Young, and 
Barnes, 1995).  Although this particular platelet reactivity response was shown to be an 
α2β1-independent event, platelet adhesion to collagen also involves α2β1-mediated 
mechanisms (Morton, Peachey, Zijenah, Goodall, Humphries, and Barnes, 1994).  
Therefore, we sought to determine whether collagen’s quaternary structure was essential 
not only for conformation-dependent processes such as platelet aggregation but also for 
specific integrin recognition events.  Cell adhesion to polymerized GFOGER-peptide was 
significantly lower than adhesion to the uncross-linked peptide surfaces and nearly half 
that of type I collagen.  This reduction in functional recognition may be due to 
differences in adsorbed peptide density or to changes in binding site accessibility or 
conformation.  Regardless, we can conclude that collagen’s quaternary structure does not 
promote nor enhance α2β1-mediated recognition and is not essential for integrin-specific 
cell adhesion. 
Next we designed three complementary schemes for tethering this GFOGER-
peptide to a surface in order to assess its activity in an immobilized conformation and 
ultimately its potential as a surface modification agent for biomaterials and tissue 
engineering applications (Fig. 3.8).  The first two immobilization schemes involve 
biotinylating the carboxyl terminus of the peptide using a PEO linker arm attached to a 
biotin group.  The biotinylated peptide was then introduced to surfaces treated with either 
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adsorbed avidin or adsorbed anti-biotin antibody, both of which resist non-specific 
protein adsorption.  The third scheme involved covalently crosslinking the peptide to 
passively adsorbed bovine serum albumin using the crosslinking agents EDC ands sulfo-
NHS.  The BSA provided a non-fouling, non-adhesive background surface with 
carboxylate anchoring groups for the peptide.  Cell adhesion results demonstrated that the 
peptide was active for all three immobilization schemes and will promote α2β1-mediated 
adhesion when covalently tethered to a substrate, as indicated by antibody blocking 
conditions.  Combined with ELISA data, these results also suggest that the peptide 
exhibits nearly three-fold higher adhesion activity in the immobilized conformation than 
passively adsorbed onto the surface.  Because the peptide can only be covalently 
crosslinked to the substratum through the primary amine terminal group, all of the 
peptides on the surface should be in a single orientation with the GFOGER cell 
recognition site in a highly accessible environment.  In contrast, when the peptide is 
passively adsorbed, it can adopt a range of orientations, some of which may not be 
favorable for binding site recognition and cell adhesion, thus explaining the lower 
activity observed on the adsorbed peptide surfaces.   
Immunofluorescent staining of MC3T3-E1 osteoblast-like cells revealed the 
assembly of focal adhesion plaques containing both the β1 integrin subunit and vinculin 
structural protein on the peptide surfaces in a pattern similar to that observed on type I 
collagen, further verifying the collagen-mimetic nature of the GFOGER-peptide.  In 
addition, since focal adhesions represent junctions of integrin-mediated intracellular 
signaling, these images suggest that the GFOGER-peptide not only promotes adhesion 
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comparable to type I collagen but may also mimic the post-adhesion signaling 
characteristics of collagen surfaces, allowing specific control of cell function.   
Conclusion 
We have engineered a collagen-mimetic, triple helical peptide and verified its 
activity using several surface modification techniques, including passive adsorption, 
specific noncovalent surface interaction, and covalent immobilization, demonstrating that 
this triple helical peptide represents a robust and versatile approach to the design of 
bioadhesive surfaces that specifically target the α2β1 integrin.  Surface immobilization 
remains the most promising method for incorporating the GFOGER peptide into 
applications that benefit from enhanced control over cell function due to higher adhesion 
activity and greater surface stability.    
In terms of a viable surface modification scheme, these studies reveal that this 
adhesion-promoting synthetic peptide of minimal recognition sequence and specific 
tertiary conformation can be covalently grafted to a stable, non-adhesive substrate to 
produce biologically active, chemically well-defined surfaces that support α2β1-specific 
cell adhesion.  Controlling integrin binding through covalent surface modification in turn 
allows us to optimize cell function for applications such as biomaterials processing and 
tissue engineering scaffold design.  In addition, these surfaces may be useful in the study 





α2β1 INTEGRIN-SPECIFIC COLLAGEN MIMETIC SURFACES 
THAT SUPPORT OSTEOBLASTIC DIFFERENTIATION 
 
Summary 
The interactions of osteoblasts with their surrounding ECM are essential for 
skeletal development, homeostasis, and maintenance of the mature osteoblastic 
phenotype. Integrins are the principal transducers of ECM signals that regulate this 
process of osteoblast commitment and differentiation.  Several studies indicate that the 
α2β1 integrin interaction with type I collagen is a crucial signal for the induction of 
osteoblastic differentiation and matrix mineralization. The integrin α2β1 recognizes the 
Gly-Phe-Hyp-Gly-Glu-Arg  (GFOGER) motif in residues 502-507 of the α1[I] chain of 
type I collagen.  This study demonstrates that an α2β1 integrin-specific GFOGER-peptide 
triggers the activation of focal adhesion kinase (FAK) and alkaline phosphatase in 
MC3T3-E1 murine immature osteoblast-like cells - two proteins that have been 
implicated in the osteoblastic differentiation pathway.  These GFOGER-peptide surfaces 
also support the expression of multiple osteoblast-specific genes, including osteocalcin 
and bone sialoprotein, and induce calcification and matrix mineralization in a manner 
similar to type I collagen, suggesting that this triple-helical peptide represents a 
*Modified from Reyes,C.D. & Garcia,A.J. Alpha2beta1 integrin-specific collagen-mimetic 
surfaces supporting osteoblastic differentiation. J. Biomed. Mater. Res. A 69, 591-600 (2004). 
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promising surface modification strategy for the design of collagen-mimetic bioadhesive 
surfaces that support osteoblastic differentiation. 
Introduction 
The interactions of osteoblasts with their surrounding ECM are essential for 
skeletal development and homeostasis and the maintenance of the mature osteoblastic 
phenotype (Xiao, Gopalakrishnan, Jiang, Reith, Benson, and Franceschi, 2002;Suzawa, 
Tamura, Fukumoto, Miyazono, Fujita, Kato, and Takeuchi, 2002;Ikeuchi, Dohi, 
Horiuchi, Ohgushi, Noshi, Yoshikawa, Yamamoto, and Sugimura, 2002;Mizuno and 
Kuboki, 2001;Regazzoni, Winterhalter, and Rohrer, 2001;Tamura, Takeuchi, Suzawa, 
Fukumoto, Kato, Miyazono, and Fujita, 2001b;Mizuno, Fujisawa, and Kuboki, 
2000;Xiao, Jiang, Thomas, Benson, Guan, Karsenty, and Franceschi, 2000a;Jikko, Harris, 
Chen, Mendrick, and Damsky, 1999;Takeuchi, Suzawa, Kikuchi, Nishida, Fujita, and 
Matsumoto, 1997b;Lynch, Stein, Stein, and Lian, 1995).  During the early stages of 
differentiation, osteoblasts synthesize an ECM consisting primarily of type I collagen.  
As matrix deposition progresses, the osteoblastic differentiation pathway is characterized 
by the activation of transcriptional pathways leading to the temporal expression of 
multiple proteins, including alkaline phosphatase, osteocalcin, and bone sialoprotein 
(Aubin and Liu, 1996;Stein, Lian, Stein, van Wijnen, Frenkel, and Montecino, 1996).  
The distinctive feature of the mature osteoblastic phenotype is their ability to induce the 
mineralization of the ECM (Aubin and Liu, 1996).   
Integrins are the central transducers of ECM signals that regulate this process of 
osteoblast commitment and differentiation.  The integrins α1β1 and α2β1 are the major 
collagen-binding integrins, with α1β1 having a higher affinity for the basement membrane 
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type IV collagen and α2β1 having a higher affinity for the fibrillar type I collagen, the 
major protein constituent of bone (Tulla, Pentikainen, Viitasalo, Kapyla, Impola, Nykvist, 
Nissinen, Johnson, and Heino, 2001;Kapyla, Ivaska, Riikonen, Nykvist, Pentikainen, 
Johnson, and Heino, 2000;Nykvist, Tu, Ivaska, Kapyla, Pihlajaniemi, and Heino, 2000).  
In fact, the α2β1 integrin is highly expressed on osteoblast-like cells and is one of the 
predominant adhesion receptors used by osteoblast-like cells to adhere to the collagen 
matrix (Gronthos, Stewart, Graves, Hay, and Simmons, 1997).  Several studies indicate 
that the α2β1 integrin interaction with type I collagen is a crucial signal for the induction 
of osteoblastic differentiation and matrix mineralization (Suzawa, Tamura, Fukumoto, 
Miyazono, Fujita, Kato, and Takeuchi, 2002;Mizuno and Kuboki, 2001;Mizuno, 
Fujisawa, and Kuboki, 2000;Jikko, Harris, Chen, Mendrick, and Damsky, 1999;Xiao, 
Wang, Benson, Karsenty, and Franceschi, 1998;Takeuchi, Suzawa, Kikuchi, Nishida, 
Fujita, and Matsumoto, 1997a).  For example, α2β1-mediated osteoblast adhesion to type 
I collagen activates Runx2/Cbfa1, a transcription factor that controls osteoblast 
differentiation and matrix mineralization (Xiao, Wang, Benson, Karsenty, and 
Franceschi, 1998;Takeuchi, Suzawa, Kikuchi, Nishida, Fujita, and Matsumoto, 1997a).  
Furthermore, the collagen-α2β1 integrin interaction has been shown to induce the 
osteoblastic phenotype in multipotent bone marrow cells (Mizuno and Kuboki, 
2001;Mizuno, Fujisawa, and Kuboki, 2000).  Integrin α2β1-mediated attachment to type I 
collagen stimulates the tyrosine phosphorylation of focal adhesion kinase (FAK) and 
subsequently the activation of extracellular signal-related kinase (ERK), a mitogen-
activated protein kinase (MAPK) that has been implicated in the control of osteoblast-
specific gene expression and matrix mineralization (Suzawa, Tamura, Fukumoto, 
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Miyazono, Fujita, Kato, and Takeuchi, 2002;Tamura, Takeuchi, Suzawa, Fukumoto, 
Kato, Miyazono, and Fujita, 2001b;Xiao, Jiang, Thomas, Benson, Guan, Karsenty, and 
Franceschi, 2000b;Takeuchi, Suzawa, Kikuchi, Nishida, Fujita, and Matsumoto, 1997b).  
Disrupting the α2β1 integrin interaction with type I collagen using function-blocking 
antibodies blocks the expression of osteoblast-specific genes, such as osteocalcin, and 
inhibits calcification and formation of a mineralized matrix (Mizuno, Fujisawa, and 
Kuboki, 2000;Jikko, Harris, Chen, Mendrick, and Damsky, 1999;Xiao, Wang, Benson, 
Karsenty, and Franceschi, 1998). 
Incorporating discrete cell adhesion motifs, such as the collagen mimetic 
GFOGER hexapeptide, into bioactive materials and surfaces offers a promising strategy 
to enhance cell-material interactions and encourage biospecific cell adhesion and 
differentiation (Hubbell, 1999).  We have previously demonstrated our ability to engineer 
stable bioadhesive surfaces that specifically target the α2β1 integrin by adsorbing or 
immobilizing a stable triple-helical, collagen-mimetic peptide that contains the GFOGER 
adhesion motif from type I collagen (Reyes and Garcia, 2003b).  This peptide specifically 
targets the α2β1 integrin receptor, and its cell adhesion activity is comparable to that of 
type I collagen (Reyes and Garcia, 2003b).  In the present study, we demonstrate that 
this α2β1 integrin-specific GFOGER-peptide triggers the activation of FAK and alkaline 
phosphatase in MC3T3-E1 murine immature osteoblast-like cells.  These surfaces also 
support the expression of multiple osteoblast-specific genes and the mineralization of the 
ECM in a manner similar to type I collagen, suggesting that this triple-helical peptide 
represents a robust approach to the design of collagen-mimetic bioadhesive surfaces that 
specifically target the α2β1 integrin.  Controlling specific integrin binding through this 
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biomolecular surface modification strategy may allow the optimization of cell function, 
in particular osteoblastic differentiation, for applications such as orthopedic biomaterials 
and bone tissue engineering scaffold design. 
Materials and Methods 
Cells and Reagents 
MC3T3-E1 murine immature osteoblast-like cells (RBD1126) were purchased 
from the Riken Cell Bank (Hirosawa, Japan).  Bovine type I collagen (Vitrogen-100) was 
purchased from Cohesion (Palo Alto, CA).  Rabbit polyclonal anti-FAK antibody was 
obtained from Upstate Biotechnology (Lake Placid, NY).  Rabbit polyclonal anti-FAK 
[pY397], anti-FAK [pY576], and anti-FAK [pY861] phospho-specific antibodies were 
purchased from BioSource International, Inc. (Camarillo, CA).  Biotin-conjugated 
donkey anti-rabbit IgG was obtained from Jackson Immunoresearch (West Grove, PA).  
Alkaline phosphates-conjugated anti-biotin (clone BN-43) mouse IgG was purchased 
from Sigma Chemical Co. (St. Louis, MO).  The micro BCA protein assay reagent kit 
was purchased from Pierce (Rockford, IL).  ECF susbtrate for Western blotting was 
acquired from Amersham Pharmacia Biotech Inc (Piscataway, NJ).  Purified calf 
intestinal alkaline phosphatase enzyme and 4-methyl-umbelliferyl-phosphate substrate 
were obtained from Sigma Chemical Co.  RNA isolation and DNA purification reagents 
were acquired from Qiagen (Valencia, CA).  Molecular biology reagents for reverse 
transcription polymerase chain reaction (RT-PCR) were purchased from Invitrogen 
(Carlsbad, CA), reagents for real-time PCR were obtained from Applied Biosystems 
(Foster City, CA), and PCR oligonucleotides were acquired from Integrated DNA 
Technologies (Coralville, IA).  Fetal bovine serum was purchased from Hyclone (Logan, 
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UT).  Additional cell culture reagents and Western blotting supplies were obtained from 
Invitrogen.  All other chemical reagents were purchased from Sigma Chemical Co. 
Cell Culture 
MC3T3-E1 cells were cultured in α-minimum essential medium (α-MEM) 
supplemented with 10% fetal bovine serum and 1% penicillin-streptomycin.  Cells were 
subcultured every two days using standard techniques.  For alkaline phosphatase activity, 
gene expression, and matrix mineralization studies, cells were seeded onto the various 
surfaces at a density of 10,000 cells/cm2 using 6-well tissue culture plates.  After 24 h, 
the culture media was supplemented with 50 µg/ml L-ascorbic acid and 3 mM sodium β-
glycerophosphate to support osteoblastic differentiation and mineralization.  Media was 
replaced every 48 h.  
Peptide and type I collagen surface preparation 
The peptide GGYGGGPC(GPP)5GFOGER(GPP)5GPC [O=hydroxyproline] was 
synthesized by the Emory University Microchemical Facility at the Winship Cancer 
Institute (Atlanta, GA), as previously described (Reyes and Garcia, 2003b).  Peptide was 
supplied in the purified form as a trifluoroacetic acid (TFA) salt and reconstituted at a 
stock concentration of 10 mg/ml in 0.1% TFA.  Type I collagen was supplied as a 3.0 
mg/ml protein solution in 0.012N HCl.  In all experiments, the peptide and type I 
collagen were diluted to 10 µg/ml in Dulbecco’s phosphate-buffered saline (DPBS).  
These solutions were then incubated on tissue culture-treated polystyrene surfaces for 1 h 
at 22ºC, followed by blocking in 1% heat-denatured BSA for 1 h. 
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Western blotting analysis of FAK activation 
MC3T3-E1 cells were seeded onto the various surfaces at a density of 30,000 
cells/cm2 for 60 min, serum free at 37ºC.  FAK activation was analyzed as previously 
described.(Garcia and Boettiger, 1999)  Adherent cells were washed once in DPBS and 
lysed in cold radioimmunoprecipitation assay (RIPA) buffer (1% Triton X-100, 1% 
sodium deoxycholate, 0.1% SDS, 150 mM NaCl, 150 mM Tris-HCl pH 7.2, 350 µg/ml 
phenylmethylsulfonyl fluoride (PMSF), 10 µg/ml leupeptin, 10 µg/ml aprotinin, and 1 
mM sodium orthovanadate) for 20 min on ice.  The lysates were pipetted up and down 
~25 times to shear the DNA and then clarified by centrifugation at 10,000g for 10 min.  
Protein concentration was then determined using a Pierce Micro BCA protein assay kit.  
Equal amounts of protein were boiled in Laemmli sample buffer (2% SDS, 10% glycerol, 
100 mM DTT, 60 mM Tris-HCl pH 6.8, and 0.001% bromophenol blue) for 10 min and 
separated on a 7% SDS-polyacrylamide gel electrophoresis (SDS-PAGE) gel.  Proteins 
were transferred electrophoretically onto nitrocellulose membranes and blocked with 
Blotto (5% non-fat dry milk, 0.02% sodium azide, 0.2% Tween 20 in PBS w/o 
Ca2+/Mg2+) overnight at 4ºC.  Membranes were then incubated with primary antibody – 
anti-FAK (1 µg/ml), anti-FAK pY397 (0.35 µg/ml), anti-FAK pY576 (0.5 µg/ml), or anti 
FAK pY861 (1 µg/ml) – in Blotto for 1 h at room temperature under gentle rocking.  
Membranes were washed in TBS-Tween (20 mM Tris HCl pH 7.6, 137 mM NaCl, 0.1% 
Tween 20) for 30 min and incubated in secondary antibody (biotin-conjugated anti-rabbit 
IgG, 1:20,000 dilution in Blotto) for 1 h at room temperature under gentle rocking.  
Membranes were washed again in TBS-Tween for 30 min and incubated in a tertiary or 
detection antibody (alkaline phosphatase-conjugated anti-biotin IgG, 1:10,000 dilution in 
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Blotto) for 1 h at room temperature under gentle rocking.  After antibody incubation, 
membranes were washed in TBS-Tween for 30 min and immunoreactivity was detected 
using ECF fluorescent substrate.  Bands were visualized using a Fuji Image Analyzer and 
further quantified using Adobe Photoshop software.  FAK phosphorylation levels were 
normalized to the amount of total FAK in each experimental run.  Multiple experimental 
runs were pooled for statistical purposes by normalizing to a control sample of lysate 
from cells seeded onto tissue culture-treated polystyrene.   
Osteblast-specific gene expression 
Osteoblast-specific gene expression was analyzed by real time reverse-
transcriptase polymerase chain reaction (real time RT-PCR).(Byers et al., 2002a)  Total 
RNA was isolated at 3 and 7 days after initial cell seeding using the Qiagen RNeasy RNA 
isolation kit.  During RNA isolation and purification, samples were treated with DNaseI 
(27 Kunitz units/sample) for 15 min at room temperature to eliminate any genomic DNA 
contamination. The concentration of purified RNA was quantified using a UV 
spectrophotometer (Shimadzu, Columbia, MD) and 1 µg of total RNA was used to 
synthesize cDNA templates by oligo(dT) priming using the Superscript First-Strand 
cDNA Synthesis System.   
Real-time RT-PCR was performed with the ABI Prism 7700 Sequence Detection 
System (Applied Biosystems; 40 cycles; melting for 15 s at 95ºC; annealing and 
extending for 60 s at 60ºC) using Sybr green DNA intercalating dye.  Gene transcript 
concentration in the sample cDNA template solutions was quantified by preparing a 
functional range of dilutions from an absolute standard for each gene.  Linear standard 
curves were then generated by plotting the log of the known concentration versus the CT 
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value (the cycle number at which the fluorescence reached a pre-determined threshold 
level).  Real-time RT-PCR oligonucleotide primers (Table 4.1) were designed using 
Primer Express software (Applied Biosystems).   
Alkaline phosphatase biochemical activity 
Alkaline phosphatase (ALP) activity was quantified at 7 days after initial cell 
seeding using a modification of the Sodek and Berkman method.(Stephansson, Byers, 
and Garcia, 2002;Sodek and Berkman, 1987)  Briefly, cells were rinsed with DPBS and 
scraped in cold 50 mM Tris-HCl.  After sonication and centrifugation, the total protein 
concentration was quantified using a Pierce Micro BCA protein assay kit.  Equal amounts 
of protein (2.5 µg) were added to 60 µg/ml 4-methyl-umbelliferyl-phosphate fluorescent 
substrate in diethanolamine buffer (pH 9.5).  After a 60 min incubation at 37ºC, the 
fluorescence was read at an excitation of 360 nm and an emission of 465 nm on an HTS 
7000 Plus BioAssay Reader (Perkin Elmer).  Enzymatic activity was standardized using 
purified calf intestinal alkaline phosphatase at known dilutions and normalized to the 
amount of total protein. 
Von Kossa staining for mineralized matrix 
 Mineralized phosphate deposits were visualized by von Kossa staining.(Byers et 
al., 2002b)  After 12 days, cultures were fixed in 70% ethanol for at least 30 min.  Plates 
were exposed to uniform light for 30 min in the presence of 5% AgNO3 to stain 
phosphate deposits in the matrix.  The stain was then fixed in 5% Na2SO3 for 2 min.  
Cultures were subsequently rinsed with deionized H2O and dried at 37ºC for 30 min.  
Mineralized surface area was quantified by averaging 16 representative 1.8x images  
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Table 4.1. Real-Time PCR Oligonucleotides for Murine Genes 
Gene Forward Primer Reverse Primer Size 
(bp) 
ALP mAP-551.F RT mAP-621.R RT 71 
   
6671532* 
5’-GGG ACT GGT ACT CGG ATA 
ACG A-3’ 
5’-CTG ATA TGC GAT GTC CTT GCA-
3’ 
 
OCN mOCN-126.F RT  mOCN-193.R RT 68 
   X04142 5’-CGG CCC TGA GTC TGA CAA A-
3’ 
5’-GCC GGA GTC TGT TCA CTA CCT 
T-3’ 
 
BSP mBSP-219.F RT mBSP-291.F RT 73 
   L20232 5’-TCC TCC TCT GAA ACG GTT 
TCC-3’ 
5’-GGA ACT ATC GCC GTC TCC ATT-
3’ 
 
ALP, alkaline phosphatase; OCN, osteocalin; BSP, bone sialoprotein 
* GenBank accession number 
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using an automated microscope stage and Image Pro image analysis software (Media 
Cybernetics, Silver Springs, MD). 
Statistics 
Data are reported as mean ± standard error.  Results were analyzed by one-way 
ANOVA using SYSTAT 8.0 (SPSS).  If treatment level differences were determined to 
be significant, pair-wise comparisons were performed using a Tukey post-hoc test.  A 
95% confidence level was considered significant.  To make the variance independent of 
the mean, analyses of PCR data were performed after logarithmic transformation. 
Results 
The collagen-mimetic peptide used in these experiments has the following 
primary sequence: GGYGGGPC(GPP)5GFOGER(GPP)5GPC (Reyes and Garcia, 2003b).  
The GPP triplets on either side of the GFOGER recognition site provide cooperative 
clusters that promote the formation of a stable right-handed triple helical structure at 
room temperature (Knight, Morton, Peachey, Tuckwell, Farndale, and Barnes, 
2000;Nagarajan, Kamitori, and Okuyama, 1998;Fields and Prockop, 1996).  This triple-
helical conformation is essential for integrin recognition and α2β1-mediated cell adhesion 
(Messent, Tuckwell, Knauper, Humphries, Murphy, and Gavrilovic, 1998;Morton, 
Peachey, Knight, Farndale, and Barnes, 1997;Morton, Peachey, Zijenah, Goodall, 
Humphries, and Barnes, 1994).  In order to evaluate its effectiveness as a collagen-
mimetic surface modification agent, we passively adsorbed the GFOGER-peptide onto 
tissue culture polystyrene surfaces and compared its biological activity with adsorbed 
type I collagen and untreated polystyrene. 
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MC3T3-E1 murine immature osteoblast-like cells were used in all experiments.  
No gross differences in cell proliferation were observed among substrates, and cultures 
reached confluence at approximately 2 days. 
Focal Adhesion Kinase (FAK) Activation 
 We previously demonstrated that GFOGER-peptide surfaces promote the 
formation of α2β1 integrin-mediated focal adhesions that are similar to those assembled on 
type I collagen (Reyes and Garcia, 2003b). Since focal adhesions represent junctions of 
integrin-mediated intracellular signaling, these results suggest that our peptide not only 
promotes adhesion comparable to type I collagen but may also mimic the post-adhesion 
signaling events characteristic of collagen surfaces, allowing us to specifically control 
cell function - in particular, osteoblastic differentiation.  Therefore, we examined whether 
these collagen-mimetic peptide surfaces trigger the activation of focal adhesion kinase 
(FAK), an intracellular signaling molecule implicated in integrin-mediated signal 
transduction and downstream osteoblastic differntiation pathways (Tamura, Takeuchi, 
Suzawa, Fukumoto, Kato, Miyazono, and Fujita, 2001b;Xiao, Jiang, Thomas, Benson, 
Guan, Karsenty, and Franceschi, 2000b;Takeuchi, Suzawa, Kikuchi, Nishida, Fujita, and 
Matsumoto, 1997b).   
Using standard Western blotting techniques, we probed the phosphorylation of 
three different tyrosine (Y) sites on FAK – Y397, the autophosphorylation site of FAK, 
binds the Src family SH2 and the p85 subunit of PI3-kinase; Y861 is the major Src 
phosphorylation site; Y576 is located in the catalytic portion of FAK and when 
phosporylated results in maximal FAK kinase activity (Reust et al., 2000).  Western 
blotting revealed comparable levels of signal activation on peptide and type I collagen 
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surfaces for all three tyrosine sites on FAK (Fig. 4.1).  These activation levels were 
significantly greater than negative control cells kept in suspension.  Fig. 4.1 shows that 
phosphorylation levels of Y397 were statistically higher on GFOGER-peptide surfaces 
compared with type I collagen.  This effect may be explained by possible differences in 
the surface density of GFOGER binding sites or by confounding effects of other cell 
binding sites present on the native collagen molecule. 
Osteoblast-Specific Gene Expression 
 To investigate the osteoblastic differentiation potential of these collagen-mimetic 
surfaces, we used real-time RT-PCR to probe osteoblast-specific gene expression in 3  
and 7 day cultures of MC3T3-E1 cells supplemented with ascorbic acid and Na-β-
glycerophosphate.  Expression levels of Runx2/Cbfa1, a transcription factor essential for 
bone formation and osteoblastic differentiation, were statistically equivalent on 
GFOGER-peptide and type I collagen surfaces and elevated compared to polystyrene 
(Fig. 4.2.a). 
Additional osteoblast-specific genes were investigated, including osteocalcin 
(OCN), bone sialoprotein (BSP), and alkaline phosphatase (ALP).  For all three of these 
bone-specific markers, RT-PCR revealed equivalent levels of gene expression on 
GFOGER-peptide and type I collagen surfaces (Fig. 4.2.b).  Transcript levels were 
significantly greater than reference surfaces, including untreated polystyrene, shown in 
Fig. 4.2.b.  In addition, these expression levels increased by day 7, indicating sustained 
up-regulation of osteoblast-specific gene expression on the integrin-specific GFOGER-












































Figure 4.1.  (a)  Western blotting results measuring site-specific tyrosine 
phosphorylation of focal adhesion kinase (FAK) in MC3T3-E1 cells seeded 
onto adsorbed peptide or adsorbed type I collagen compared with cells kept 
in suspension (1 hour serum-free cell adhesion or suspension).  Three 
tyrosine sites on FAK are shown.  (b)  Representative Western blot for 
phosphorylated tyrosine-397 on FAK.  pY397 ANOVA: p<0.002; *peptide 
or collagen > suspension (p<0.001), †peptide > collagen (p<0.03).  pY861 
ANOVA: p<0.00003; *peptide = collagen > suspension (p<0.00008).  pY576 
ANOVA: p<0.03; *peptide = collagen > suspension (p<0.03).  (mean ± 


























































































Figure 4.2.  Osteoblast-specific gene expression measured by real-time RT-
PCR for (a) Runx2 transcription factor and (b) alkaline phosphatase (ALP), 
osteocalcin (OCN), and bone sialoprotein (BSP) in MC3T3-E1 cells seeded for 
3 or 7 days on adsorbed peptide, adsorbed type I collagen, or polystyrene. 
Runx2 ANOVA: p<0.04; *day 3 peptide = collagen > polystyrene (p<0.05), 
*day 7 peptide = collagen > polystyrene (p<0.0008).  ALP ANOVA: 
p<0.0006; *day 3 peptide = collagen > polystyrene (p<0.001), *day 7 peptide 
= collagen > polystyrene (p<0.003).  OCN ANOVA: p<0.0003; *day 3 peptide 
= collagen > polystyrene (p<0.00002), *day 7 peptide = collagen > polystyrene 
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 Alkaline Phosphatase Biochemical Activity 
 An alkaline phosphatase biochemical assay revealed similar levels of activation 
on GFOGER-peptide and type I collagen surfaces after 7 days (Fig. 4.3).  These levels 
were significantly greater than activity on several reference surfaces, including tissue 
culture plastic (data not shown) and polystyrene (Fig. 4.3).   
Matrix Mineralization 
 Matrix mineralization was examined in MC3T3-E1 cultures after 12 days.  A von 
Kossa stain for phosphate deposits revealed that the percentage of mineralized area on the 
GFOGER-peptide surfaces was statistically equivalent to that of type I collagen (Fig. 
4.4).  Both were significantly greater than the mineralized area of several reference 
surfaces, including tissue culture plastic and untreated polystyrene (Fig. 4.4).  This 
mineralization data reveals that the collagen-mimetic peptide is capable of promoting 
matrix mineralization in osteoblast cultures, demonstrating the effects of controlled α2β1 
integrin binding on cell function - in this case, osteoblastic differentiation. 
Discussion 
Regulating cell behavior at a biomaterial interface requires strict control over the 
material's surface properties and an ability to assign the material a defined biological 
activity similar to that of the native ECM.  Targeting a specific integrin-ligand interaction 
allows directed control over subsequent signaling pathways and cell functions without the 
confounding effects of additional binding sites present on the whole ECM molecule.  We 
have previously designed a triple-helical collagen-mimetic peptide that preferentially 













































Figure 4.3.  Alkaline phosphatase (ALP) biochemical activity from MC3T3-
E1 cells seeded on adsorbed peptide, adsorbed type I collagen, or polystyrene 
for 7 days.  ANOVA: p<0.000002; *peptide = collagen > polystyrene 
(p<0.002).  (mean ± standard error; three separate experiments in triplicate) 
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Figure 4.4.  Matrix mineralization of MC3T3-E1 cells seeded on adsorbed 
peptide, adsorbed type I collage, tissue culture plastic, and polystyrene for 12 
days.  (a)  von Kossa staining of mineralized matrix.  (b)  Quantification of 
mineralized area.  ANOVA: p<0.00002; *peptide = collagen > tissue culture 
= polystyrene (p<0.001). 
GFOGER-Peptide Collagen 




































 formation. (Reyes and Garcia, 2003b)  The present study explores whether this integrin-
specific peptide is capable of promoting similar signaling events and differentiation 
responses as native type I collagen in the osteoblast cell model. 
One of the initial events triggered by the binding of the α2β1 integrin to type I 
collagen is the association of the integrin’s cytosolic domain with focal adhesion kinase 
(FAK), followed by phosphorylation at multiple sites to achieve full FAK activation.  
Phosphorylation of FAK’s Y397 forms a binding site for Src-family kinases whereas 
Y861 is the major Src phosphorylation site (Reust, Roy, Ergang, Mernaugh, and Hanks, 
2000;Calalb et al., 1996).  In addition, the phosphorylation of Y576 in the kinase 
activation loop enhances FAK kinase activity (Reust, Roy, Ergang, Mernaugh, and 
Hanks, 2000;Calalb, Zhang, Polte, and Hanks, 1996).  In all cases, specific activation of 
various tyrosine sites on FAK trigger signaling pathways that in turn affect cell functions 
such as differentiation.    Several studies prove that the signaling pathway from the α2β1 
integrin to ERK/MAPK (extracellular signal-related kinase/mitogen-actived protein 
kinase) via FAK is required for osteoblastic differentiation (Lai et al., 2001;Tamura, 
Takeuchi, Suzawa, Fukumoto, Kato, Miyazono, and Fujita, 2001b;Takeuchi, Suzawa, 
Kikuchi, Nishida, Fujita, and Matsumoto, 1997b).  In order to demonstrate the collagen-
mimetic nature of the GFOGER-peptide, we compared its ability to trigger FAK 
phosphorylation with that of native type I collagen surfaces.  A Western blot for specific 
tyrosine phosphorylation sites on FAK revealed similar levels of activation for cells 
plated on either GFOGER-peptide or type I collagen surfaces. These results indicate that 
the peptide triggers similar signaling pathways to type I collagen surfaces and may 
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promote the same phenotypic responses as the native molecule, including osteoblastic 
differentiation. 
However, the β1 integrin-FAK cascade is an initial signal transduction pathway 
that is widely activated among mesenchymal cells and therefore is not necessarily a 
specific indicator of osteoblastic differentiation (Guan, 1997).  To verify that these 
peptide-induced signaling pathways result in the progression of the osteoblast phenotype, 
we examined the expression of Runx2/Cbfa1, a transcriptional activator that is essential 
for osteoblastic differentiation and bone formation.  Runx2 DNA binding sequences have 
been discovered in the promoters of several osteoblast-specific genes, including 
osteocalcin (Ducy and Karsenty, 1995) and bone sialoprotein (Benson et al., 1999).  
Exogenous expression of Runx2 in nonosteoblastic cells induces expression of these 
genes (Byers et al., 2002c).  The Runx2 transcription factor has been investigated as a 
central link between cell surface integrin activation by matrix proteins and subsequent 
osteoblast-specific gene expression (Xiao, Jiang, Thomas, Benson, Guan, Karsenty, and 
Franceschi, 2000b;Xiao, Wang, Benson, Karsenty, and Franceschi, 1998;Takeuchi, 
Suzawa, Kikuchi, Nishida, Fujita, and Matsumoto, 1997a).  An increase in the expression 
of the type II isoform of this factor occurs in primary rat osteoblasts and murine MC3T3-
E1 cells during progressive development of the osteoblast phenotype (Banerjee et al., 
2001b).  This developmental increase in Runx2 mRNA is paralleled by similar increases 
in Runx2 protein and osteoblast-specific DNA binding activity (Banerjee et al., 2001a).  
Real time RT-PCR results demonstrated the upregulation of this key osteoblast-specific 
transcription factor on both type I collagen and GFOGER-peptide surfaces, 
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demonstrating the ability of this collagen-mimetic peptide to trigger the transcriptional 
machinery necessary for osteoblastic differentiation. 
To determine whether this pattern of increased Runx2 gene expression parallels 
similar increases in the expression of other osteoblast-specific genes, the transcript levels 
of osteocalcin, bone sialoprotein, and alkaline phosphatase were also examined.  Alkaline 
phosphatase, the enzyme that initiates phosphate precipitation, is an early indicator of 
osteoblastic differentiation (Aubin and Liu, 1996).  Osteocalcin is an ECM protein often 
used as a marker of the mature osteoblastic phenotype (Weinreb et al., 1990).  Bone 
sialoprotein has been shown to enhance in vitro hydroxyapatite nucleation and thus plays 
a critical role in initiating bone mineralization (Hunter et al., 1996).  Real time RT-PCR 
results demonstrated the sustained upregulation of these three genes on GFOGER-peptide 
surfaces after 3 and 7 days in culture.  Gene expression patterns matched those observed 
on type I collagen surfaces, further verifying the collagen-mimetic nature of this peptide 
and its potential to trigger similar differentiation signals as type I collagen. 
Osteoblastic differentiation is also characterized by the activation of multiple 
proteins including alkaline phosphatase.  The alkaline phosphatase enzyme is often used 
as a marker for increased osteoblastic metabolic activity and an early indicator of 
osteoblastic differentiation (Aubin and Liu, 1996).  An alkaline phosphatase biochemical 
assay revealed equivalent levels of activation on GFOGER-peptide and type I collagen 
surfaces after 7 days.  Since alkaline phosphatase is the enzyme responsible for 
hydrolyzing phosphate esters and precipitating bone mineral (Aubin and Liu, 1996), these 
results suggest that this collagen-mimetic peptide might also be capable of promoting 
bone matrix mineralization in a manner similar to that of type I collagen. 
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 In vitro mineralization was examined as an endpoint indicator of osteoblastic 
phenotype and the ultimate assessment of this collagen-mimetic biomolecular strategy.  
Several studies have demonstrated the critical role of type I collagen in mediating the 
signaling cascade for expression of a mature osteoblastic phenotype and subsequent in 
vitro matrix mineralization (Mizuno and Kuboki, 2001;Mizuno, Fujisawa, and Kuboki, 
2000;Jikko, Harris, Chen, Mendrick, and Damsky, 1999;Xiao, Wang, Benson, Karsenty, 
and Franceschi, 1998;Lynch, Stein, Stein, and Lian, 1995).  Under the appropriate 
conditions, immature osteoblast-like MC3T3-E1 cells endogenously express all factors 
necessary for in vitro mineralization.  An enhanced capacity for mineralization was 
observed for cells cultured on type I collagen compared with reference surfaces.  This 
enhanced mineralization was comparable to results from cells cultured on collagen-
mimetic GFOGER-peptide.  This capacity for mineralization on the GFOGER peptide-
coated surfaces is in accordance with the previously observed up-regulation in osteoblast-
specific gene expression and protein activity.  These results verify the collagen-mimetic 
nature of the GFOGER-peptide and demonstrate the effects of controlled α2β1 integrin-
binding on cell function, in this case osteoblastic differentiation. 
Conclusion 
In conclusion, we have designed a triple-helical collagen-mimetic peptide that 
specifically targets the α2β1 integrin receptor and promotes density dependent cell 
adhesion (Reyes and Garcia, 2003b), focal adhesion formation (Reyes and Garcia, 
2003b), and FAK phosphorylation.  These collagen-mimetic surfaces also support 
equivalent levels of osteoblastic gene expression, alkaline phosphatase activity, and 
matrix mineralization as native type I collagen.  Designing biomaterials surfaces and 
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tissue engineering scaffolds using whole ECM molecules, such as type I collagen, is 
often limited by a lack of specificity for particular integrins and thus exhibit minimal 
control over cellular responses.  In addition, native ECM proteins often have binding sites 
for other ligands, such as fibronectin or von Willebrand factor.  Such ligands trigger 
separate signaling cascades that may ultimately confound phenotypic responses and 
interfere with controlled cell function.  The GFOGER-peptide targets a specific integrin-
ligand interaction that has been shown to be crucial in the development and maintenance 
of the osteoblast phenotype, as well as the mineralization of the extracellular matrix.  As 
such, this peptide represents a robust and versatile approach to the design of collagen-
mimetic bioadhesive surfaces that specifically target the α2β1 integrin.  We have 
previously demonstrated that this adhesion-promoting synthetic peptide of minimal 
recognition sequence and specific tertiary conformation can be covalently grafted to a 
stable, non-adhesive substrate to produce biologically active, chemically well-defined 
surfaces that support α2β1-specific cell adhesion (Reyes and Garcia, 2003b).  Controlling 
integrin binding through bioactive surface modification in turn allows control over cell 
function and possibly enhancement of tissue formation in tissue engineering, 
biomaterials, and wound healing devices.  In particular, we have demonstrated the 
efficacy of this biomolecular strategy in the area of osteoblastic differentation and matrix 





COLLAGEN-MIMETIC PEPTIDE SURFACE COATING 




Implant osseointegration, defined as close bone apposition and functional 
fixation, is a prerequisite for clinical success in orthopaedic and dental applications, many 
of which are restricted by implant loosening (Pilliar, 2005;Anderson, 2001).  Surface 
modification approaches have had limited success in promoting integration.  Our strategy 
to improve osseointegration of titanium implants focuses on presenting the GFOGER 
collagen-mimetic peptide that triggers α2β1 cellular integrin receptor binding, which is 
crucial for bone mineral deposition.  Titanium surfaces presenting integrin-specific 
GFOGER peptide trigger osteoblastic differentiation in primary rat bone marrow stromal 
cells, including bone-specific gene expression, alkaline phosphatase activity, and mineral 
deposition, leading enhanced osteoblastic function compared to unmodified orthopaedic-
grade titanium.  Furthermore, this integrin-targeted surface coating significantly 
improved peri-implant bone regeneration and mechanical osseointegration compared to 
untreated titanium in a rat tibia cortical bone implant model.  Our study establishes a 
simple, single-step biologically active implant coating that enhances bone repair and 
implant integration for clinical orthopaedic and dental applications. 
 94
Introduction 
Upon implantation, synthetic materials elicit an inflammatory response that 
results in a foreign body reaction and fibrous encapsulation.(Anderson, 2001)  The 
foreign body reaction severely limits device integration and in vivo performance of 
numerous biomedical devices, including chemical biosensors, electrical leads/electrodes, 
therapeutic delivery systems, and orthopaedic and cardiovascular prostheses.  Extensive 
efforts have concentrated on surface treatments and coatings to improve host tissue-
implant integration.  For instance, current orthopaedic and dental implant surface 
technologies focus on rough/porous coatings for bone ingrowth and bone-bonding 
ceramic coatings to promote integration with the surrounding bone and provide 
mechanical fixation (Bauer and Schils, 1999b),(Ducheyne and Qiu, 1999).   
However, while these approaches are generally successful, they can be restricted 
by slow rates of osseointegration and poor mechanical anchorage in challenging clinical 
cases, such as those associated with large bone loss and poor bone quality (Ducheyne and 
Qiu, 1999).  Since the extracellular matrix controls both cell adhesion and function, 
recent biomimetic strategies have focused on the immobilization of matrix components, 
including native structural proteins (Bernhardt, van den, Bierbaum, Beutner, 
Scharnweber, Jansen, Beckmann, and Worch, 2005;Becker, Geissler, Hempel, Bierbaum, 
Scharnweber, Worch, and Wenzel, 2002), peptide sequences (Bernhardt, van den, 
Bierbaum, Beutner, Scharnweber, Jansen, Beckmann, and Worch, 2005;Elmengaard, 
Bechtold, and Soballe, 2005a;Elmengaard, Bechtold, and Soballe, 2005b;Alsberg, 
Anderson, Albeiruti, Rowley, and Mooney, 2002b;Ferris, Moodie, Dimond, Gioranni, 
Ehrlich, and Valentini, 1999b), or synthetic derivatives based on matrix molecules 
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(Lutolf and Hubbell, 2005).  The most common peptide-based strategy involves the 
surface deposition of peptides containing the Arg-Gly-Asp (RGD) sequence, which 
mediates cell attachment to several matrix proteins, including fibronectin, vitronectin, 
osteopontin, and bone sialoprotein.  However, these bio-inspired strategies have yielded 
marginal increases in implant integration and mechanical fixation (Schliephake et al., 
2002;Ferris, Moodie, Dimond, Gioranni, Ehrlich, and Valentini, 1999b).  Because RGD 
is recognized by a large number of integrins in numerous cell types, this approach lacks 
specificity for particular targeted integrin signaling events and results in non-
discriminatory attachment of cells to the RGD-coated surfaces.  Therefore, engineering 
peptides that specifically target integrin signaling cascades implicated in specific tissue 
responses, for example osteogenesis, would allow the optimization of surface coatings for 
enhanced integration and performance. 
The α2β1 integrin is highly expressed on osteoblasts and is one of the predominant 
adhesion receptors for type I collagen (Gronthos, Stewart, Graves, Hay, and Simmons, 
1997).  α2β1 integrin-type I collagen interactions provide crucial signals for the induction 
of osteoblastic differentiation and matrix mineralization (Suzawa, Tamura, Fukumoto, 
Miyazono, Fujita, Kato, and Takeuchi, 2002;Mizuno and Kuboki, 2001;Mizuno, 
Fujisawa, and Kuboki, 2000;Jikko, Harris, Chen, Mendrick, and Damsky, 1999;Xiao, 
Wang, Benson, Karsenty, and Franceschi, 1998;Takeuchi, Suzawa, Kikuchi, Nishida, 
Fujita, and Matsumoto, 1997a;Lynch, Stein, Stein, and Lian, 1995). For example, α2β1-
mediated osteoblast adhesion to type I collagen activates Runx2/Cbfa1 (Xiao, Wang, 
Benson, Karsenty, and Franceschi, 1998;Takeuchi, Suzawa, Kikuchi, Nishida, Fujita, and 
Matsumoto, 1997a), a transcription factor that regulates osteogenesis.  Furthermore, the 
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collagen-α2β1 integrin interaction induces osteoblastic differentiation in multipotent bone 
marrow stromal cells (Mizuno and Kuboki, 2001;Mizuno, Fujisawa, and Kuboki, 2000).  
We designed a stable triple-helical, collagen-mimetic peptide that contains the GFOGER 
adhesion motif from type I collagen that is recognized by the α2β1 integrin (Reyes and 
Garcia, 2003b).  This collagen-mimetic peptide specifically targets the α2β1 integrin 
receptor and promotes density-dependent cell adhesion (Reyes and Garcia, 2003b), focal 
adhesion kinase signaling (Reyes and Garcia, 2004), and osteoblastic differentiation 
(Reyes and Garcia, 2004) in the MC3T3-E1 immature osteoblast cell line.  We 
hypothesized that coating titanium implants with this peptide enhances peri-implant bone 
formation and mechanical osseointegration, thus providing a simple, clinically relevant 
strategy for improving orthopaedic implant integration. 
Materials and Methods 
Cell isolation and culture 
 Primary bone marrow stromal cells were harvested from the femora of young 
adult male Wistar rats in accordance with an IACUC-approved protocol (Maniatopoulos 
et al., 1988).   After excision, hindleg femora and tibiae were cleared of soft tissue and 
processed through three consecutive 15 min rinses in growth medium (α-minimal 
essential medium supplemented with 10% fetal bovine serum, 1% penicillin–
streptomycin, and 0.3 µg/ml amphotericin B).  The ends of the long bones were then 
removed and the marrow space was flushed with culture medium (3-5 ml), using a 
syringe with an 18-gauge needle.  Marrow isolates were pooled, centrifuged, resuspended 
in growth medium, and seeded for adhesion-dependent selection on tissue culture 
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polystyrene dishes.  Non-adherent hematopoietic cells were removed during subsequent 
medium exchanges, which occurred every other day.  Cells were subcultured every two 
days according to standard techniques.  For in vitro osteogenic assays, cells were seeded 
at 10,000 cells/cm2 in growth medium.  After 24 h, cultures were maintained in 
osteogenic medium consisting of growth medium supplemented with 50 µg/ml L-ascorbic 
acid and 3 mM sodium β-glycerophosphate. 
In vitro GFOGER peptide surface preparation 
 The peptide GGYGGGPC(GPP)5GFOGER(GPP)5GPC [O=hydroxyproline] was 
synthesized by the Emory University Microchemical Facility at the Winship Cancer 
Institute (Atlanta, GA).(Reyes and Garcia, 2003b)  Peptide was supplied in the purified 
form as a trifluoroacetic acid (TFA) salt and reconstituted at a stock concentration of 10 
mg/ml in 0.1% TFA.  For the in vitro assays, glass chamber slides (16-well Lab-Tek 
Chamber Slides, Nalge Nunc) or tissue culture-treated polystyrene dishes were coated 
with 300 Ǻ of pure titanium using an electron beam evaporator at a chamber base 
pressure between 1-2 x 10-6 torr with a deposition rate of 1.5 Å/second.  The GFOGER 
peptide was diluted to 20 µg/ml in Dulbecco’s phosphate-buffered saline (PBS) and 
incubated on the titanium surfaces for 1 h at 22ºC in preparation for all assays. 
Cell adhesion assay 
Cell adhesion to functionalized and untreated titanium surfaces was measured 
using a centrifugation assay that applies controlled detachment forces (Reyes and Garcia, 
2003a;Reyes and Garcia, 2003b).  Titanium-coated glass chamber slide wells were 
reassembled using a silicone-based adhesive and coated with 20 µg/ml GFOGER peptide 
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as described above or 20 µg/ml GRGDSPC peptide (BACHEM).  Control titanium slides 
were coated with 10% FBS (to model serum protein adsorption) or blocking buffer (5% 
non-fat dry milk in PBS to produce a non adhesive support).  Stromal cells were loaded 
with 2 µg/ml calcein-AM (Molecular Probes), a membrane permeable green-fluorescent 
dye, detached using trypsin + EDTA, and resuspended serum-free in PBS with 2 mM 
dextrose.  Cells were seeded onto the substrates (10,000 cells/well) and allowed to attach 
for 1 h at 37ºC.  For blocking experiments, cells were incubated in the presence of 20 
µg/ml anti-rat α2 antibody (hamster anti-rat CD49b monoclonal antibody, clone Ha1/29, 
BD Pharmingen) or 20 µg/ml anti-rat αv antibody (mouse anti-rat integrin αv chain 
monoclonal antibody, clone 21, BD Pharmingen).  Isotype control antibodies had no 
effect on cell adhesion (data no shown).  Initial fluorescence intensity was measured to 
quantify the number of adherent cells prior to application of centrifugal force.  After 
filling the wells with PBS/dextrose and sealing with transparent adhesive tape, substrates 
were inverted and spun at a fixed speed in a centrifuge (Beckman Allegra 6, GH 3.8 
rotor) to apply a centrifugal force corresponding to 12g. After centrifugation, media was 
exchanged and fluorescence intensity was read to measure remaining adherent cells. For 
each well, adherent cell fraction was calculated as the ratio of post-spin to pre-spin 
fluorescence readings. 
Osteoblast-specific gene expression 
Gene expression was analyzed by qRT-PCR.(Byers et al., 2002d)  Total RNA was 
isolated at 7 days after initial cell seeding using the Qiagen RNeasy RNA isolation kit.  
During RNA isolation and purification, samples were treated with DNaseI (27 Kunitz 
units/sample) for 15 min at room temperature to eliminate any genomic DNA 
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contamination. The concentration of purified RNA was quantified using a NanoDrop 
(NanoDrop Technologies) and 1 µg of total RNA was used to synthesize cDNA 
templates by oligo(dT) priming using the Superscript First-Strand cDNA Synthesis 
System.   
qRT-PCR was performed with the ABI Prism 7700 Sequence Detection System 
(Applied Biosystems; 40 cycles; melting for 15 s at 95ºC; annealing and extending for 60 
s at 60ºC) using SYBR Green DNA intercalating dye.  Gene transcript concentration in 
the sample cDNA template solutions was quantified by preparing a functional range of 
dilutions from an absolute standard for each gene.  Linear standard curves were then 
generated by plotting the log of the known concentration versus the CT value (the cycle 
number at which the fluorescence reached a threshold level).  Oligonucleotide primers 
(Table 5.1) were designed using Primer Express software (Applied Biosystems).   
 
Gene/Gen Bank 
Accession Number Forward Primer Reverse Primer 
Runx 2 / NM009820 5’-GGCCTTCAAGGTTGTAGCCC-3’ 5’-CCCGGCCATGACGGTA-3’ 
OCN / X04141 5’-ACGAGCTAGCGGACCACATT-3’ 5’-CCCTAAACGGTGGTGCCATA-3’
BSP / J04215 5’-TGACGCTGGAAAGTTGGAGTT-3’ 5’-GCCTTGCCCTCTGCATGTC-3’ 
 
Alkaline phosphatase biochemical activity and calcium incorporation assays 
 ALP activity was quantified at 7 days after cell seeding using a modification of 
the Sodek and Berkman method (Stephansson, Byers, and Garcia, 2002;Sodek and 
Berkman, 1987).  Briefly, cells were rinsed with PBS and scraped in cold 50 mM Tris-
HCl.  After sonication and centrifugation, the total protein concentration was quantified 
using a Pierce Micro BCA protein assay kit.  Equal amounts of protein (2.5 µg) were 
Table 5.1. Real-Time PCR Oligonucleotides for Rat Genes 
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added to 60 µg/ml 4-methyl-umbelliferyl-phosphate fluorescent substrate in 
diethanolamine buffer (pH 9.5).  After a 60 min incubation at 37ºC, the fluorescence was 
read at an excitation of 360 nm and an emission of 465 nm on an HTS 7000 Plus 
BioAssay Reader (Perkin Elmer).  Enzymatic activity was standardized using purified 
calf intestinal alkaline phosphatase at known dilutions and normalized to the amount of 
total protein. 
Calcium content was determined by dissolving mineralized deposits with 1 N 
acetic acid overnight. Appropriately diluted sample (25 µl) was added to 300 µl of 
arsenazo III-containing Calcium Reagent (Diagnostic Services Ltd). The absorbance of 
the resulting samples was measured at 650 nm and compared to a linear standard curve of 














Figure 5.1.  Diagram of cylindrical titanium implant rod with tapered 
stop collar and transverse hole for pull-out mechanical testing.  The 
metal is ASTM F67 Grade 4 commercially pure titanium. 
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Tibial implantation procedure 
 Commercially pure titanium implants (Fig. 5.1) were sonicated in de-ionized 
water for 20 min to remove surface debris.  Implants were then dipped in 4% HF for 30 
sec to remove the existing oxide layer and then incubated in 35% HNO3 for 30 min at 50 
ºC to regenerate a new oxide coating.  Samples were transferred to 1.8 N NaOH for 1 min 
to terminate the oxidation reaction.  Implants were then rinsed and boiled in de-ionized 
water for 1 h.  To create the bioactive coating, the implants were incubated in 20 µg/ml 
GFOGER peptide solution for 1 h.  Control titanium rods were incubated in PBS. 
 Implantations were conducted in accordance with an IACUC-approved protocol 
(Branemark, Ohrnell, Nilsson, and Thomsen, 1997).    Both hind legs of anesthetized, 
mature Sprague-Dawley male rats (250-350 g) were shaved and scrubbed with alcohol.  
The medial aspect of the proximal tibial metaphysis was exposed through an antero-
medial skin incision, leaving the medial collateral ligament intact.  Using a saline-cooled 
drill at ~2 rotations per minute (to avoid thermal trauma), two defects were created in 
each tibia.  Sterile implant rods were press fit into the defects.  Periosteum was mobilized 
and sutured over the implantation site, and the skin was closed with wound clips.  
Subjects were euthanized after 4 weeks and proximal tibiae were fixed in neutral buffered 
formalin for histology or recovered without fixation and maintained in PBS-moistened 
gauze for immediate mechanical testing. 
 Based on power calculations and previous reports in the literature (Branemark, 
Ohrnell, Nilsson, and Thomsen, 1997), we estimated that a minimum of eight implants 
per experimental group are required to detect differences of 10% in mechanical testing 
and a minimum of four implants per experimental group are required for 
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histomorphometry for a total of 11 implants per experimental group.  In this model, each 
animal receives four implants, two per experimental condition.  Each tibia contained one 
implant from each of the two conditions, in alternating positions.  We used a total of eight 
animals with 16 implants per condition – seven for histology and nine for mechanical 
testing.  One additional animal with two implants per condition was included as an extra 
in the event of tibia breakage during harvest or during the apparatus set-up for 
mechanical testing. 
Histology and histomorphometry analyses and mechanical testing 
 Excised tibiae were fixed in 10% neutral buffered formalin for 1 week.  Samples 
were then embedded, ground, and stained by Wasatch Histo Consultants, Inc.  Briefly, 
the formalin-fixed tibiae were dehydrated in a graded series of alcohol incubations and 
then embedded in poly(methyl methacrylate).  Ground sections of 50-80 µm were 
generated using the Exakt Grinding System.  Two longitudinal ground sections were 
generated per tibia, each containing two titanium plugs inserted transverse to the tibia’s 
long axis.  Sections were then stained with Sanderson’s Rapid Bone Stain™ and a van 
Gieson counter stain.  Bone implant contact (BIC) was measured as the percentage of 
implant’s circumference that was in direct contact with bone tissue (Adobe Photoshop CS 
imaging software). 
 Implant mechanical fixation to the bone was measured with a pull-out force test 
using a biomechanical testing apparatus (EnduraTEC Bose ELF 3200).  Immediately 
after explantation, tibiae were cleaned of all soft tissue and prepared for mechanical 
testing.  The ends of each excised tibia were secured in a custom designed holding 
apparatus with the exposed head of each implant facing in the direction of the pull motion 
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and centered along the axis of motion. A 0.014” diameter piano wire was threaded 
through the implant head and both wire ends attached firmly to an 11 lb. INTERFACE 
load cell. Samples were pre-loaded with 2 N to ensure proper and identical wire tautness 
among implants. Tests were performed at a constant force rate of 0.2 N/sec using 
WINTEST application software. The direction of the pull was parallel to the long axis of 
the implant. The pull-out force (N) was the maximum load achieved before failure and 
was determined from the recorded load vs. displacement data. 
 Statistics 
 Data are reported as mean ± standard error.  Results were analyzed by one-way 
ANOVA using SYSTAT 8.0 (SPSS).  If treatment level differences were determined to 
be significant, pair-wise comparisons were performed using a Tukey post-hoc test.  A 
95% confidence level was considered significant.  All of the in vitro assays were 
performed as two separate experiments in triplicate.  The quantitative histomorphometry 
consisted of a total sample size of seven implants per condition.  The mechanical testing 
consisted of a total sample size of nine implants per condition. 
Results 
To reproduce titanium implant surfaces in vitro, polystyrene culture dishes were 
coated with a 300 Ǻ titanium layer via electron beam evaporation.  The GFOGER peptide 
was then passively adsorbed onto the titanium at a concentration of 20 µg/ml, creating the 
integrin-targeted bioactive coating.   
Surface plasmon resonance spectroscopy revealed a final surface density of 123.2 
± 6.2 ng/cm2.  Primary rat bone marrow stromal cells were used to validate this surface 
treatment strategy in vitro due to their inherent osteogenic potential.  A centrifugation cell 
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adhesion assay demonstrated greater stromal cell adhesion on the GFOGER-peptide 
surfaces compared to titanium surfaces pre-exposed to linear RGD peptide or serum (Fig. 
5.2).  In fact, cell adhesion to the RGD-treated surface was equivalent to background 
levels observed on titanium blocked with non-adhesive proteins, reflecting the inability of 
this short peptide to passively adsorb onto titanium.  Importantly, a blocking anti-α2 
antibody completely eliminated cell adhesion to GFOGER-treated surfaces, verifying the 
peptide’s specificity for the α2β1 integrin.  However, this α2β1 antibody had no effect on 
adhesion to serum-exposed titanium, demonstrating that stromal cell adhesion to 
untreated titanium is not mediated by α2β1 integrin.  Since untreated titanium adsorbs 
abundant RGD-containing serum proteins, such as vitronectin, adhesion to these surfaces 
most likely involves the αvβ3 integrin, which recognizes RGD in a wide variety of 
proteins and synthetic peptides.  Indeed, a function-perturbing anti-αv antibody had no 
effect on adhesion to the GFOGER peptide but completely blocked adhesion above 
background on the serum-exposed titanium.  These results clearly demonstrate that the 
bioactive GFOGER peptide specifically targets the α2β1 integrin.  These adhesion results 
also show that untreated titanium surfaces, which directly adsorb serum proteins, 
preferentially engage the αvβ3 integrin.  Because GFOGER peptide-coated and control 
titanium surfaces each interact with unique integrins, these surfaces may recruit different 
cell populations at the implant site and/or have diverse effects on cellular maturation and 
bone formation in vivo. 
To investigate the osteoblastic differentiation potential of these surfaces, we used 
quantitative RT-PCR (qRT-PCR) to probe osteoblast-specific gene expression in 7 day 




























































Figure 5.2.  Cell adhesion is greater on adsorbed GFOGER surfaces 
than untreated titanium (Ti) and is specific for the α2β1 integrin.  Data 
represent 1 h serum-free bone marrow stromal cell adhesion and 
subsequent centrifugation at 12g for 5 min.  Surfaces are adsorbed 
GFOGER peptide on Ti, adsorbed linear RGD peptide, adsorbed fetal 
bovine serum (10% in PBS), and non-adhesive blocked Ti.  Cells were 
seeded without antibody or in the presence of either anti-α2 or anti-αv
integrin blocking antibodies.  ANOVA: p<1E-9; *GFOGER w/o Ab > 


































































































































































































Figure 5.3.  GFOGER surfaces enhance the expression of multiple 
osteoblast-specific genes.  Data represent osteoblast-specific gene 
expression measured by qRT-PCR for Runx2 transcription factor, 
osteocalcin (OCN), and bone sialoprotein (BSP) in rat bone marrow 
stromal cells seeded for 7 days on GFOGER surfaces or untreated Ti. 
Runx2 ANOVA: *GFOGER > Ti (p<0.02); OCN ANOVA: *GFOGER 
> Ti (p<0.002); BSP ANOVA: *GFOGER > Ti (p<0.05).   
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transcription factor essential for bone formation and osteoblastic differentiation (Xiao, 
Jiang, Thomas, Benson, Guan, Karsenty, and Franceschi, 2000b;Xiao, Wang, Benson, 
Karsenty, and Franceschi, 1998;Takeuchi, Suzawa, Kikuchi, Nishida, Fujita, and 
Matsumoto, 1997a), were elevated on the GFOGER-treated surfaces compared to 
untreated titanium (Fig. 5.3).  The upregulation of this key osteoblast-specific 
transcription factor demonstrates the ability of the bioactive GFOGER-peptide surface to 
trigger the transcriptional machinery necessary for osteoblastic differentiation.  To 
determine whether this pattern of increased Runx2 gene expression parallels similar 
increases in the expression of other osteoblast-specific genes, the transcript levels of 
osteocalcin and bone sialoprotein were also examined.  For both bone-specific markers, 
qRT-PCR revealed greater levels of gene expression on the GFOGER-peptide surfaces 
compared with untreated titanium (Fig. 5.3).  These results indicate that the α2β1 
integrin-targeted peptide promotes the expression of multiple genes specifically 
associated with a mature osteoblastic phenotype. 
Osteoblastic differentiation is also characterized by the activation of multiple 
proteins, including alkaline phosphatase (ALP).  The ALP enzyme is often used as a 
marker for osteoblastic metabolic activity and an early indicator of osteoblastic 
differentiation.(Aubin and Liu, 1996)  An ALP biochemical assay revealed elevated 
levels of activation on the GFOGER-peptide coating compared to untreated titanium 
(Fig. 5.4.a).  Because ALP is the enzyme responsible for hydrolyzing phosphate esters 
and inducing bone mineralization (Aubin and Liu, 1996), these results suggest that this 















































































































































Figure 5.4.  GFOGER surfaces enhance (a) alkaline phosphatase (ALP) 
activity and (b) matrix calcification in rat bone marrow stromal cultures 
compared to untreated titanium (Ti).  ALP ANOVA: *GFOGER > Ti 
(p<0.02); Ca+2 ANOVA: *GFOGER > Ti (p<2E-4). 
 109
Matrix mineralization was examined as an in vitro end-point indicator of the osteoblastic 
phenotype in the bone marrow stromal cells.  Calcium phosphate mineral deposition was 
examined after 14 days in culture using calcium content analysis.  Cultures on GFOGER-
treated surfaces displayed a three-fold enhancement in calcium-based mineral deposition 
compared to untreated titanium (Fig. 5.4.b).  This enhanced capacity for mineralization 
on the peptide-treated surfaces is in excellent agreement with the observed up-regulation 
in osteoblast-specific gene expression and ALP activity.  These results verify the 
advantageous effects of controlled α2β1 integrin-binding on cell function, in this case 
osteoblastic differentiation and matrix mineralization.   
 To evaluate the performance of the bioactive GFOGER peptide treatment in vivo, 
we quantified osseointegration in a rat tibia cortical bone model using quantitative 
histomorphometry and pull-out mechanical testing.(Branemark, Ohrnell, Nilsson, and 
Thomsen, 1997)  We designed a cylindrical titanium implant rod with a tapered stop 
collar (Fig. 5.1).  The tapered head ensures that all implants are inserted into the bone at 
the same depth, guaranteeing uniform bone contact among treatments.  Using a saline-
cooled drill, two defects 2 mm in diameter were created in the medial aspect of the 
proximal tibial metaphysis.  Implant rods consisting of GFOGER peptide functionalized 
or untreated (control) titanium were press fit into the cortical defects.   After four weeks, 
the rat tibiae were harvested and evaluated for bone apposition by histological staining 
and mechanical integration by pull-out testing.  Histological sections revealed substantial 
and contiguous bone mineral along the periphery of GFOGER-treated titanium implants 
(Fig. 5.5.a).  Less mineral staining was visible on untreated titanium and the mineral 
















































Figure 5.5.  GFOGER surfaces improve peri-implant bone formation and mechanical 
osseointegration in an in vivo rat tibia cortical bone implantation model.  (a)
Representative micrographs show 50-80 µm longitudinal ground sections of rat tibia 
stained with Sanderson’s Rapid Bone Stain™ and van Gieson counterstain.  Cells 
stain dark to light blue, soft tissue elements stain blue-green, and bone matrix stains 
yellow orange to autumn orange.  The top right micrograph is a GFOGER peptide-
coated implant and shows an example of implant placement.  (b)  GFOGER surfaces 
exhibit greater amounts of newly formed bone at the implant surface compared with 
untreated Ti.  Bone apposition is measured as the percentage of implant’s 
circumference that is in direct contact with bone mineral in the histological sections. 

















































Figure 5.6.  GFOGER surfaces demonstrate greater mechanical integration with the 
surrounding tissue compared with untreated Ti.  Osseointegration is measured as the 
maximum force [N] necessary to dislodge the implant in a pull-out test.  ANOVA: 
*GFOGER > Ti (p<0.02). 
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quantification to determine the percentage of the bone-implant apposition (bone implant 
contact, BIC) demonstrated a nearly two-fold enhancement in bone apposition on the 
GFOGER peptide-coated surfaces compared to untreated titanium (Fig. 5.5b).  Pull-out 
mechanical testing indicated significantly higher mechanical fixation of the peptide-
functionalized implants compared to untreated titanium (Fig. 5.6).  These results 
demonstrate a greater quantity and continuity of peri-implant bone mineral on the 
integrin-targeted GFOGER peptide surfaces in vivo as well as enhanced mechanical 
integrity and osseointegration.   
Discussion 
 This work proposes a specific biomolecular strategy to improve bone regeneration 
and osseointegration by exploiting the activity of type I collagen, the most abundant 
matrix component in bone.  In particular, type I collagen modulates intracellular signal 
transduction by binding to the α2β1 integrin, which enhances the expression of the 
osteoblastic phenotype (Suzawa, Tamura, Fukumoto, Miyazono, Fujita, Kato, and 
Takeuchi, 2002;Mizuno and Kuboki, 2001;Mizuno, Fujisawa, and Kuboki, 2000;Jikko, 
Harris, Chen, Mendrick, and Damsky, 1999;Xiao, Wang, Benson, Karsenty, and 
Franceschi, 1998;Takeuchi, Suzawa, Kikuchi, Nishida, Fujita, and Matsumoto, 1997a).  It 
also exhibits low immunogenicity and high conformational stability, making it extremely 
suitable for implantation.  However, designing surface treatments using whole matrix 
molecules, such as type I collagen, is often limited by a lack of specificity for particular 
integrins and thus exhibit minimal control over cellular responses.  In addition, native 
matrix proteins often have binding sites for other ligands, such as fibronectin or von 
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Willebrand factor.  Such ligands may trigger separate signaling cascades that may 
ultimately confound phenotypic responses and interfere with desired cell function.   
The GFOGER peptide strategy described in this study targets the α2β1 integrin-
ligand interaction that is crucial for the development and maintenance of the osteoblast 
phenotype as well as the mineralization of the extracellular matrix.  In vitro assays using 
bone marrow stromal cells verified that a GFOGER peptide coating enhances expression 
of multiple osteoblast-specific genes and alkaline phosphatase activity when compared to 
untreated titanium controls.  This bioactive treatment also improved calcification of the 
extracellular matrix, demonstrating functional osteoblastic differentiation.  Notably, the 
cortical bone implantation studies revealed greater bone tissue formation on the surface 
of GFOGER-treated titanium implants, in terms of both quantity and connectivity.  Most 
significantly, we have shown that the GFOGER peptide coating improved the implant’s 
mechanical fixation and functional osseointegration as determined by a quantitative pull-
out test.  Faster integration of these GFOGER coated implants would result in sooner and 
more reliable loading in a clinical setting, improving device function and patient 
outcomes.   
Not only does this bioactive coating enhance bone formation and implant 
integration, but it is also created using a single-step procedure conducted under 
physiological conditions, thus eliminating the cytotoxicity and biocompatibility concerns 
associated with covalent immobilization methods.  As such, this GFOGER peptide 
surface treatment represents a simple, clinically relevant approach to improving 
orthopaedic and dental titanium implant integration.  Due to the fundamental character of 
receptor-ligand principles and the significance of cell-collagen interactions in multiple 
 114
tissues, this material coating strategy may also have the potential to improve implant 




MIXED BIOMEMTIC INTEGRIN-SPECIFIC SURFACES 
SYNERGISTICALLY MODULATE SIGNAL TRANSDUCTION 
 
Summary 
Cell adhesion to the extracellular matrix (ECM) through cell-surface integrin 
receptors is essential to development, wound healing, and tissue remodeling, and 
therefore represents a central theme in the design of bioactive surfaces that successfully 
interface with the body.  Extensive studies have focused on functionalizing surfaces with 
single integrin ligands, such as RGD, FN, or COL, in order to control both cell adhesion 
and differentiation.  However, the native cellular environment is characterized by a 
variety of matrix proteins that target multiple integrins implicated in a downstream 
cellular response.   
The objective of this study is to engineer bioactive hybrid surfaces that control 
cell function by mimicking integrin-ECM interactions.  We target two specific integrins 
essential to differentiation in several cell systems – the type I collagen (COL-I) receptor 
α2β1 and the fibronectin (FN) receptor α5β1 – by tethering varying densities of a 
recombinant FN fragment and a collagen-mimetic peptide onto non-adhesive supports. 
The wide range of controlled mixed ligand densities generated by this process 
demonstrates the feasibility of generating integrin-specific hybrid surfaces. Results 
indicate increased cell adhesion and synergistic activation of FAK, which underscore the 
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advantage of specifically targeting more than one integrin implicated in a particular 
signaling pathway and downstream cellular effect.  Proliferation rate results confirm that 
the enhanced signaling effects of mixed ligand surfaces translate to downstream cellular 
responses.  This study suggests that, instead of focusing on a single integrin-ligand 
interaction, in some cases it may be advantageous to consider the interplay of multiple 
integrins implicated in a desired cell response and their combined effect on downstream 
cellular signals. 
Introduction 
Extracellular matrices (ECMs) play critical roles in tissue morphogenesis, 
homeostasis, and repair by providing structural and signaling scaffolds that organize, 
coordinate, and regulate cellular activities (De Arcangelis and Georges-Labouesse, 
2000a;Reichardt, 1999).  Therefore, extracellular matrix proteins are attractive 
biomimetic targets for functionalizing synthetic materials in order to control cell 
functions and tissue structure and regeneration (Hubbell, 2004b).  Extensive studies have 
focused on functionalizing surfaces with single integrin ligands, such as RGD, FN, or 
COL, in order to control both cell adhesion and differentiation.   
In particular, biomimetic strategies presenting short bioadhesive oligopeptides, 
including the arginine-glycine-aspartic (RGD) motif present in numerous ECM 
components, to target integrin adhesion receptors have demonstrated in vitro control of 
cell adhesion and differentiation, and more importantly, enhancements in tissue healing 
responses in vivo, including bone formation and integration (Elmengaard et al., 
2005c;Alsberg et al., 2002a;Eid et al., 2001;Ferris et al., 1999a), nerve regeneration (Yu 
and Bellamkonda, 2003;Schense et al., 2000), and corneal tissue repair (Li et al., 2003).  
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However, these bio-inspired strategies are limited by low activity of the oligopeptides 
compared to the native ligand due to the absence of complementary or modulatory 
domains (Garcia et al., 2002).  For example, binding of integrin α5β1 requires both the 
PHSRN sequence in the 9th type III repeat and RGD motif in the 10th type III repeat of 
fibronectin (FN) (Aota et al., 1994b), which synergistically bind to α5β1 to provide stable 
adhesion (García et al., 2002;Redick et al., 2000).  Moreover, linear RGD peptides 
exhibit limited specificity among particular integrin receptors (Hersel et al., 2003).  This 
limitation is particularly important as recent evidence suggests that integrin binding 
specificity regulates cell proliferation and differentiation (Keselowsky et al., 
2005b;Cheng et al., 2001;Moursi et al., 1997b).  These single-component biomimetic 
strategies also ignore the complexity of the extracellular matrix and the involvement of 
more than one integrin signaling pathway in a particular downstream cellular response. 
As an alternative strategy, we have focused on engineering high molecular weight 
ligands that recapitulate the primary, secondary, and tertiary structure of the native matrix 
protein in order to reconstitute full biological activity as well as integrin binding 
specificity.  The recombinant fragment of FN encompasses both the PHSRN sequence in 
the 9th type III repeat and RGD motif in the 10th type III repeat of FN in their native 
structural orientations and is therefore specific for the α5β1 integrin.  The GFOGER 
peptide mimics the triple-helical structure of native type I collagen and targets the α2β1 
integrin.   
The objective of this study is to engineer bioactive hybrid surfaces that control 
cell function by mimicking two separate integrin interactions, α5β1 and α2β1, using the 
FN- and collagen-mimetic ligands to mimic signals from native ECM.  Both of these 
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integrin-ligand interactions have been implicated in several differentiation pathways, 
including osteoblastic differentiation.  Our strategy uses mixed biotinylated ligands on 
avidin substrates, providing a simple and easily controlled approach to efficiently screen 
a large number of mixed surface compositions using short term assays.  These surfaces 
were examined for cell adhesion, integrin binding, and integrin-mediated signaling 
responses.   
Materials and Methods 
Cells and Reagents 
HT1080 human fibrosarcoma cells (CCL-121, American Type Culture Collection, 
Manassas, VA) were grown in Dulbecco’s Modified Eagle medium containing 10% fetal 
bovine serum and 1% penicillin-streptomycin and subcultured every two days using 
standard techniques. 
NHS-fluorescein, biotin-LC-PEO-amine reagent, and Slide-A-Lyzer Dialysis 
Cassettes (3,500 MWCO) were purchased from Pierce.  Anti-FITC alkaline phosphatase 
conjugate (A5719) was purchased from Sigma.  Anti-FN (HFN7.1) was obtained from 
the Developmental Studies Hybridoma Bank (Iowa City, IA).  Rabbit polyclonal anti-
FAK antibody was obtained from Upstate Biotechnology (Lake Placid, NY).  Rabbit 
polyclonal anti-FAK [pY397], anti-FAK [pY576], and anti-FAK [pY861] phospho-
specific antibodies were purchased from BioSource International, Inc. (Camarillo, CA).  
Biotin-conjugated donkey anti-rabbit IgG was obtained from Jackson Immunoresearch 
(West Grove, PA).  Alkaline phosphates-conjugated anti-biotin (clone BN-43) mouse IgG 
was purchased from Sigma Chemical Co. (St. Louis, MO).  The micro BCA protein assay 
reagent kit was purchased from Pierce (Rockford, IL).  ECF susbtrate for spot blotting 
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was acquired from Amersham Pharmacia Biotech Inc (Piscataway, NJ).  Purified calf 
intestinal alkaline phosphatase enzyme and 4-methyl-umbelliferyl-phosphate substrate 
were obtained from Sigma Chemical Co.  DH5α and JM109 bacterial cells used for 
cloning and fragment production were obtained from Invitrogen and Promega (Madison, 
WI), respectively. The XA3 Pinpoint Vector biotinylation expression system was 
obtained from Promega.  The APC BrdU Flow Kit was purchased from BD Biosciences 
(San Jose, CA).  Fetal bovine serum was purchased from Hyclone (Logan, UT).  
Additional bacterial and mammalian cell culture reagents and spot blotting supplies were 
obtained from Invitrogen (Carlsbad, CA).  All other chemical reagents were purchased 
from Sigma Chemical Co.. 
GFOGER Peptide Synthesis, Biotinylation and FITC Labeling 
The peptide GGYGGGPC(GPP)5GFOGER(GPP)5GPC [O=hydroxyproline] was 
synthesized by the Emory University Microchemical Facility at the Winship Cancer 
Institute (Atlanta, GA), as previously described (Reyes and Garcia, 2003b).  Peptide was 
supplied in the purified form as a trifluoroacetic acid (TFA) salt and reconstituted at a 
stock concentration of 10 mg/ml in 0.1% TFA.    In all experiments, the GFOGER 
peptide was diluted to 10 µg/ml in Dulbecco’s phosphate-buffered saline (DPBS). 
For surface immobilization, the GFOGER peptide was biotinylated using a biotin-
LC-PEO-amine reagent as previously described (Reyes and Garcia, 2002).  The terminal 
primary amine of this molecule selectively labels the terminal carboxyl group of the 
GFOGER peptide. 
For antibody detection, a subset of the biotinylated GFOGER peptide stock was 
labeled with fluorescein using an NHS-ester labeling reagent (NHS-fluorescein, Pierce) 
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targeting the terminal primary amine.  For the coupling reaction, 0.5 mg of NHS-
fluorescein was dissolved in 500 µl of DMSO to form a stock reagent solution.  The stock 
reagent was slowly added to the GFOGER peptide stock solution (1 part NHS-fluorescein 
to 10 parts GFOGER peptide solution), while vortexing.  The sample was then placed on 
ice for 2 h.  Unreacted NHS-fluorescein was removed by overnight dialysis in PBS.  The 
final concentration of fluorescein-labeled GFOGER peptide was determined by 
monitoring the 280 nm absorbance on a Shimadzu UV-1601 UV-visible 
spectrophotometer (Shimadzu, Columbia, MD). 
Fibronectin Fragment (FNIII7-10) Expression and Purification 
A monobiotinylated fibronectin fragment spanning the 7-10th type III repeats of 
FN, FNIII7-10, was produced using standard recombinant DNA techniques.  cDNA 
encoding for human FNIII7-10 was ligated into the XA3 plasmid (Pinpoint System, 
Promega) and the resulting construct, which encodes for FNIII7-10 with a biotin tagging 
sequence at the amine terminus, was amplified in DH5α cells and purified using Qiagen 
kits.  DNA sequencing confirmed the ligated product.   
JM109 bacterial cells were transformed with the FNIII7-10-XA3 plasmid and 
streaked onto LB agar plates containing 100 µg/ml ampicillin and 2 µm d-biotin in 100 
mM sodium phosphate buffer (pH 7.2) and incubated overnight.  Colonies were isolated 
and dynamically cultured in 8 ml LB broth with 40 µg/ml ampicillin for 12 h at 37˚C.  
Next, 1.5 ml of concentrated bacterial small culture was added to 500 ml LB broth 
containing 100 µg/ml ampicillin and 2 µm d-biotin for 12-16 h.  At 6 h, 100 µM 
isopropyl-β-d-thiogalactopyranoside (IPTG)  was added to augment protein production.  
The cell broth was spun down at 8000g for 10 min at 4˚C, and the cell pellet was 
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resuspended at 10 ml/gram cell paste in cell lysis buffer (50 mM Tris-HCl pH 7.5, 50 
mM NaCl, 5% glycerol).  Lysozyme (1 mg/ml) was then added to the cell suspension and 
stirred at 4˚C for 20 min, and sodium deoxycholate (1 mg/ml) was added , stirring 
continuously for 5 min.  Next, DNAase I was added at 40 µg/ml for an additional 10 min.  
The lysate was centrifuged at 10,000g for 20 min, and the protein supernatant recovered, 
filtered through a 0.45 µm sterile filter, and frozen at -80˚C.   
Upon thawing, the solution was purified by affinity chromatography using a 5 ml 
column of Ultralink Immobilized Monomeric Avidin (Pierce) connected to a gradient 
pump, UV monitor, and fraction collector (BioRad, Hercules, CA).  After sequential 
washes (10 min) of the column with regeneration, elution, and DPBS buffers, the protein 
solution was allowed to bind to the column for 1 h at a 0.4 ml/min flow rate.  After 
washing for 15 min with DPBS, elution buffer (0.5 mg/ml d-biotin in DPBS) was flowed 
through at 1 ml/min and the fractions monitored for protein concentration.  Each fraction 
containing substantial concentrations of protein was filtered using Millipore (Bedford, 
MA) 30 kDa Microcon centrifugal filter devices to remove d-biotin.  Purified fractions 
was verified >98 % pure FNIII7-10 by SDS-PAGE and Western blotting.  Purified samples 
were flash frozen for storage at -80˚C.  
Mixed Ligand Surface Preparation 
Tissue culture treated polystyrene surfaces were incubated with avidin 
(NeutrAvidin, 100 µg/ml, Pierce) for 1 h at at 22ºC.  The surface was then blocked with 
1% heat denatured bovine serum albumin (BSA) for 1 h to prevent non-specific protein 
adsorption.  After washing with DPBS, varying concentrations of FNII7-10 (0-5 µg/ml in 
PBS) were introduced to the avidin support layers for 1 h at 22ºC.  Surfaces were washed 
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with DPBS and incubated with varying concentrations of GFOGER peptide (0-5 µg/ml in 
PBS) for 1 h at 22ºC.   
Relative Surface Density Measurements 
Mixed ligand surfaces were generated in a 96-well plate as previously described 
and blocked with 5% FBS in DPBS (blocking buffer) for 1 h.  The surfaces were then 
incubated with an anti-FITC alkaline phosphatase conjugated antibody (1:1000 dilution 
in blocking buffer)  for GFOGER peptide detection or a mouse anti-FN antibody 
(HFN7.1, 1:4000 dilution) for FNIII7-10 detection for 1 h at 37°C.  After washing, the 
wells that were incubated with the mouse anti-FN antibody were then incubated with an 
anti-mouse alkaline phosphatase conjugated antibody (1:1000 dilution) for 1 h at 37°C.  
After rinsing all wells, substrate (4-methyl-umbelliferyl-phosphate, 60 µg/ml) was added 
for 1 h at 37°C.  Reaction product fluorescence was measured in a microwell plate reader 
(360-nm excitation, 465-nm emission). 
Centrifugation Cell Adhesion Assay 
Mixed ligand surfaces were generated in a 96-well plate as previously described 
and blocked with 5% non-fat dry milk in PBS for 1 h to prevent non-specific protein 
adsorption and cell adhesion.  Serum free cell adhesion to these surfaces was measured 
using a centrifugation assay as previously described (Reyes and Garcia, 2003a).  Briefly, 
near-confluent HT1080 cells were loaded with 2 µg/ml calcein-AM and resuspended 
serum-free in PBS + 2 mM dextrose.  Cells were seeded onto the substrates (10,000 
cells/well) and allowed to attach for 1 h at 37°C.  For blocking experiments, cells were 
incubated in suspension for 15 minutes in the presence of 20 µg/ml anti-human VLA-2 
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(α2β1) integrin monoclonal antibody (MAB1998Z) or anti-human CD49e (α5) antibody 
and then seeded onto the mixed ligand surfaces for 1 hour at 37°C.  The surfaces were 
then inverted and centrifuged at the specified speed for 5 min on a Beckman Allegra 6 
centrifuge (GH 6.8 rotor) to detach the cells.  The post-spin fluorescence data was 
normalized by the pre-spin data and plotted against ligand concentration to obtain 
adhesion profiles (fraction of adherent cells vs. coating concentration). 
Immunofluorescent Staining for Focal Adhesions 
Mixed ligand surfaces were prepared in 35 mm dishes as described above and 
blocked with 5% non-fat dry milk in PBS for 1 h to prevent non-specific protein 
adsorption and cell adhesion.  HT1080 cells were seeded at a density of 225 cells/mm2 in 
10% serum for 6 h.  Cells were then permeabilized in ice-cold buffer (50 mM NaCl, 150 
mM sucrose, 3 mM MgCl2, 50 mM Tris, pH 6.8) supplemented with 0.5% Triton X-100 
and protease inhibitors (20 µg/ml aprotinin, 1 µg/ml leupeptin, 2 mM 
phenylmethylsulfonyl fluoride) for 5 min to remove membranes and soluble non-
cytoskeletal cytoplasmic components.  Detergent extracted cells were fixed in cold 
formaldehyde (3.7% in DPBS) for 5 min, blocked in blocking buffer (5% FBS in DPBS) 
for 1 h, and incubated with anti-vinculin (1:500 dilution in blocking buffer) 1 h at 37°C.  
Primary antibody were visualized using an AlexaFluor 488-conjugated secondary 
antibody (anti-mouse IgG; 1:200 dilution) with a 1 h incubation.  Images were captured 
using a Nikon Eclipse E400 fluorescence microscope with a 100x objective and 
ImagePro Plus image acquisition software. 
Immunoprecipitation and Western Blotting of Integrins 
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Mixed ligand surfaces were prepared in 60 mm dishes as described above and 
blocked with 5% non-fat dry milk in PBS for 1 h to prevent non-specific protein 
adsorption and cell adhesion.  HT1080 cells were seeded at a density of 30,000 cells/cm2 
in 10% serum for 1 h.  Cells were then lysed in 250 µl mild lysis buffer (1% NP-40, 0.15 
N NaCl, 0.01 M sodium phosphate, pH 7.2, 2 mM EDTA, 50 mM sodium fluoride, 0.2 
mM sodium orthovanadate, 100 U/ml aprotinin).  Protein concentration was determined 
using a Pierce Micro BCA protein assay kit. 
For the immunoprecipitation, volumes equivalent to 200 µg of sample protein 
were added to NET gel buffer (50mM tris HCl, pH7.5, 100 mM NaCl, 0.1% NP-40, 1 
mM EDTA, pH 8.0, 0.25% gelatin, 0.02% NaN3) for a total volume of 500 µl.  To 
precipitate the α2 integrin, 5 µl of rabbit anti-human integrin α2 polyclonal antibody 
(AB1936, Chemicon) was added to each sample.  These mixtures were then incubated 
overnight at 4ºC to encourage antibody binding.   
Twelve hours later, 40 µl of protein A agarose beads (Immunopure, Pierce) was 
added to each sample and incubated for 3 hours with agitation.  The beads were washed 
two times with NET gel buffer and one time with 0.1% NP-40 in 10 mM Tris.  The beads 
were then boiled in Laemmli sample buffer (2% SDS, 10% glycerol, 100 mM DTT, 60 
mM Tris-HCl pH 6.8, and 0.001% bromophenol blue) for 10 min and separated on a 7% 
SDS-polyacrylamide gel electrophoresis (SDS-PAGE) gel.   
Proteins were transferred electrophoretically onto nitrocellulose membranes and 
blocked with Blotto (5% non-fat dry milk, 0.02% sodium azide, 0.2% Tween 20 in PBS 
w/o Ca2+/Mg2+) overnight at 4ºC.  Membranes were then incubated with primary 
antibody – rabbit anti-integrin α5 polyclonal antibody (1:1000 dilution, AB1928, 
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Chemicon) or rabbit anti-human integrin α2 polyclonal antibody for verification of the IP 
(1:1000, AB1936, Chemicon)  – in Blotto for 1 h at room temperature under gentle 
rocking.  Membranes were washed in TBS-Tween (20 mM Tris HCl pH 7.6, 137 mM 
NaCl, 0.1% Tween 20) for 30 min and incubated in secondary antibody (biotin-
conjugated anti-rabbit IgG, 1:20,000 dilution in Blotto) for 1 h at room temperature under 
gentle rocking.  Membranes were washed again in TBS-Tween for 30 min and incubated 
in a tertiary or detection antibody (alkaline phosphatase-conjugated anti-biotin IgG, 
1:10,000 dilution in Blotto) for 1 h at room temperature under gentle rocking.  After 
antibody incubation, membranes were washed in TBS-Tween for 30 min and 
immunoreactivity was detected using ECF fluorescent substrate.  Bands were visualized 
using a Fuji Image Analyzer. 
BrdU Analysis of Cell Proliferation 
Proliferation was measured using the APC bromodeoxyuridine (BrdU) flow kit 
from BD Biosciences according to the manufacturer’s instruction manual.  Mixed ligand 
surfaces were generated on 60 mm dishes and blocked with 5% non-fat dry milk in PBS 
for 1 hour to prevent non-specific protein adsorption and cell adhesion.  HT1080 cells 
were seeded at a density of 5,000 cells/cm2 in 10% serum for 24 h.  Cells were then 
exposed to BrdU for 12 h to identify actively cycling populations.  Cells were then fixed 
and permeabilized via the BrdU flow kit reagents.  DNase was added to the samples to 
expose DNA epitopes.  An APC-conjugated anti-BrdU antibody was used to stain for 
incorporated BrdU.  Each sample was analyzed for APC-positive staining via flow 
cytometry. 
Spot Blotting Analysis of Focal Adhesion Kinase Activation 
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Mixed ligand surfaces were generated in a 96-well plate as previously described 
and blocked with 5% non-fat dry milk in PBS for 1 hour to prevent non-specific protein 
adsorption and cell adhesion.  HT1080 cells were incubated in serum-free suspension 
(DMEM + 5% BSA) for 40 minutes with mild shaking to reduce focal adhesion kinase 
(FAK) background activation.  The cells were then seeded onto the surfaces (10,000 
cells/well) and allowed to attach for 2 h at 37°C.  For blocking experiments, cells were 
incubated in suspension for last 15 minutes in the presence of 20 µg/ml anti-human VLA-
2 (α2β1) integrin monoclonal antibody (MAB1998Z) or anti-human CD49e (α5) antibody 
and then seeded onto the surfaces for 2 h at 37°C.   
Adherent cells were washed once with DPBS and lysed with 110 µl cold 
radioimmunoprecipitation assay (RIPA) buffer (1% Triton X-100, 1% sodium 
deoxycholate, 0.1% SDS, 150 mM NaCl, 150 mM Tris-HCl pH 7.2, 350 µg/ml 
phenylmethylsulfonyl fluoride (PMSF), 10 µg/ml leupeptin, 10 µg/ml aprotinin, and 1 
mM sodium orthovanadate) for 20 min on ice.  Lysates were then split in half (to probe 
for total FAK and activated FAK) and added to the wells of a Minifold I Spot-Blot 
System (Schleicher & Schuell Bioscience) containing a 0.20 µm pore nitrocellulose 
membrane, prepared according to the instructions.  The lysates were incubated for 30 min 
and then filtered through the membrane with a vacuum for 5 min.  Membranes were 
blocked with blotto (5% non-fat dry milk, 0.02% sodium azide, 0.2% Tween 20 in PBS 
w/o Ca2+/Mg2+) overnight at 4ºC.   
The membranes were then incubated with primary antibody – anti-FAK (1 µg/ml) 
or anti-FAK pY397 (0.35 µg/ml) – in blotto for 1 h at room temperature, rocking.  
Membranes were washed in TBS-Tween (20 mM Tris HCl pH 7.6, 137 mM NaCl, 0.1% 
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Tween 20) for 30 min and incubated in secondary antibody (biotin-conjugated anti-rabbit 
IgG, 1:20,000 dilution in blotto) for 1 h at room temperature, rocking.  Membranes were 
washed again in TBS-Tween for 30 min and incubated in a tertiary or detection antibody 
(alkaline phosphatase-conjugated anti-biotin IgG, 1:10,000 dilution in blotto) for 1 h at 
room temperature, rocking.  After antibody incubation, membranes were washed in TBS-
Tween for 30 min and immunoreactivity was detected using an ECF fluorescent 
substrate.  Bands were visualized using a Fuji Image Analyzer and further quantified and 
analyzed using Adobe Photoshop software.  FAK phosphorylation levels were 
normalized to the amount of total FAK in each experimental run.   
Statistics 
All experiments were performed at least three times in triplicate unless otherwise 
noted.  Data are reported as mean ± standard error.  Results were analyzed by one-way 
ANOVA using SYSTAT 8.0 (SPSS).  If treatment level differences were determined to 
be significant, pair-wise comparisons were performed using a Tukey post-hoc test.  A 
95% confidence level was considered significant. 
Results and Discussion 
Mixed Collagen- and Fibronectin-Mimetic Surfaces 
The collagen-mimetic GFOGER peptide used in these experiments has the 
following primary sequence: GGYGGGPC(GPP)5GFOGER(GPP)5GPC.  This synthetic 
peptide has been engineered to contain the hexapeptide sequence, GFOGER, from type I 
collagen that is recognized by the α2β1 integrin.  The GPP triplets on either side of the 
GFOGER recognition site provide cooperative clusters that promote the formation of a 
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stable right-handed triple helical structure at room temperature (Knight, Morton, 
Peachey, Tuckwell, Farndale, and Barnes, 2000;Nagarajan, Kamitori, and Okuyama, 
1998;Fields and Prockop, 1996).  This triple-helical conformation is essential for integrin 
recognition and α2β1-mediated cell adhesion (Messent, Tuckwell, Knauper, Humphries, 
Murphy, and Gavrilovic, 1998;Morton, Peachey, Knight, Farndale, and Barnes, 
1997;Morton, Peachey, Zijenah, Goodall, Humphries, and Barnes, 1994).   
The fibronectin-mimetic ligand used in these experiments is FNIII7-10 (Fig. 6.1), 
a recombinant fragment of fibronectin (FN) that spans the 7-10th type III repeats of FN 
and contains the PHSRN and RGD adhesion motifs that cooperatively form the 





To create model mixed ligand surfaces, we exploited the high affinity and 
specificity of the biotin-avidin interaction.  NeutrAvidin biotin-binding protein, a 
commercially available deglycosylated avidin derivative with exceptionally low 
Figure 6.1.  The fibronectin-mimetic ligand is FNIII7-10, a 
recombinant fragment of fibronectin (FN) that spans the 7-10th  type 
III repeats of FN and contains the PHSRN and RGD adhesion 




nonspecific binding properties, was passively adsorbed onto tissue culture treated 
polystyrene as a non-fouling support layer.  To generate mixed ligand surfaces, the 
biotinylated ligands were added sequentially to the NeutrAvidin support layer.  Based on 
the significant size differences between the FNIII7-10 fragment and the GFOGER-
peptide, biotinylated fragment was introduced to the NeutrAvidin surface first for 1 hr.  
After rinsing, biotinylated GFOGER-peptide was added for an additional hour.  Control 
experiments demonstrated that only biotinylated ligands were immobilized onto the 
NeutrAvidin surfaces (data not shown).   
Relative Surface Density Measurements 
An ELISA assay was used to determine the relative ligand densities present on the 
mixed surface formulations.  For detection purposes, fluorescein was coupled to the 
terminal amine of the GFOGER peptide using NHS-fluorescein.  The immobilized 
ligands were then be detected by ELISA using anti-FN or anti-fluorescein antibodies. 
Fig. 6.2 shows the immobilized ligand densities for 4 FNIII7-10 coating concentrations 
(0, 0.2, 2.5, 5 µg/ml), each of which were incubated in 2-fold serial dilutions of 
GFOGER-peptide (from 0 to 5 µg/ml).  As expected, the density of immobilized FNIII7-
10 (Fig. 6.2, triangles, right axis) increases with increasing FNIII7-10 coating 
concentration and is insensitive to the coating concentration of GFOGER-peptide 
(horizontal axis).  This effect is due to the fact that the FN fragment is allowed to tether 
before the GFOGER peptide is introduced.  The density of tethered GFOGER-peptide 
(Fig. 6.2, circles, left axis) increases with peptide coating concentration and is modulated 
by the density of immobilized FN.   
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GFOGER - 0 FN 
GFOGER - 0.2 FN 
GFOGER - 2.5 FN
GFOGER - 5 FN
FN - 0.2 FN
FN - 2.5 FN
FN - 5 FN
Figure 6.2.  Mixed fibronectin- and collagen-mimetic surfaces. 
Varying concentrations of biotinylated FNIII7-10 and GFOGER-
peptide (FITC labeled) were tethered to passively adsorbed 
NeutrAvidin.  Relative surface density was quantified via ELISA 
using anti-FN antibody (Triangles, right axis) or anti-FITC 
antibody to detect the GFOGER-peptide (circles, left axis). 
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The leftmost GFOGER-peptide tethering profile represents a surface that contains no FN 
fragment.  As the amount of FN fragment added to the surface increases, the fragment 
begins to occupy the surface anchoring sites first, leaving less available sites for 
GFOGER peptide tethering.  This decrease in GFOGER immobilization with increasing 
amounts FNIII7-10 shifts the tethering profiles to the right, until the FN fragment is 
saturated on the surface.  The wide range of controlled mixed ligand densities generated 
by this process demonstrates the feasibility of our proposed surface engineering strategy. 
Cell Adhesion on the Mixed Ligand Surfaces 
Cell adhesion on these mixed ligand surfaces was examined using a centrifugation 
assay in which HT1080 human fibrosarcoma cells were seeded for 1 h in serum-free 
conditions and then centrifuged to detach the cells.  The resultant cell adhesion profiles 
(Fig. 6.3) correlated well with the relative ligand densities reflected in the ELISA data.  
The line graph shows that for high FNIII7-10 coating concentrations (Fig. 6.3.a, circles), 
adhesion is dominated by the FN fragment and the adhesion profiles are insensitive to 
changes in the GFOGER-peptide density, especially at low peptide densities.  It is only 
when the amount of GFOGER peptide on the surface is nearly saturated that subsequent 
increases in adhesion are observed.  As FNIII7-10 coating concentration decreases, 
adhesion drops at the lower peptide densities and the data begins to approach the more 
familiar profile of density-dependent increases in cell adhesion with increasing GFOGER 
peptide density (Fig. 6.3.a, triangles, squares).  When the FN fragment is completely 
eliminated from the surface, the adhesion profile again shifts to the right demonstrating 
the reduced adhesive potential of the single-ligand functionalized surfaces compared with 
the mixed ligands (Fig. 6.3.a, diamonds).   
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Figure 6.3.  (a)  HT1080 human fibrosarcoma cell adhesion on mixed 
ligand surfaces. (1 hour cell adhesion, 12g centrifugation for 5 min.)   (b) 
Contour plot of cell adhesion on mixed ligand surfaces. 
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A contour plot of the cell adhesion data (Fig. 6.3.b), demonstrates the adhesive advantage 
of using saturating levels of both ligands, compared to the single ligand surfaces.  
Adhesion increases with increasing FNIII7-10 until the FN fragment is saturated on the 
surface.  Adding GFOGER-peptide to this saturated level of FNIII7-10, further increases 
the surface’s adhesive potential.  Similarly, adhesion also increases with increasing 
GFOGER peptide.  Adding FNIII7-10 to the surface first results in a decrease in cell 
adhesion, due to the fact that the FNIII7-10 is occupying anchoring sites that were  
previously available to the GFOGER peptide, reducing the amount of α2β1 ligand on the 
surface.  However, high densities of both ligands results in the highest observed levels of 
cell adhesion.   
The relative contributions of the α2β1 integrin and the α5β1 integrin are 
demonstrated by blocking each integrin separately with a function blocking antibody.  
Blocking the α2β1 integrin (Fig. 6.4.a) completely eliminates the effect of increasing 
GFOGER peptide density observed in Fig. 6.3.  Adhesion increases with increasing 
FNIII7-10 density and remains insensitive to any changes in GFOGER peptide density.  
Conversely, blocking the α5β1 integrin (Fig. 6.4.b) completely eliminates the effect of 
increasing FNIII7-10 density.  Cell adhesion increases with increasing GFOGER peptide 
and the adhesion profiles are identical at two different levels of FNIII7-10 density (Fig. 
6.4.b, circles, triangles).  As expected, the blocking antibodies also eliminate any 











































































Figure 6.4.  Effects of integrin blocking on cell adhesion.  (a)  Cell 
adhesion on mixed ligand surfaces in the presence of an α2β1 integrin 
blocking antibody.  (b)  Cell adhesion on mixed ligand surfaces in the 
presence of an α5β1 integrin blocking antibody.  Squares represent 
cells seeded on increasing densities of FNII7-10 in the absence of 










FNIII7-10 Mixed GFOGER 
(a) 
(b) 
Figure 6.5.  (a)  Immunofluorescent staining for vinculin in focal 
adhesions on GFOGER, FNIII7-10, and mixed ligand surfaces.  (b) 
Immunoprecipitation for alpha 2 and blotting for alpha 5 to identify 
co-localization of the two integrins in focal adhesions. 
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Focal Adhesions on the Mixed Ligand Surfaces 
HT1080 cells were seeded onto mixed ligand surfaces for 6 hours in 10% serum 
to promote the formation of focal adhesions, which are characterized by clustered 
integrin components and intracellular structural and signaling proteins attached to the 
actin cytoskeleton.  The cells were then extracted, fixed, and stained for vinculin, an 
intracellular structural protein that localizes to focal adhesion plaques.  
Immunofluorescent staining for vinculin (Fig. 6.5.a) reveals that both the single ligand 
and the mixed ligand surfaces promote the formation of these focal adhesion structures.  
The two single ligand surfaces are characterized by several relatively small, punctate 
structures diffusely distributed around the periphery of the cell.  In contrast, the mixed 
ligand surfaces consistently promote the formation of larger, distinct adhesion plaques 
localized right at the cell edges.   
To get a better understanding of these adhesion structures, we have also 
immunoprecipitated the α2 integrin under mild lysis conditions and then blotted the IP 
fraction for the presence of the α5 integrin.  Heightened staining suggests that the two 
integrins physically co-localize to membrane complexes on the mixed surfaces to a much 
greater extent than on either of the single component surfaces (Fig 6.5.b). 
Since focal adhesions represent junctions of integrin-mediated intracellular 
signaling, these images suggest a possible advantage of the mixed ligand presentation in 
triggering post-adhesion signaling events. 
Synergistic Focal Adhesion Kinase Activation 
To analyze the effect of the mixed ligand presentations in triggering post-
adhesion signaling events, we examined the extent to which these mixed ligand surfaces  
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Figure 6.6.  Synergistic activation of focal adhesion kinase (FAK) 
on mixed ligand surfaces.  (a)  Quantification of spot blotting for 
phosphorylated tyrosine 397 on FAK (2 hour cell adhesion).  (b) 
Contour plot of FAK activation on mixed ligand surfaces. 
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trigger the activation of focal adhesion kinase (FAK), an intracellular signaling molecule 
implicated in integrin-mediated signal transduction and downstream differntiation 
pathways.  Using standard spot blotting techniques, we probed the phosphorylation of 
tyrosine 397, which is the autophosphorylation site of FAK and also binds SH2 and PI3-
K.  The results (Fig. 6.6) clearly demonstrate a synergistic activation of FAK on these 
mixed surfaces.  While FAK phosphorylation does increase with both increasing peptide 
and increasing FN fragment, we observe at least a three-fold increase in FAK activity at 
high levels of both ligands.  At saturating levels of FN fragment alone or GFOGER 
peptide alone, the FAK activity levels reach ~0.5 (rel. units); at saturating levels of both 
ligands, FAK activity is around 2.1 (rel. units).  This data underscores the advantage of 
specifically targeting more than one integrin implicated in a particular signaling pathway 
and downstream cellular effect. 
To demonstrate the integrin specificity of this synergistic effect, this assay was 
repeated using the integrin blocking antibodies (Fig. 6.7).  The leftmost data set in Fig. 
6.7 shows FAK activation in the absence of any function-blocking antibodies, which 
recapitulates the same synergistic effect of the mixed ligand presentation demonstrated in 
Fig. 6.6.  Antibody blocking of the α2 integrin reduces FAK activation on the GFOGER 
surfaces to background levels (Fig 6.7, middle).  It also eliminates the synergistic 
enhancement in signaling on the mixed ligand surfaces.  Instead the signaling is 
statistically equivalent to that of the single ligand, FN fragment surface.  A similar effect 
is observed upon blocking the α5 integrin (Fig 6.7, right).  Activation levels on the FN 
fragment surface fall to background levels and the mixed ligand surface is now 





































Figure 6.7.  Integrin specificity of synergistic FAK activation on 
mixed ligand surfaces.  Data shows tyrosine phosphorylation levels 
on the biomimetic surfaces in the absence and presence of integrin 
blocking antibodies.  * indicates greater than mixed with anti-α2 or 
anti-α5.  † indicates greater than no ligand with anti-α2.  ‡ indicates 











Figure 6.8.  Flow cytometry quantification of HT1080 cell 
proliferation using BrdU incorporation (BrdU added 24 hrs 
after cell seeding, incorporated for 12 hrs; * indicates different 














binding of these two separate integrins on the mixed ligand surface is responsible for the 
synergistic enhancement of this downstream intracellular signal. 
Proliferation on Mixed Ligand Surfaces 
To determine whether this synergy in intracellular signaling translates to a 
downstream cellular response, we examined proliferation on mixed and single ligand 
functionalized surfaces using BrdU incorporation.  Fig. 6.8 demonstrates enhanced 
proliferation rate on the mixed surfaces, paralleling both the cell adhesion and the FAK 
activation data. 
Conclusion 
The wide range of controlled mixed ligand densities generated by this process 
demonstrates the feasibility of generating integrin-specific hybrid surfaces.  We have 
shown that these mixed ligand surface formulations result in greater cell adhesion and 
focal adhesion assembly.  The mixed surfaces also trigger a synergistic activation of focal 
adhesion kinase, when compared with single ligand surfaces.  Proliferation results 
confirm that the enhanced signaling effects of mixed ligand surfaces translate to 
downstream cellular responses.   
In conclusion, we have demonstrated that the presentation of multiple integrin-
binding ligands synergize to enhance intracellular signaling and proliferation.  This study 
suggests that, instead of focusing on a single integrin-ligand interaction, in some cases it 
may be advantageous to consider the interplay of multiple integrins implicated in a 
desired cell response and their combined effect on downstream cellular signals.  This may 
allow the rational engineering of optimal biospecific surfaces for implant coatings and 
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COLLAGEN-MIMETIC, FIBRONECTIN-MIMETIC, AND MIXED 




Extracellular matrix proteins are attractive biomimetic targets for functionalizing 
orthopaedic implant surfaces in order to promote healing, bone formation, and implant 
fixation.  Extensive studies have focused on functionalizing surfaces with single integrin 
ligands, such as RGD, FN, or COL, in order to control both cell adhesion and 
differentiation.  However, these strategies are limited by lack of integrin specificity, lack 
of control over cellular and tissue responses, and lack of complexity inherent in multiple 
integrin signaling cascades. 
We target two specific integrins essential to differentiation in osteoblast cells – 
the type I collagen (COL-I) receptor α2β1 and the fibronectin (FN) receptor α5β1 – using 
the GFOGER triple helical peptide and the recombinant FNIII7-10 fibronectin fragment.  
This study compares the osseointegrative potential of these single-component integrin-
specific peptides to a mixed surface treatment presenting both peptides.  We also examine 
the efficacy of the biomimetic integrin-targeted peptides compared to their native matrix 
proteins as implant coating treatments. 
The in vivo results indicate that either of the integrin-targeted peptide treatments 
is sufficient to improve bone formation and implant mechanical integration compared to 
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unmodified titanium.  These biomimetic peptides also show improved osseointegration 
over the native matrix proteins, fibronectin and type I collagen.  However, the 
combination treatment of both biomimetic peptides did not confer any osseointegrative 
advantage over the single-component coatings.  The in vitro bone marrow stromal cell 
differentiation assays corroborate the in vivo results. 
Introduction 
Implant osseointegration, defined as close bone apposition and functional 
fixation, is a prerequisite for clinical success in orthopaedic and dental applications, many 
of which are restricted by implant loosening (Pilliar, 2005;Anderson, 2001).  
Extracellular matrices (ECMs) play critical roles in tissue morphogenesis and repair by 
providing structural and signaling scaffolds that organize, coordinate, and regulate 
cellular activities at an implantation site (De Arcangelis and Georges-Labouesse, 
2000b;Reichardt, 1999).  Therefore, extracellular matrix proteins are attractive 
biomimetic targets for functionalizing orthopaedic implant surfaces in order to promote 
healing, bone formation, and implant fixation (Hubbell, 2004a).  Extensive studies have 
focused on functionalizing surfaces with single integrin ligands, such as RGD, FN, or 
COL, in order to control both cell adhesion and differentiation.  However, these 
biomimetic strategies are limited by lack of specificity for particular integrins and 
downstream signaling events and thus allow minimal control over cell and tissue 
responses.  In addition, native ECM proteins often have binding sites for other ligands, 
such as fibronectin or von Willebrand factor.  Such ligands trigger separate signaling 
cascades that may ultimately confound phenotypic responses and interfere with 
controlled cell function.  Finally, these single-component biomimetic strategies ignore the 
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complexity of the extracellular matrix and the involvement of more than one integrin 
signaling pathway in a particular downstream cellular response. 
Our strategy to improve osseointegration of titanium implants focuses on 
mimicking multiple integrin-ECM interactions and conferring integrin specificity using 
peptides with appropriate binding sites and conformations.  We target two specific 
integrins essential to differentiation in osteoblast cells – the type I collagen (COL-I) 
receptor α2β1 and the fibronectin (FN) receptor α5β1 – using the GFOGER triple helical 
peptide and the recombinant FNIII7-10 fibronectin fragment.  This study compares the 
osseointegrative potential of these single-component integrin-specific peptides to a mixed 
surface treatment presenting both peptides.  We also examine the efficacy of the 
biomimetic integrin-targeted peptides compared to their native matrix proteins as implant 
coating treatments. 
The ligand-modified titanium surfaces are evaluated for osteoblastic 
differentiation in bone marrow stromal cells in vitro, including bone-specific gene 
expression, alkaline phosphatase activity, and mineral production.  They are also 
examined for their ability to improve peri-implant bone regeneration and mechanical 
osseointegration in a rat tibia cortical bone implant model.  This study establishes 
integrin-specific peptide implant coatings that enhance bone repair and implant 
integration for clinical orthopaedic and dental applications. 
Materials and Methods 
Cell isolation and culture 
 Primary bone marrow stromal cells were harvested from the femora of young 
adult male Wistar rats in accordance with an IACUC-approved protocol.(Maniatopoulos, 
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Sodek, and Melcher, 1988)   After excision, hindleg femora and tibiae were cleared of 
soft tissue and processed through three consecutive 15 min rinses in growth medium (α-
minimal essential medium supplemented with 10% fetal bovine serum, 1% penicillin–
streptomycin, and 0.3 µg/ml amphotericin B).  The ends of the long bones were then 
removed and the marrow space was flushed with culture medium (3-5 ml), using a 
syringe with an 18-gauge needle.  Marrow isolates were pooled, centrifuged, resuspended 
in growth medium, and seeded for adhesion-dependent selection on tissue culture 
polystyrene dishes.  Non-adherent hematopoietic cells were removed during subsequent 
medium exchanges, which occurred every other day.  Cells were subcultured every two 
days according to standard techniques.  For in vitro osteogenic assays, cells were seeded 
at 10,000 cells/cm2 in growth medium.  After 24 h, cultures were maintained in 
osteogenic medium consisting of growth medium supplemented with 50 µg/ml L-ascorbic 
acid and 3 mM sodium β-glycerophosphate. 
In vitro biomimetic surface preparation 
For the in vitro assays, tissue culture-treated polystyrene dishes were coated with 
300 Ǻ of pure titanium using an electron beam evaporator at a chamber base pressure 
between 1-2 x 10-6 torr with a deposition rate of 1.5 Å/second.  The GFOGER peptide 
and FNIII7-10 fragment were diluted to 20 µg/ml in Dulbecco’s phosphate-buffered 
saline (PBS) and incubated on the titanium surfaces for 1 h at 22ºC in preparation for all 
assays.  For mixed surfaces, the FN fragment was incubated first for 1 h, the surface was 
washed three times with PBS, ad the GFOGER peptide was incubated next for an 
additional 1 h. 
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Osteoblast-specific gene expression 
Gene expression was analyzed by qRT-PCR.(Byers et al., 2002e)  Total RNA was 
isolated at 7 days after initial cell seeding using the Qiagen RNeasy RNA isolation kit.  
During RNA isolation and purification, samples were treated with DNaseI (27 Kunitz 
units/sample) for 15 min at room temperature to eliminate any genomic DNA 
contamination. The concentration of purified RNA was quantified using a NanoDrop 
(NanoDrop Technologies) and 1 µg of total RNA was used to synthesize cDNA 
templates by oligo(dT) priming using the Superscript First-Strand cDNA Synthesis 
System.   
qRT-PCR was performed with the ABI Prism 7700 Sequence Detection System 
(Applied Biosystems; 40 cycles; melting for 15 s at 95ºC; annealing and extending for 60 
s at 60ºC) using SYBR Green DNA intercalating dye.  Gene transcript concentration in 
the sample cDNA template solutions was quantified by preparing a functional range of 
dilutions from an absolute standard for each gene.  Linear standard curves were then 
generated by plotting the log of the known concentration versus the CT value (the cycle 
number at which the fluorescence reached a threshold level).  Oligonucleotide primers 
(Table 7.1) were designed using Primer Express software (Applied Biosystems).   
 
Gene/Gen Bank 
Accession Number Forward Primer Reverse Primer 
OCN / X04141 5’-ACGAGCTAGCGGACCACATT-3’ 5’-CCCTAAACGGTGGTGCCATA-3’
BSP / J04215 5’-TGACGCTGGAAAGTTGGAGTT-3’ 5’-GCCTTGCCCTCTGCATGTC-3’ 
 
Table 7.1. Real-Time PCR Oligonucleotides for Rat Genes 
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Alkaline phosphatase biochemical activity and calcium incorporation assays 
 ALP activity was quantified at 7 days after cell seeding using a modification of 
the Sodek and Berkman method (Stephansson, Byers, and Garcia, 2002;Sodek and 
Berkman, 1987).  Briefly, cells were rinsed with PBS and scraped in cold 50 mM Tris-
HCl.  After sonication and centrifugation, the total protein concentration was quantified 
using a Pierce Micro BCA protein assay kit.  Equal amounts of protein (2.5 µg) were 
added to 60 µg/ml 4-methyl-umbelliferyl-phosphate fluorescent substrate in 
diethanolamine buffer (pH 9.5).  After a 60 min incubation at 37ºC, the fluorescence was 
read at an excitation of 360 nm and an emission of 465 nm on an HTS 7000 Plus 
BioAssay Reader (Perkin Elmer).  Enzymatic activity was standardized using purified 
calf intestinal alkaline phosphatase at known dilutions and normalized to the amount of 
total protein. 
Calcium content was determined by dissolving mineralized deposits with 1 N 
acetic acid overnight. Appropriately diluted sample (25 µl) was added to 300 µl of 
arsenazo III-containing Calcium Reagent (Diagnostic Services Ltd). The absorbance of 
the resulting samples was measured at 650 nm and compared to a linear standard curve of 
CaCl2 in 1 N acetic acid. 
Tibial implantation procedure 
 Commercially pure titanium implants (Fig. 7.1) were sonicated in de-ionized 
water for 20 min to remove surface debris.  Implants were then dipped in 4% HF for 30 
sec to remove the existing oxide layer and then incubated in 35% HNO3 for 30 min at 50 
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ºC to regenerate a new oxide coating.  Samples were transferred to 1.8 N NaOH for 1 min 
to terminate the oxidation reaction.  Implants were then rinsed and boiled in de-ionized 
water for 1 h.  To create the bioactive coating, the implants were incubated in 20 µg/ml 
GFOGER peptide, FNIII7-10, FN, or type I collagen solution for 1 h.  Mixed surfaces 
were generated by sequential adsorption of FNIII7-10 first, followed by GFOGER 









 Implantations were conducted in accordance with an IACUC-approved 
protocol.(Branemark, Ohrnell, Nilsson, and Thomsen, 1997)    Both hind legs of 
anesthetized, mature Sprague-Dawley male rats (250-350 g) were shaved and scrubbed 
with alcohol.  The medial aspect of the proximal tibial metaphysis was exposed through 
an antero-medial skin incision, leaving the medial collateral ligament intact.  Using a 
saline-cooled drill at ~2 rotations per minute (to avoid thermal trauma), two defects were 
created in each tibia.  Sterile implant rods were press fit into the defects.  Periosteum was 
mobilized and sutured over the implantation site, and the skin was closed with wound 
clips.  Subjects were euthanized after 4 weeks and proximal tibiae were fixed in neutral 
Figure 7.1.  Diagram of cylindrical titanium implant rod with tapered 
stop collar and transverse hole for pull-out mechanical testing.  The 
metal is ASTM F67 Grade 4 commercially pure titanium. 
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buffered formalin for histology or recovered without fixation and maintained in PBS-
moistened gauze for immediate mechanical testing. 
 Based on power calculations and previous reports in the literature,(Branemark, 
Ohrnell, Nilsson, and Thomsen, 1997) we estimated that a minimum of eight implants per 
experimental group are required to detect differences of 10% in mechanical testing and a 
minimum of four implants per experimental group are required for histomorphometry for 
a total of 11 implants per experimental group.  In this model, each animal receives four 
implants, two per experimental condition.  Each tibia contained two implants from the six 
conditions.  The sample conditions were distributed according to a randomized block 
design, in which the six conditions were randomized according to proximal/distal and 
left/right tibia placement, but were constrained into blocks containing one each of the six 
conditions.  Within each block, condition placement was randomized.  This results in a 
randomly distributed design that avoids instances where the same condition is implanted 
twice in a single leg.  We used a total of twenty-one animals with 14 implants per 
condition – four for histology and ten for mechanical testing.  Two additional animals 
with two implants per condition were included as extras in the event of tibia breakage 
during harvest or during the apparatus set-up for mechanical testing. 
Histology and histomorphometry analyses and mechanical testing 
 Excised tibiae were fixed in 10% neutral buffered formalin for 1 week.  Samples 
were then embedded, ground, and stained by Wasatch Histo Consultants, Inc.  Briefly, 
the formalin-fixed tibiae were dehydrated in a graded series of alcohol incubations and 
then embedded in poly(methyl methacrylate).  Ground sections of 50-80 µm were 
generated using the Exakt Grinding System.  Two longitudinal ground sections were 
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generated per tibia, each containing two titanium plugs inserted transverse to the tibia’s 
long axis.  Sections were then stained with Sanderson’s Rapid Bone Stain™ and a van 
Gieson counter stain.  Bone implant contact (BIC) was measured as the percentage of 
implant’s circumference that was in direct contact with bone tissue (Adobe Photoshop CS 
imaging software). 
 Implant mechanical fixation to the bone was measured with a pull-out force test 
using a biomechanical testing apparatus (EnduraTEC Bose ELF 3200).  Immediately 
after explantation, tibiae were cleaned of all soft tissue and prepared for mechanical 
testing.  The ends of each excised tibia were secured in a custom designed holding 
apparatus with the exposed head of each implant facing in the direction of the pull motion 
and centered along the axis of motion. A 0.014” diameter piano wire was threaded 
through the implant head and both wire ends attached firmly to an 11 lb. INTERFACE 
load cell. Samples were pre-loaded with 2 N to ensure proper and identical wire tautness 
among implants. Tests were performed at a constant force rate of 0.2 N/sec using 
WINTEST application software. The direction of the pull was parallel to the long axis of 
the implant. The pull-out force (N) was the maximum load achieved before failure and 
was determined from the recorded load vs. displacement data. 
 Statistics 
Data are reported as mean ± standard error.  Results were analyzed by one-way 
ANOVA using SYSTAT 8.0 (SPSS).  If treatment level differences were determined to 
be significant, pair-wise comparisons were performed using a Tukey post-hoc test.  A 
95% confidence level was considered significant.  All of the in vitro assays were 
performed as two separate experiments in triplicate.  The quantitative histomorphometry 
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consisted of a total sample size of seven implants per condition.  The mechanical testing 
consisted of a total sample size of nine implants per condition. 
Results 
In Vitro Osteoblastic Differentiation on Biomimetic Peptide Coatings 
In vitro rat bone marrow stromal cell differentiation assays were performed 
concurrently with the in vivo osseointegration study.  To reproduce titanium implant 
surfaces in vitro, polystyrene culture dishes were coated with a 300 Ǻ titanium layer via 
electron beam evaporation.  The biomimetic peptides and matrix proteins were then 
passively adsorbed onto the titanium at a concentration of 20 µg/ml, creating the integrin-
targeted bioactive coating.  Mixed ligand surfaces were generated by sequential 
adsorption of the fibronectin fragment and the GFOGER peptide 
To investigate the osteoblastic differentiation potential of these surfaces, we used 
quantitative RT-PCR (qRT-PCR) to probe osteoblast-specific gene expression in 7 day 
cultures of bone marrow stromal cells (Fig. 7.2).  For both bone sialoprotein (BSP) and 
osteocalcin (OCN), qRT-PCR revealed greater levels of gene expression on the 
GFOGER-peptide surfaces compared with untreated titanium.  These expression levels 
were equivalent to those observed on surfaces coated with native type I collagen.  The FN 
fragment and mixed ligand surfaces did not enhance BSP and OCN gene expression 
compared to control titanium. 
Osteoblastic differentiation is also characterized by the activation of multiple 
proteins, including alkaline phosphatase (ALP).  The ALP enzyme is often used as a 
marker for osteoblastic metabolic activity and an early indicator of osteoblastic 











































































































Figure 7.2.  GFOGER surfaces enhance the expression of multiple 
osteoblast-specific genes.  Data represent osteoblast-specific gene 
expression measured by qRT-PCR for osteocalcin (OCN), and bone 
sialoprotein (BSP) in rat bone marrow stromal cells seeded for 7 
days on biomimetic surfaces, native matrix proteins or untreated Ti. 
BSP ANOVA: p<0.0007, *GFOGER, COLI > Ti (p<0.003); OCN 



































































































































Figure 7.3.  Biomimetic surfaces enhance (a) alkaline 
phosphatase (ALP) activity and (b) matrix calcification in rat 
bone marrow stromal cultures compared to untreated titanium 
(Ti).  ALP ANOVA: p<0.0004, *GFOGER, FNIII, Mixed > 
Ti (p<0.02); Ca+2 ANOVA: p<0.0007, *GFOGER, FNIII, 
Mixed > Ti (p<0.01). 
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levels of activation on the GFOGER-peptide, FN fragment, and mixed ligand coatings 
compared to untreated titanium (Fig. 7.3.a).  Because ALP is the enzyme responsible for 
hydrolyzing phosphate esters and inducing bone mineralization,(Aubin and Liu, 1996) 
these results suggest that this bioactive surface treatment may also be capable of 
promoting enhanced bone matrix mineralization. 
Mineralization was examined as an in vitro end-point indicator of the osteoblastic 
phenotype in the bone marrow stromal cells.  Calcium phosphate mineral deposition was 
examined after 14 days in culture using calcium content analysis.  Cultures on GFOGER-
, FN fragment, and mixed ligand-treated surfaces displayed nearly two-fold enhancement 
in calcium-based mineral deposition compared to untreated titanium (Fig. 7.3.b).  These 
results verify the advantageous effects of controlled integrin-binding on cell function, in 







In Vivo Osseointegration of Biomimetic Peptide Coatings 
 To evaluate the performance of the bioactive treatments in vivo, we quantified 
osseointegration in a rat tibia cortical bone model using quantitative histomorphometry 
and pull-out mechanical testing.(Branemark, Ohrnell, Nilsson, and Thomsen, 1997)  We 
designed a cylindrical titanium implant rod with a tapered stop collar (Fig. 7.1).  The 
 Total Number of Samples 
Implant Surface Histomorphometry Mechanical Testing 
GFOGER  4 10 
FNIII7-10 4 10 
Mixed 4 10 
Type I Collagen 4 10 
Fibronectin 4 10 
Ti 4 10 
Table 7.2. Design for 
osseointegration study. 
Samples were implanted 
using a randomized 
block design.  A total of 
21 animals were 
included in the study.  
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tapered head ensures that all implants are inserted into the bone at the same depth, 
guaranteeing uniform bone contact among treatments.  Using a saline-cooled drill, two 
defects 2 mm in diameter were created in the medial aspect of the proximal tibial 
metaphysis.  Titanium implant rods were press fit into the cortical defects.   Table 7.2 
shows the six coating treatments that were evaluated in this study.  After four weeks, the 
rat tibiae were harvested and evaluated for bone apposition by histological staining and 
mechanical integration by pull-out testing.  Histological sections revealed substantial and 
contiguous bone mineral along the periphery of GFOGER-treated, FNIII7-10-treated, and 
mixed ligand-treated titanium implants (Fig. 7.4.a), with no apparent increase in bone 
formation on the mixed ligand condition.  Less bone mineral is visible on surfaces treated 
with the native proteins, FN and type I COL, and the adjacent mineral appears more 
porous.  Significantly less mineral staining was visible on untreated titanium and the 
mineral deposits appear in isolated patches along the surface of the implants.  Image 
quantification to determine the percentage of the bone-implant apposition (bone implant 
contact, BIC) demonstrated a nearly forty percent enhancement in bone apposition on the 
collagen-mimetic, fibronectin-mimetic, and mixed ligand surfaces compared to untreated 
titanium (Fig. 7.4.b).  Again, no advantage is evident with the combination treatment.  
However, the two single component biomimetic peptides induced greater bone formation 
and apposition than either of native ECM protein coatings, demonstrating the benefit of 
integrin-target mimetic peptides over whole biomolecules.  
Pull-out mechanical testing results reflected the same trends observed in the 
histology and histomorphometry data.  Mechanical testing demonstrated significantly 

















Figure 7.4.  Biomimetic surfaces improve peri-implant bone formation and 
mechanical osseointegration in an in vivo rat tibia cortical bone implantation 
model.  (a)  Representative micrographs show 50-80 µm longitudinal ground 
sections of rat tibia stained with Sanderson’s Rapid Bone Stain™ and van 
Gieson counterstain.  Cells stain dark to light blue, soft tissue elements stain 
blue-green, and bone matrix stains yellow orange to autumn orange.  (b)
Biomimetic surfaces exhibit greater amounts of newly formed bone at the 
implant surface compared with untreated Ti or native ECM proteins.  Bone 
apposition is measured as the percentage of implant’s circumference that is in 
direct contact with bone mineral in the histological sections.  ANOVA: p<4E-
6, *GFOGER, Frag, Mixed > Ti (p<0.002), †GFOGER > COL (p<0.01), 



































































































































Figure 7.5.  Biomimetic surfaces demonstrate greater mechanical integration 
with the surrounding tissue compared with untreated Ti or native ECM 
proteins.  Osseointegration is measured as the maximum force [N] necessary 
to dislodge the implant in a pull-out test.  ANOVA: p<9E-7, *GFOGER, 
Frag, Mixed > Ti (p<0.0009), †GFOGER > COL (p<0.01), ‡Frag > FN 
(p<0.004).   
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titanium (Fig. 7.5).  No additional mechanical benefit was conferred by the mixed ligand 
treatment, confirming the results from the bone apposition analysis.  Once more, the two 
biomimetic peptide coatings outperformed both of the native protein coatings. 
These results demonstrate a greater quantity and continuity of peri-implant bone 
mineral on the integrin-targeted peptide surfaces in vivo as well as enhanced mechanical 
integrity and osseointegration when compared with either untreated titanium or titanium 
treated with native fibronectin or type I collagen.  However, the two single biomimetic 
peptide treatments were sufficient to enhance bone mineral formation and mechanical 
osseointegration, and there was no additional advantage demonstrated by the mixed 
ligand presentation. 
Discussion 
 This work evaluates the ability of two peptide coatings to improve bone 
regeneration and osseointegration, alone and in combination, by exploiting their specificy 
for integrins that are critical to osteoblast differentiation – the collagen-binding α2β1 and 
fibronectin-binding α5β1.  In particular, type I collagen modulates intracellular signal 
transduction by binding to the α2β1 integrin, which enhances the expression of the 
osteoblastic phenotype (Suzawa, Tamura, Fukumoto, Miyazono, Fujita, Kato, and 
Takeuchi, 2002;Mizuno and Kuboki, 2001;Mizuno, Fujisawa, and Kuboki, 2000;Jikko, 
Harris, Chen, Mendrick, and Damsky, 1999;Xiao, Wang, Benson, Karsenty, and 
Franceschi, 1998;Takeuchi, Suzawa, Kikuchi, Nishida, Fujita, and Matsumoto, 1997a).  It 
also exhibits low immunogenicity and high conformational stability, making it extremely 
suitable for implantation.  Osteoblasts and osteoprogenitor cells also express α5β1, the 
principal FN receptor (Gronthos, Stewart, Graves, Hay, and Simmons, 1997).  Adhesive 
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interactions involving α5β1 and FN have also been identified as central to osteoblastic 
functions.   
However, designing surface treatments using whole matrix molecules, such as 
type I collagen or FN, is often limited by a lack of specificity for particular integrins and 
thus exhibit minimal control over cellular responses.  In addition, native matrix proteins 
often have binding sites for other ligands, such as fibronectin or von Willebrand factor.  
Such ligands may trigger separate signaling cascades that may ultimately confound 
phenotypic responses and interfere with desired cell function.   
The advantage of the short biomimetic peptides over the native ECM proteins was 
evident in the in vivo osseointegration study.  The cortical bone implantation studies 
revealed greater bone tissue formation on the surface of GFOGER-treated and FNIII7-10-
treated titanium implants, in terms of both quantity and connectivity, compared to control 
titanium.  The bone formation on the biomimetic peptides was also significantly greater 
than that observed on the surfaces treated with the native collagen and fibronectin 
molecules.  
 Most significantly, we have shown that the GFOGER peptide and the FN 
fragment improved the titanium implant’s mechanical fixation and functional 
osseointegration as determined by a quantitative pull-out test.  Again, mechanical pull-
out load was greater on the peptide coatings compared to the full matrix biomolecules.  
Faster integration of these biomimetic peptide-coated implants would result in sooner and 
more reliable loading in a clinical setting, improving device function and patient 
outcomes.   
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However, is interesting to note that the combination treatment of both GFOGER-
peptide and FN fragment did not confer any additional advantage over the single peptide 
coatings with respect to bone formation, apposition, or mechanical fixation.  It is possible 
that either one of the integrin-targeted peptides saturates the osteogenic potential of the 
α2β1 and α5β1 signaling pathways.  For example, the presence of an α2β1-binding peptide 
on the implant surface many induce cells at the interface to produce the corresponding 
α5β1-binding protein and vice versa, thus maximizing the integrin-based osteogenic 
signaling environment.  In this case, a mixed ligand presentation has no additional 
benefit. 
The data also demonstrates that GFOGER-peptide improves bone formation and 
osseointegration in vivo to a much greater extent than native type I collagen.  However, in 
vitro, these two treatments are equivalent.  This is most likely due to the heterogeneous 
cell population encountered in vivo.  In that environment, the full collagen molecule may 
have multiple effects on a variety of non-osteoblastic cell types.  These effects may 
modulate or confound collagen’s enhancement of osteoblastic signaling.  Because of 
GFOGER-peptides’ short, integrin-targeted design, many of these effects are eliminated, 
thus enhancing its specificity for osteoblastic cells.  This specificity allows the peptide to 
encourage an osteogenic cell population at the surface of the implant.   
Not only do these bioactive coatings enhance bone formation and implant 
integration, but they also created using a single-step procedure conducted under 
physiological conditions, thus eliminating the cytotoxicity and biocompatibility concerns 
associated with covalent immobilization methods.  As such, these peptide surface 
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treatments represent a simple, clinically relevant approach to improving orthopaedic and 




SUMMARY OF CONCLUSIONS 
 
Bioactive surfaces that provide specific signals to cells through well-characterized 
integrin-ligand interactions may lead to controlled cellular responses and improved tissue 
formation in tissue engineering and wound healing applications.  The first goal of this 
study was to engineer stable bioadhesive surfaces that specifically target the α2β1 
integrin, allowing us to directly control intracellular signaling and, ultimately, cell 
function.  We designed a stable triple-helical, collagen-mimetic peptide that contains the 
GFOGER adhesion motif from type I collagen.  The peptide has the following primary 
sequence: GGYGGGPC(GPP)5GFOGER(GPP)5GPC.  The GPP triplets on either side of 
the GFOGER recognition site provide cooperative clusters that promote the formation of 
a stable right-handed triple helical structure at room temperature (Knight, Morton, 
Peachey, Tuckwell, Farndale, and Barnes, 2000;Nagarajan, Kamitori, and Okuyama, 
1998;Fields and Prockop, 1996).  This triple-helical conformation is essential for integrin 
recognition and α2β1-mediated cell adhesion (Messent, Tuckwell, Knauper, Humphries, 
Murphy, and Gavrilovic, 1998;Morton, Peachey, Knight, Farndale, and Barnes, 
1997;Morton, Peachey, Zijenah, Goodall, Humphries, and Barnes, 1994). 
We demonstrate that the GFOGER peptide specifically targets the α2β1 integrin 
receptor, and its cell adhesion activity is comparable to that of type I collagen.  We have 
also verified its activity using several surface modification techniques, including passive 
adsorption, specific noncovalent surface interaction, and covalent immobilization, 
demonstrating that this triple helical peptide represents a robust and versatile approach to 
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the design of bioadhesive surfaces that specifically target the α2β1 integrin.  Surface 
immobilization remains the most promising method for incorporating the GFOGER 
peptide into applications that benefit from enhanced control over cell function due to 
higher adhesion activity and greater surface stability.    
In terms of a viable surface modification scheme, these studies reveal that this 
adhesion-promoting synthetic peptide of minimal recognition sequence and specific 
tertiary conformation can be covalently grafted to a stable, non-adhesive substrate to 
produce biologically active, chemically well-defined surfaces that support α2β1-specific 
cell adhesion.  Controlling integrin binding through covalent surface modification in turn 
allows us to optimize cell function for applications such as biomaterials processing and 
tissue engineering scaffold design.  In addition, these surfaces may be useful in the study 
of fundamental α2β1-mediated adhesion events in various cell models and 
biotechnological applications. 
The α2β1 integrin interaction with type I collagen is a crucial signal for the 
induction of osteoblastic differentiation and matrix mineralization.  The integrin-
specificity of the GFOGER-peptide makes it a very attractive candidate for engineering 
surfaces to promote osteoblastic differentiation and bone formation.  Next, we explored 
whether this integrin-specific peptide is capable of promoting similar signaling events 
and differentiation responses as native type I collagen in the osteoblast cell model.  We 
demonstrate that this α2β1 integrin-specific GFOGER-peptide triggers the activation of 
FAK and alkaline phosphatase in MC3T3-E1 murine immature osteoblast-like cells.  
These surfaces also support the expression of multiple osteoblast-specific genes and the 
mineralization of the ECM in a manner similar to type I collagen, suggesting that this 
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triple-helical peptide represents a robust approach to the design of collagen-mimetic 
bioadhesive surfaces that specifically target the α2β1 integrin.  Controlling specific 
integrin binding through this biomolecular surface modification strategy may allow the 
optimization of cell function, in particular osteoblastic differentiation, for applications 
such as orthopedic biomaterials and bone tissue engineering scaffold design.   
Implant osseointegration, defined as close bone apposition and functional 
fixation, is a prerequisite for clinical success in orthopaedic and dental applications, many 
of which are restricted by implant loosening (Pilliar, 2005),(Anderson, 2001).  Surface 
modification approaches have had limited success in promoting integration.  Our strategy 
to improve osseointegration of titanium implants focused on presenting the GFOGER 
collagen-mimetic peptide that triggers α2β1 cellular integrin receptor binding, which is 
crucial for bone mineral deposition.  We have demonstrated that titanium surfaces 
presenting integrin-specific GFOGER peptide trigger osteoblastic differentiation in bone 
marrow stromal cells, including bone-specific gene expression, alkaline phosphatase 
activity, and mineral deposition, leading enhanced osteoblastic function compared to 
unmodified orthopaedic-grade titanium.   
To evaluate the performance of the bioactive GFOGER peptide treatment in vivo, 
we quantified osseointegration in a rat tibia cortical bone model using quantitative 
histomorphometry and pull-out mechanical testing (Branemark, Ohrnell, Nilsson, and 
Thomsen, 1997).  Our studies revealed greater bone tissue formation on the surface of 
GFOGER-treated titanium implants, in terms of both quantity and connectivity.  Most 
significantly, we have shown that the GFOGER peptide coating improved the implant’s 
mechanical fixation and functional osseointegration as determined by a quantitative pull-
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out test.  Faster integration of these GFOGER coated implants would result in sooner and 
more reliable loading in a clinical setting, improving device function and patient 
outcomes.   
Not only does this bioactive coating enhance bone formation and implant 
integration, but it is also created using a single-step procedure conducted under 
physiological conditions, thus eliminating the cytotoxicity and biocompatibility concerns 
associated with covalent immobilization methods.  As such, this GFOGER peptide 
surface treatment represents a simple, clinically relevant approach to improving 
orthopaedic and dental titanium implant integration.   
Cell adhesion to the extracellular matrix (ECM) through cell-surface integrin 
receptors is essential to development, wound healing, and tissue remodeling, and 
therefore represents a central theme in the design of bioactive surfaces that successfully 
interface with the body.  Extensive studies have focused on functionalizing surfaces with 
single integrin ligands, such as RGD, FN, or COL, in order to control both cell adhesion 
and differentiation.  However, the native cellular environment is characterized by a 
variety of matrix proteins that target multiple integrins implicated in a downstream 
cellular response.  Conversely, many biomimetic strategies are limited by low activity of 
the oligopeptides compared to the native ligand due to the absence of complementary or 
modulatory domains (Garcia, Schwarzbauer, and Boettiger, 2002).   
As an alternative strategy, we have focused on engineering high molecular weight 
ligands that recapitulate the primary, secondary, and tertiary structure of the native matrix 
protein in order to reconstitute full biological activity as well as integrin binding 
specificity.  The recombinant fragment of FN encompasses both the PHSRN sequence in 
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the 9th type III repeat and RGD motif in the 10th type III repeat of FN in their native 
structural orientations and is therefore specific for the α5β1 integrin.  The GFOGER 
peptide mimics the triple-helical structure of native type I collagen and targets the α2β1 
integrin.   
The objective of our next study was to engineer bioactive hybrid surfaces that 
control cell function by mimicking two separate integrin interactions, α5β1 and α2β1, 
using the FN- and collagen-mimetic ligands to mimic signals from native ECM.  Both of 
these integrin-ligand interactions have been implicated in several differentiation 
pathways, including osteoblastic differentiation.  Our strategy used mixed biotinylated 
ligands on avidin substrates, providing a simple and easily controlled approach to 
efficiently screen a large number of mixed surface compositions using short term assays. 
The wide range of controlled mixed ligand densities generated by this process 
demonstrates the feasibility of generating integrin-specific hybrid surfaces.  We have 
shown that these mixed ligand surface formulations result in greater cell adhesion and 
focal adhesion assembly.  The mixed surfaces also trigger a synergistic activation of focal 
adhesion kinase, when compared with single ligand surfaces.  Proliferation results 
confirmed that the enhanced signaling effects of mixed ligand surfaces translate to 
downstream cellular responses.   
We have demonstrated that the presentation of multiple integrin-binding ligands 
synergize to enhance intracellular signaling and proliferation.  This study suggests that, 
instead of focusing on a single integrin-ligand interaction, in some cases it may be 
advantageous to consider the interplay of multiple integrins implicated in a desired cell 
response and their combined effect on downstream cellular signals.  This may allow the 
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rational engineering of optimal biospecific surfaces for implant coatings and tissue 
engineering scaffolds that exploit that complexity of the extracellular matrix and its 
signaling characteristics. 
Extracellular matrix proteins are attractive biomimetic targets for functionalizing 
orthopaedic implant surfaces in order to promote healing, bone formation, and implant 
fixation.  We target two specific integrins essential to differentiation in osteoblast cells – 
the type I collagen (COL-I) receptor α2β1 and the fibronectin (FN) receptor α5β1 – using 
the GFOGER triple helical peptide and the recombinant FNIII7-10 fibronectin fragment.  
Our final study compared the osseointegrative potential of these single-component 
integrin-specific peptides to a mixed surface treatment presenting both peptides.  We also 
examine the efficacy of the biomimetic integrin-targeted peptides compared to their 
native matrix proteins as implant coating treatments. 
The advantage of the short biomimetic peptides over the native ECM proteins was 
evident in the in vivo osseointegration study.  The cortical bone implantation studies 
revealed greater bone tissue formation on the surface of GFOGER-treated and FNIII7-10-
treated titanium implants, in terms of both quantity and connectivity, compared to control 
titanium.  The bone formation on the biomimetic peptides was also significantly greater 
than that observed on the surfaces treated with the native collagen and fibronectin 
molecules.  
 Most significantly, we have shown that the GFOGER peptide and the FN 
fragment improved the titanium implant’s mechanical fixation and functional 
osseointegration as determined by a quantitative pull-out test.  Again, mechanical pull-
out load was greater on the peptide coatings compared to the full matrix biomolecules.  
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Faster integration of these biomimetic peptide-coated implants would result in sooner and 
more reliable loading in a clinical setting, improving device function and patient 
outcomes.   
However, is interesting to note that the combination treatment of both GFOGER-
peptide and FN fragment did not confer any additional advantage over the single peptide 
coatings with respect to bone formation, apposition, or mechanical fixation.  It is possible 
that either one of the integrin-targeted peptides saturates the osteogenic potential of the 
α2β1 and α5β1 signaling pathways.  For example, the presence of an α2β1-binding peptide 
on the implant surface many induce cells at the interface to produce the corresponding 
α5β1-binding protein and vice versa, thus maximizing the integrin-based osteogenic 
signaling environment.  In this case, a mixed ligand presentation has no additional 
benefit. 
In conclusion, this thesis proposes a specific biomolecular strategy to engineer 
implant surfaces that enhance bone formation and osseointegration.  By achieving the 
three specific aims previously outlined, we achieved the following outcomes.  First, we 
designed and evaluated a collagen mimetic peptide as an α2β1 integrin-specific surface 
modification agent for biomaterials, implant surface treatments, and tissue engineering 
scaffolds.  This peptide was verified in the osteoblast cell model, but may be applied to 
several other cell systems that express α2β1, including platelets, epithelial cells, 
fibroblasts, chondrocytes, endothelial cells, and lymphocytes.  We also established the 
extent to which the presentation of multiple integrin-binding ligands synergize to enhance 
intracellular signaling.  This allows for the rational engineering of optimal biospecific 
surfaces for implant coatings and tissue engineering scaffolds.  Finally, by analyzing the 
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osseointegrative properties of these bioinspired materials, we have established the 
potential of this biomimetic ligand approach as a beneficial surface treatment for 
orthopaedic implants.  As a whole, this project has established a targeted biomolecular 
surface engineering strategy for designing and optimizing biologically active implant 





We heave demonstrated that GFOGER-peptide passively adsorbed to titanium 
implant surfaces enhances peri-implant bone formation, apposition, and mechanical 
integration.  The main advantage of this approach is the simplicity of the single-step 
surface coating, compared to covalent modifications schemes.  However, future work 
might focus on determining whether covalent tethering would provide additional benefits 
in an osseointegration model.  While the processing steps for covalent surface 
modification are more complex, tethering allows prolonged and controlled exposure to 
the biomimetic ligand.  Optimal surface densities for osteoblastic differentiation can be 
determined in vitro and applied to the implant surfaces.   
A surface tethering approach would also allow control over the background 
surface.  With our passive adsorption study, the background titanium was left unblocked 
and thus able to non-specifically adsorb proteins from implant site.  With a covalent 
crosslinking scheme, the anchoring groups can be engineered to present a non-adhesive, 
non-fouling background surface, allowing precise control over the ligands presented to 
the cells at the implant interface.   
One potential system for peptide tethering is mixed self-assembled monolayers 
(SAMs) of alkanethiols on gold, which represent a robust, controlled, and stable system 
for long term assays.  Mixed SAMs of an EG3-terminated thiol 
[HS(CH2)11(OCH2CH2)3OH] and an EG6COOH-terminated thiol 
[HS(CH2)11(OCH2CH2)6OCH2CO2H] can be used to generate various surface 
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compositions (EG = ethylene glycol) (Fig. 9.1).  The EG3 moiety provides a non-fouling, 
protein-resistant background while the COOH group provides a versatile functionality for 
tethering the GFOGER-peptide, fibronectin-mimetic ligand, or other bio-inspired 
molecules using conventional EDC/NHS bioconjugation chemistry.  This system has 
been validated for the immobilization of several peptides and proteins by Whitesides and 
colleagues.(Lahiri et al., 1999)   Other possible non-fouling covalent tethering systems 
include PEG brushes grown on titanium and titanium coated with PEG-based polymer 
networks. 
Future studies might also focus on combining the GFOGER-peptide with other 
implant surface technologies to enhance osseointegration, such as physicochemical or 
morphological surface treatments.  In particular, several in vivo and in vitro studies have 
focused on generating surfaces with rough microtopographies to improve osteoblast 
differentiation and bone formation (Lossdorfer, Schwartz, Wang, Lohmann, Turner, 
Wieland, Cochran, and Boyan, 2004;Boyan, Lossdorfer, Wang, Zhao, Lohmann, 
Cochran, and Schwartz, 2003;Li, Ferguson, Beutler, Cochran, Sittig, Hirt, and Buser, 
2002;Martin, Schwartz, Hummert, Schraub, Simpson, Lankford, Jr., Dean, Cochran, and 
Figure 9.1.  Mixed EG6COOH/EG3 SAM 
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Boyan, 1995;Groessner-Schreiber and Tuan, 1992;Buser, Schenk, Steinemann, Fiorellini, 
Fox, and Stich, 1991;Roberts, Smith, Zilberman, Mozsary, and Smith, 1984).  In vivo 
studies have demonstrated that rougher surfaces promote higher levels of bone formation 
and apposition compared to smoother surfaces (Buser, Schenk, Steinemann, Fiorellini, 
Fox, and Stich, 1991) and exhibit increased removal torque (Li, Ferguson, Beutler, 
Cochran, Sittig, Hirt, and Buser, 2002).  In vitro studies reveal that microrough implant 
surface topographies improve the phenotypic expression of osteoblast-like cells (Martin, 
Schwartz, Hummert, Schraub, Simpson, Lankford, Jr., Dean, Cochran, and Boyan, 
1995;Groessner-Schreiber and Tuan, 1992), promote the formation of an osteogenic 
microenvironment (Boyan, Lossdorfer, Wang, Zhao, Lohmann, Cochran, and Schwartz, 
2003), and reduce osteoclast formation and activity (Lossdorfer, Schwartz, Wang, 
Lohmann, Turner, Wieland, Cochran, and Boyan, 2004).  These results have lead to the 
development of several methods to produce rougher implant surfaces, including plasma-
spraying, acid etching, and sandblasting as well as sintered-bead and metal fiber surfaces.  
These surface roughness approaches not only improve mechanical interlocking and 
stability and enhance surface area for greater binding of attachment proteins and growth 
facts, but they also alter phenotypic expression in osteoblast (Schwartz and Boyan, 1994).  
However, while these approaches are generally successful, they can be restricted by slow 
rates of osseointegration and poor mechanical anchorage in challenging clinical cases, 
such as those associated with large bone loss and poor bone quality (Bauer and Schils, 
1999a).  These limitations might be alleviated by a combination of microrough implant 
surfaces with bioactive peptide surface coatings to improve osseointegration at all time 
points of implant healing. 
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Our results from the in vitro mixed ligands studies were very promising.  We 
demonstrated synergistic enhancement of intracellular signaling with the combined 
presentation of GFOGER-peptide and FNIII7-10.  Proliferation results confirmed that the 
enhanced signaling effects of mixed ligand surfaces translate to downstream cellular 
responses.  While the mixed ligand presentation did not offer any additional advantage 
over the single ligands in an osseointegration model, mixed integrin-targeted approaches 
may be able to enhance cellular response in other applications.  This strategy can be 
examined in other systems, such as chondrocyte differentiation or angiogenesis. 
Finally, we have demonstrated the ability of the GFOGER-peptide to improve 
bone formation in an implant osseointegration application.  This collagen-mimetic 
peptide might also be applied to other orthopaedic applications, such as bone tissue 
engineering.  We have already presented schemes for covalently tethering the peptide to 
carboxyl groups on a surface.  This is a very versatile bioconjugation technique that can 
easily be applied to polymeric scaffolds to enhance cell adhesion and bone in-growth.   
The biomolecular approach validated in this thesis provides a versatile and robust 
strategy for developing bioactive surfaces that support osteoblastic differentiation and 
enhance bone repair.  Due to the fundamental character of the receptor-ligand principles 
addressed in this research project, these general engineering strategies can also be applied 
to a variety of other cell systems in the body and may well contribute to the genesis of 




A CENTRIFUGATION CELL ADHESION ASSAY FOR HIGH-




 A quantitative analysis of cell adhesion is essential in understanding physiological 
phenomena and designing biomaterials, implant surfaces, and tissue engineering 
scaffolds.  The most common cell adhesion assays used to evaluate biomaterial surfaces 
lack sensitivity and reproducibility and/or require specialized equipment and skill-
intensive operation.  We describe a modified centrifugation cell adhesion assay that 
employs simple and convenient techniques using standard laboratory equipment and 
provides reliable, quantitative measurements of cell adhesion.  This centrifugation assay 
applies controlled and uniform detachment forces to a large population of adherent cells, 
providing robust statistics for quantifying cell adhesion.  The applicability of this system 
to the design and characterization of biomaterial surfaces is demonstrated by evaluating 
cell adhesion on substrates using different coating proteins, cell types, seeding times, and 
relative centrifugal forces (RCF).  Results verify that this centrifugation cell adhesion 
assay represents a simple, convenient, and standard method for high-throughput 
characterization of a variety of biomaterial surfaces and conditions. 
*Modified from Reyes,C.D. & Garcia,A.J. A centrifugation cell adhesion assay for high-
throughput screening of biomaterial surfaces. J. Biomed. Mater. Res. A 67, 328-333 (2003). 
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INTRODUCTION 
Cell adhesion to extracellular matrix proteins influences cellular morphology and 
migration and provides signals that direct cell proliferation, migration, and differentiation 
(Hynes, 2002;Hynes, 1992).  Soluble adhesion proteins, such as vitronectin and 
fibronectin, present in blood plasma, peritoneal exudates, and tissue culture solutions 
adsorb onto biomaterial surfaces (Horbett, 1996).  Since cells respond specifically to 
these proteins, subsequent cell adhesion to this interfacial protein film ultimately directs 
physiological responses to implanted surfaces.  Therefore, a quantitative analysis of cell 
adhesion is essential in understanding physiological phenomena and designing 
biomaterials, implant surfaces, and tissue engineering scaffolds. 
Cell attachment to surfaces may be influenced by a diverse range of factors, 
including cellular properties, the physical and chemical properties of the underlying 
biomaterial, interfacial chemical conditions, and protein adsorption.  Methods for 
examining cell adhesion on various surfaces generally focus on measuring the relative 
ability of adherent cells to remain attached when exposed to a detachment force(Weiss, 
1961).  The simplest and most common adhesion assay consists of seeding cells onto 
substrates of interest, washing off “non-adherent” cells with a physiological buffer, and 
counting the remaining cells.  Although these wash assays provide qualitative 
observations of cell attachment, they are limited by a lack of sensitivity and 
reproducibility due to the application of uneven, unknown detachment forces.  These 
limitations often mask important differences among treatments and generally provide 
inconclusive or contradictory information. 
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 In order to obtain reproducible and reliable measurements of cell adhesion, 
several quantitative adhesion assays have been developed (Bundy et al., 2001;Nauman et 
al., 1999;Chesla et al., 1998;Garcia et al., 1997;Nugiel et al., 1996;Usami et al., 
1993;Evans et al., 1991;Truskey and Pirone, 1990;Lotz et al., 1989;Horbett et al., 
1988;Lawrence et al., 1987;Hertl et al., 1984;McClay et al., 1981;Doroszewski et al., 
1977;Mohandas et al., 1974).  These assays are generally classified according to the 
nature of the force used in the detachment process and often fall into the categories of 
micromanipulation, hydrodynamic shear, and centrifugation.  While these assays provide 
quantitative measurements of cell adhesion, most configurations require specialized 
equipment and/or time- and skill-intensive operation.  In contrast, centrifugation assays 
employ simple and convenient techniques using standard laboratory equipment and 
provide reliable, quantitative measurements of cell adhesion.  In this configuration, a 
substrate containing adherent cells is spun at a particular speed to apply a controlled 
detachment force perpendicular to the cell-substrate contact area (Giacomello et al., 
1999;Lotz, Burdsal, Erickson, and McClay, 1989;Hertl, Ramsey, and Nowlan, 
1984;McClay, Wessel, and Marchase, 1981).  The applied detachment force can be 
varied over a range of speeds and may be applied for selected intervals of time.  
However, only a single force can be applied per experiment and, in some cases, the 
cellular attachment strength may exceed the forces developed in the centrifuge system.  
We describe a modified centrifugation cell adhesion assay that applies controlled and 
uniform detachment forces to a large population of adherent cells, providing robust 
statistics for quantifying cell adhesion.  The applicability of this system in biomaterials 
design/characterization is demonstrated by evaluating cell adhesion on substrates using 
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different adsorbed protein layers, cell types, seeding times, and relative centrifugal forces 
(RCF).  This assay represents a simple, convenient, and standard method for high-
throughput characterization of a variety of biomaterial surfaces and conditions. 
Materials and Methods 
Cells and Reagents 
HT1080 human fibrosarcoma cells (CCL-121, American Type Culture Collection, 
Manassas, VA) were grown in Dulbecco’s Modified Eagle medium containing 10% fetal 
bovine serum and 1% penicillin-streptomycin.  MC3T3-E1 murine immature osteoblast-
like cells (RIKEN Cell Bank, Tokyo, Japan) were cultured in α-Modified Eagle Medium 
supplemented with 10% fetal bovine serum and 1% penicillin-streptomycin.  Murine 
NIH3T3 fibroblasts (CRL-1658, American Type Culture Collection) were grown in 
Dulbecco’s Modified Eagle medium containing 10% newborn calf serum and 1% 
penicillin streptomycin.  All cell types were subcultured every two days using standard 
techniques. 
Calcein-AM was obtained from Molecular Probes (Eugene, OR).  Bovine serum 
albumin (BSA) was purchased from Sigma (St. Louis, MO).  Bovine type I collagen 
(Vitrogen-100) was from Cohesion (Palo Alto, CA).  Fetal bovine and newborn calf sera 
were purchased from Hyclone (Logan, UT).  Human plasma fibronectin, Dulbecco’s 
phosphate-buffered saline (DPBS) and additional cell culture reagents were obtained 
from Invitrogen Life Technologies (Carlsbad, CA).   
Cell Adhesion Assay 
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Cell adhesion to protein-coated surfaces was measured using a centrifugation 
assay that applies controlled detachment forces.  Tissue culture polystyrene 96-well 
plates (Corning 3595) were coated with fibronectin in Dulbecco’s phosphate-buffered 
saline (DPBS) or type I collagen in deionized H2O for 1 hour at room temperature.  The 
protein coating concentrations started at 10 µg/ml in the top row and followed 1:2 serial 
dilutions vertically down the plate with the bottom row serving as negative controls with 
no adsorbed protein.  Conditions were replicated in three separate columns on the same 
microplate.  All wells were then blocked in 1% heat-denatured BSA for 1 hour to prevent 
non-specific cell adhesion.  
Near-confluent HT1080, MC3T3-E1, or NIH3T3 cells growing on 100 mm tissue 
culture plates were rinsed in PBS and incubated in 5 ml of 2 µg/ml calcein-AM, a 
membrane-permeable fluorescent label, in PBS + 2 mM dextrose for 20 minutes at 37ºC.  
Cells were then detached in 0.5% trypsin and 0.53 mM EDTA for 3 minutes and 
resuspended in serum-containing media.  After washing and resuspending in PBS-
dextrose, cells were seeded onto protein-coated substrates (10,000 cells/well) and allowed 
to attach for selected time intervals at 22ºC.  Each well was then carefully aspirated to 
remove floating cells and refilled with fresh PBS-dextrose for an initial fluorescence 
reading to determine the density of cells prior to detachment.  The lid was removed and 
the plate was covered with sealing tape (Nalge Nunc) and centrifuged upside-down at a 
specified speed for 5 minutes on a Beckman Allegra 6 centrifuge (GH 6.8 rotor) to detach 
the cells.  The wells were carefully aspirated with a Finnpipette electronic multi-channel 
pipettor set to the slowest flow rate and refilled with fresh PBS-dextrose for a post-spin 
fluorescence reading to determine the density of remaining adherent cells.  Fluorescence 
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data was obtained from a Perkin Elmer HTS 7000 Plus Bio Assay microwell plate reader 
(485 nm excitation, 535 nm emission).  The post-spin fluorescence data were normalized 
by the pre-spin data to obtain adherent fractions (f) which were plotted against protein 
coating concentration (c) or surface density (measured independently with radiolabeled 
proteins) to determine adhesion profiles.  Adhesion profiles were fitted to the following 
4-parameter sigmoidal curve to obtain estimates for the protein concentration for half-
maximal adhesion (C50) using SigmaPlot (SPSS Science, Chicago, IL): 










+=                                        (1) 
The parameters fsat and b represent the maximum adhesive fraction and the slope of the 
curve at the inflection point, respectively.  The parameter fo represents background cell 
adhesion on the negative control surfaces coated with heat-denatured BSA.  The 
parameter C50 represents an effective inverse adhesive affinity for the surface and was 
used as a measure of adhesion strength to compare different surfaces.  All experiments 
were performed in triplicate in three separate runs. 
Determining the Relative Centrifugal Force Across the Plate 
 The shape of the 96-well plate prevents all wells from being completely in line 
with the plane of rotation.  Therefore the relative centrifugal force imposed on the cells 
varies laterally across the plate according to the following equation: 
222)( xrVF ocellmediumcellC +⋅⋅−= ωρρ    (2) 
in which Fc is the relative centrifugal force, ρcell is the specific density of the cell (~1.07 
g/cm3); ρmedium is the specific density of the medium (~ 1 g/cm3); Vcell is the cell volume 
(~1700 µm3), ro is the radius of rotation (determined by the dimensions of the rotor), and 
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x is the lateral distance from the center of the plate (determined by the column location).  
The maximum percentage of variation in centrifugal force for a given system can then be 












Finchange   (3) 
in which xmax is the maximum lateral distance from the center of the plate (for columns 1 
and 12).  The centrifuge rotor used in these experiments had a rotation radius, ro, of 163 
mm.  The 96-well plate had a maximum lateral distance, xmax, of 5 cm.  Therefore, 
according to  Eq. 3, the maximum percentage of variation in centrifugal force in these 
experiments is ~4.3%, which was considered within the experimental error of the assay.  
However, to avoid biasing the adhesion data, the column numbers were randomized for 
each replicate and each separate run.  As shown in Eq. 3, the rotation radius of the 
centrifuge rotor used in these experiments determines the variation in relative centrifugal 
force across the plate.  If a rotor with a shorter rotation radius, ro, was used for this assay, 
the force variation across the plate might be too large to ignore.  In this case, Eq. 2 should 
be used to calculate the actual centrifugal force imposed on the cells for each column on 
the 96-well plate.  To ensure a relatively uniform force on all cells, the furthermost 
columns can also be eliminated based on the results from Eq. 2. 
Statistics 
C50 values were analyzed by one-way ANOVA using SYSTAT 8.0 (SPSS).  If 
treatment level differences were determined to be significant, pair-wise comparisons 




Cell Adhesion for Multiple Detachment Forces 
To verify that this adhesion assay can distinguish differences in the fraction of 
remaining cells at different detachment forces, HT1080 cells were seeded onto two 
separate fibronectin-coated plates as described in Materials and Methods.  The plates 
were then centrifuged at two different centrifugation speeds for 5 minutes to detach cells:  
500 rpm, and 1000 rpm, which correspond to 45g, and 182g, respectively.  The 
detachment force imposed on the adherent cell layer is proportional to these relative 
centrifugal forces (RCF) according to the following equation: 
                                                RCFVF cellmediumcellD ⋅⋅−= )( ρρ                                      (4) 
in which FD is the detachment force per cell; ρcell is the specific density of the cell 
(1.07 g/cm3); ρmedium is the specific density of the medium (1.00 g/cm3); and Vcell is the 
cell volume (~1700 µm3).  Fig. A.1.a shows characteristic adhesion profiles depicting 
sigmoidal increases in the adherent cell fraction as a function of fibronectin surface 
density.  The sigmoid curve follows the expected relationship for a cell population with a 
normally distributed adhesive capacity.  This profile was curve fit to a sigmoid curve in 
which C50 represents the mean inverse cell adhesion affinity and can be used as a 
measure of adhesion strength.  As shown in Fig. A.1.a, increases in the applied 
detachment force result in rightward shifts in the adhesion profile indicating that higher 
protein concentrations are required for equivalent adhesion levels.  In addition, for a 
given concentration of fibronectin, the fraction of adherent cells decreases with 
increasing centrifugation force, verifying that this centrifugation assay provides well-  
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Figure A.1.  (a) HT1080 cell adhesion to adsorbed fibronectin at 
two levels of detachment force:  45g and 182g (1 hour cell 
adhesion, centrifugation for 5 min.).  (b) Curvefit parameter C50 as 
a function of detachment force (mean ± standard error; three 
separate experiments in triplicate)
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controlled detachment forces that modulate the density of cells remaining on the surface 
after centrifugation.   
A common method of analyzing cell adhesion strength in a centrifugation assay 
involves generating a plot of the adherent cell fraction as a function of detachment force 
(Giacomello, Neumayer, Colombatti, and Perris, 1999;Lotz, Burdsal, Erickson, and 
McClay, 1989;McClay, Wessel, and Marchase, 1981).  This method requires a large 
number of experiments, each performed with a separate plate spun at different 
centrifugation speeds to generate reasonable curve fit parameters for comparison.  The 
central advantage of the centrifugation assay and analysis presented here lies in its ability 
to generate reliable measurements of cell adhesion strength in one experiment with a 
single detachment force, using the cell adhesion parameter, C50.  As indicated above, this 
parameter is related to cell adhesion strength.  Fig. A.1.b shows decreasing C50 values 
with increasing detachment forces, validating the use of the C50 value as a measure of the 
mean inverse cell adhesion affinity and a reliable indicator of cell adhesion strength.  
Blocking with antibodies against either fibronectin or fibronectin-specific integrin 
receptors completely eliminated all adhesion above background (data not shown), 
demonstrating that this technique specifically evaluates surface-mediated cell adhesion. 
Cell Adhesion at Multiple Cell Seeding Times 
To demonstrate that this adhesion assay can detect the adhesion strengthening 
phenomenon that occurs with increased adhesion time(Gallant et al., 2002), HT1080 cells 
were seeded onto three fibronectin-coated plates and incubated separately for 30 minutes, 
1 hour, and 2 hours.  At the appropriate seeding time, the plate was centrifuged at 250 
rpm (12g) for 5 minutes to detach the cells.  Fig. A.2 shows leftward shifts in the  
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  Tukey Pairwise Comparison 
 C50 (ng/cm2) 1 hour adhesion 2 hour adhesion 
30 min. adhesion 25.1 ± 0.2 p < 0.002 p < 0.0002 
1 hour adhesion 19.6 ± 0.1 - p < 0.001 
2 hour adhesion 13.7 ± 0.2 - - 



























Figure A.2.  HT1080 cell adhesion to adsorbed fibronectin at 
three cell seeding times:  30 minutes, 1 hour, and 2 hours (12g 
centrifugation for 5 min.).  (mean ± standard error; three separate 
experiments in triplicate) 
Table A.1.  C50 values for HT1080 cell adhesion to adsorbed 
fibronectin for 3 minutes, 1 hour, and 2 hours (12g centrifugation for 5 
min.).  (mean ± standard error; three separate experiments in triplicate) 
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adhesion profiles with increasing adhesion time, resulting in decreasing C50 values with 
increased adhesion time.  These leftward shifts indicate higher adhesion at lower 
fibronectin densities, demonstrating increasing cell adhesion strength with increasing 
adhesion time.  Statistical analyses revealed significant differences in adhesion strength, 
as determined by C50 values, between the different cell seeding times (Table A.1).  In 
addition, at any given fibronectin concentration, an increase in the fraction of adherent 
cells is evident with increasing cell adhesion time, verifying that this adhesion assay can 
resolve differences in cell adhesion strength as a result of time-dependent adhesion 
strengthening. 
Cell Adhesion to Different Proteins 
To confirm that this centrifugation assay can screen different adhesion substrates 
in a single experiment, three columns of a 96-well plate were coated with fibronectin and 
three columns were coated with type I collagen.  HT1080 cells were seeded 
simultaneously on both protein layers and incubated for 1 hour.  The plate was then 
centrifuged at 250 rpm (12g) for 5 minutes to detach the cells.  Fig. A.3 shows the 
adhesion profiles for these cells on the two protein-coated surfaces, revealing differences 
in adhesion based on the different receptor-ligand interactions characteristic of these two 
systems.  These results verify that this adhesion assay can resolve differences in cell 
adhesion on multiple adhesion substrates. 
Adhesion of Various Cell Models 
All previous experiments were performed using HT1080 human fibrosarcoma 
cells.  To demonstrate the versatility of this assay, adhesion experiments were also 
performed using two other cell models:  NIH3T3 fibroblasts and MC3T3-E1 immature  
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Figure A.3.  HT1080 cell adhesion to adsorbed fibronectin and 
adsorbed type I collagen (1 hour cell adhesion, 12g centrifugation 
for 5 min.).  (mean ± standard error; three separate experiments in 
triplicate) 
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Figure A.4.  HT1080, NIH3T3, and MC3T3-E1 cell adhesion to 
adsorbed fibronectin (1 hour cell adhesion, 12g centrifugation for 
5 min.).  (mean ± standard error; three separate experiments in 
triplicate) 
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osteoblast-like cells.  All three cell types were seeded onto a single plate coated with 
fibronectin.  The plate was then centrifuged at 250 rpm (12g) for 5 minutes to detach the 
cells.  Fig. A.4 demonstrates unique adhesion profiles for the three cell models, verifying 
that this adhesion assay can screen multiple cell types in one experiment. 
Discussion 
This paper describes a simple protocol for a centrifugation cell adhesion assay 
that applies controlled and steady detachment forces normal to the growth surface and 
quantifies cell density before and after the force application.  The ease and convenience 
of this assay underscores its relevance to the initial design, evaluation, and comparison of  
a variety of surfaces for biomaterials and tissue engineering applications.  It requires 
neither the construction nor characterization of a specific hydrodynamic environment, as 
would be the case with any flow assay, yet provides sensitive and reproducible 
measurements, unlike the commonly used yet uncontrolled wash assay.  Following 
centrifugation, the fraction of adherent cells is plotted as a function of ligand 
concentration to obtain the adhesion profile characteristic of a given cell model and test 
surface.  As demonstrated in the present analysis, curve fitting to a sigmoidal profile 
(adherent fraction vs. ligand density) provides robust measurements of adhesion strength 
that allow for direct comparisons among treatments.  The curve-fit parameter C50 (see Eq. 
1), the concentration of protein required for 50% maximal adhesion, represents a reliable 
measurement of cell adhesion.  This value is less sensitive to variations among separate 
experimental runs than the absolute fluorescence levels and thus is most appropriate for 
statistical comparisons across experiments. 
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 We have verified that this centrifugation assay can apply various detachment 
forces for in vitro studies of adhesion.  For analytical purposes, a cell adhesion assay 
must also provide a simple system in which the environment, the cell model, and the 
substratum surface may be varied in a well-defined manner.  Experiments with different 
adsorbed protein layers and different cell models demonstrate that this centrifugation 
assay is capable of evaluating multiple cell-surface combinations on a single 96-well 
plate.  We have recently used this assay to analyze cell adhesion to biomimetic surfaces 
(Reyes and Garcia, 2002) and substrates of varying surface chemistry (Keselowsky et al., 
2002). Therefore this assay can distinguish differences in adhesion among different types 
of cells and surfaces under various conditions of growth and chemical environment, 
allowing high-throughput screening of various biomaterials surfaces and coatings as well 
as engineered protein and peptide surface layers.  In addition to cell type and surface 
conditions, the time-dependent adhesion strengthening may also be of interest in 
evaluating cell-surface interactions.  Several morphological and biochemical changes, 
including cell spreading, focal adhesion formation, and stress fiber assembly, occur over 
time as cells adhere to the underlying substratum (Burridge and Chrzanowska-Wodnicka, 
1996;Lotz, Burdsal, Erickson, and McClay, 1989).  Adhesion experiments with multiple 
cell seeding times demonstrate that this centrifugation assay can resolve differences in 
adhesion profiles due to time-dependent adhesion strengthening.  However, subsequent 
experiments suggest that the assay loses sensitivity for longer adhesion times (>2 hrs).  
This limitation most likely results from the centrifuge’s inability to generate a high 
enough detachment force to isolate an accurate adhesion profile for cells that have been 
seeded for extended periods of time. 
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 In summary, this centrifugation adhesion assay proves a flexible tool for 
quantitatively examining the adhesive properties of cells seeded on various substrates 
under controlled detachment conditions.  The adhesion profiles generated from this assay 
allow the efficient comparison of multiple biomaterial surface treatments and protein 
coatings relevant to cell culture applications as well as biomaterial surface modifications 
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CATHERINE DIANE REYES 
 
Catherine was born in Washington D.C. on July 28, 1978, to William and Ursula 
Reyes.  Three months later, Catherine’s family moved to Frankfurt, Germany, where she 
attended preschool and kindergarten.  While learning how to count, fingerpaint, and eat 
liverwurst, Catherine aspired to become a fireman (because of the red hats) or a radio 
host (because she loved hearing herself on tape).  The arrival of a baby brother was only a 
brief obstacle in her round-the-clock red hat/microphone training. 
Her career aspirations shifted, however, when the family relocated to Bangkok, 
Thailand, where she attended the International School of Bangkok.  Selected to 
participate in a program inexplicably called Reading Radish, which involved surprisingly 
little reading and much coloring, drawing, and painting, she discovered her calling as an 
artist.  She produced many significant works during this period, including “The 
Wonderful World of OZ” and “Still Life with Pumpkins.”   
However, the winds of fate would once again shift with another move, this time to 
sunny Miami, Florida, just in time for Catherine to start the fourth grade at Holy Rosary 
Catholic School.  Her wildly creative artistic spirit was soundly squashed by the 
inexorable presence of green plaid and nothing but green plaid, as far as the eye could 
see.  Surrounded by what were surely living fossils dressed up as nuns, Catherine became 
obsessed with paleontology.  Dinosaurs were her passion.  She would become a 
paleontologist and travel to exotic lands in search of the next –asaurus and possibly find 
treasure and fame and Indiana Jones along the way.   
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In the fifth grade, she had a brief bite from the drama bug when she was chosen to 
portray the pivotal role of Girl #3 in a play about a witch with a blue nose.  While her 
practiced elocution was admittedly pitch-perfect, her aversion to general attention 
doomed her acting career early on. 
Her introduction to the public school system began in the seventh grade, when she 
transferred to Southwood Middle School.  In a desperate effort to avoid any sort of 
physical education class, Catherine signed up for Creative Writing.  In a rather 
transparent attempt to increase the extremely unpopular class’s enrollment the next year, 
Ms. Levin proclaimed Catherine the next great American writer, the likes of (and I’m not 
kidding here, she actually said this) Leo Tolstoy or Michael Crichton.  It worked.  
Catherine took Creative Writing all three years of Middle School (successfully avoiding 
P.E.).  She would be a writer, a great American one, the likes of… well, you know. 
With a growing body of sappy poetry and eerie yet brilliant short stories, 
Catherine began the tenth grade at Miami Palmetto Senior High School, secure in her 
intentions to join the upper ranks of the literati.  However, Palmetto High offered no 
writing class whatsoever.  It did, however, mandate the dreaded physical education.  
Catherine confronted P.E. head-on, running the mile in a respectable fourteen minutes 
and fifty-nine seconds (although, she is quite sure she skipped the final lap), coming in 
second to last in her class.  Clearly, athletics were not for her. 
She did, however, demonstrate an aptitude for physics (even though she was 
never really sure what “physics” meant) and later chemistry (which involve lots of letters 
and arrows… fun!).  Teachers were impressed.  Especially since it seemed that scientific 
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aptitude usually resided on the Y chromosome, explaining their propensity to add the 
incredulous phrase “and she’s a girl” to every bit of praise.  
She moved to Boston in 1996, in what was, climatically speaking, the worst 
decision she has ever made, to attend the Massachusetts Institute of Technology.  
Freshman year was rocky.  Luckily, due to an odd pass/fail system, freshman year no 
longer exists.  So we’ll move to the sophomore year, when she discovered a passion for 
anthropology, became one of four people to frequent the literature department, and 
resigned herself to an engineering major.  Catherine graduated in 2000 with an S.B. in 
Materials Science and Engineering, otherwise know as the science of “stuff.” 
Fate called that Spring and, oddly, Fate had a Puerto Rican accent.  Catherine 
began graduate school at Georgia Tech, made lots of cool friends, learned all kinds of 
fascinating things, met and married a cute, amazing, sweet, wonderful boy, adopted a 
stripey gray cat with an attitude and an addiction to cuddlies and a blonde, silly, pink-
nosed, crazy puppy with a cowlick, visisted many incredible places, had tons of 
adventures, and lived happily ever after. 
